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Riassunto 
 
Il termine “proteomica” è utilizzato per indicare la procedura di identificazione 
di un elevato numero di proteine in miscele molto complesse provenienti da organelli 
cellulari o, addirittura, interi microrganismi. I moderni studi sul proteoma possono 
essere divisi essenzialmente in due settori principali: la proteomica di espressione 
che è rivolta alla definizione qualitativa e quantitativa dei livelli di espressione delle 
proteine, e la proteomica funzionale il cui obiettivo è quello di definire il ruolo delle 
proteine nella cellula e descrivere le vie di trasduzione del segnale. E’ noto che nelle 
cellule molti processi sono governati non solo dall’abbondanza relativa delle proteine 
ma anche da regolazioni transienti dell’attività, dell’associazione e localizzazione di 
proteine e complessi proteici. Queste proprietà sono sottilmente controllate da una 
serie di modifiche post-traduzionali eventualmente reversibili (1).  
Una delle più importanti modifiche è senza dubbio la fosforilazione, che 
influenza l’attività delle proteine e i punti critici di numerosi processi cellulari.  
La fosforilazione si comporta come “interruttore” molecolare o modulatore 
dell’attività e della localizzazione delle proteine e regola l’assemblaggio e la 
dissociazione di complessi macromolecolari. Per capire come funzionino questi 
meccanismi è necessario identificare la proteina coinvolta in un particolare processo 
cellulare e lo specifico residuo amminoacidico modificato. Questa informazione non 
può essere determinata dalla sequenza del gene (2). Infatti, dal codice genetico è 
possibile risalire alla sequenza primaria di una proteina ma non è possibile stabilire e 
capire il tipo di modifica a cui sarà sottoposta e in quale momento della vita cellulare 
verrà modificata e/o quale amminoacido verrà coinvolto nella modifica. 
Tuttavia, la rilevazione della fosforilazione incontra varie difficoltà: la presenza 
in una proteina di più possibili siti di fosforilazione determina una particolare 
eterogeneità molecolare, a causa della differente specificità delle chinasi, (3). 
Un’ulteriore difficoltà è dovuta al fatto che la fosforilazione è sub-stechiometrica 
poiché solo una parte della popolazione molecolare di proteina substrato viene 
modificata in un particolare momento della vita cellulare, in seguito ad un segnale 
assai spesso transiente. 
Il metodo più comune per l'analisi di fosfoproteine comporta l'uso di traccianti 
radioattivi in vivo e/o in vitro. Un approccio alternativo, meno sensibile, consiste 
nell’uso di coloranti fluorescenti. Il Pro-Q Diamond, appartiene a questa classe di 
reattivi, che permettono di rivelare selettivamente le fosfoproteine separate mediante 
elettroforesi SDS-PAGE. Altri approcci si basano sull’ arricchimento preliminare delle 
fosfoproteine, utilizzando anticorpi specifici come nel caso delle proteine con residui 
di fosfotirosina; altri ancora sfruttano la capacità del gruppo fosfato di coordinarsi a 
metalli come il gallio o ferro (IMAC) (4). Tuttavia questa strategia presenta lo 
svantaggio di avere specificità variabile a causa dell’affinità dei cationi per i gruppi 
acidi, carichi negativamente(5). Una più fine identificazione dei siti di fosforilazione è 
in genere condotta attraverso frazionamento HPLC (high pressure liquid 
cromatografy) delle miscele peptidiche seguito dall’analisi mediante spettrometria di 
massa tandem delle singole frazioni (6). Utilizzando sistemi cromatografici 
nanoHPLC e spettrometri di massa “ibridi” è possibile raggiungere una maggiore 
sensibilità rispetto alle strumentazioni classiche. 
Un progetto inteso alla caratterizzazione dell’insieme di proteine che sono 
modificate in vivo mediante fosforilazione è alla base della comprensione dei 
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meccanismi con cui le proteine sono attivate o inibite all'interno della cascata della 
trasduzione del segnale (fosfoproteoma).  
La prima parte del lavoro di tesi è stata rivolta all’elaborazione di una strategia 
che ha reso possibile l’identificazione e l’analisi quantitativa di proteine fosforilate in 
corrispondenza dei residui di P-Ser e P-Thr. La messa a punto di questa strategia ha 
previsto l’utilizzo di una proteina modello fosforilata in serina: l’alfa caseina. I peptidi 
O-fosforilati sono stati sottoposti ad una reazione di beta eliminazione del gruppo 
fosfato, ottimizzando le condizioni già riportate in letteratura. I residui di 
deidroalanina, ΔSer, e acido deidro-ammino 2,butirrico, ΔThr sono stati modificati per 
addizione di una delle due funzionalità tioliche del ditiotreitolo (DTT) sul gruppo 
vinilico generato. 
L’introduzione di un gruppo tiolico in corrispondenza del sito iniziale di 
fosforilazione ha permesso, mediante un passaggio di purificazione con una resina 
attivata a gruppi tiolici, l’isolamento selettivo dei soli peptidi fosforilati. Questi ultimi 
sono stati identificati mediante spettrometria di massa MALDI ed ESI. La 
spettrometria di massa tandem ha permesso di ottenere le informazioni necessarie 
sulla sequenza dei peptidi e l’esatta localizzazione del sito di fosforilazione. Il 
problema dell’analisi quantitativa è stato affrontato utilizzando l’approccio dei reattivi 
della classe di tipo ICAT (7). L’analisi quantitativa relativa è stata realizzata 
utilizzando uno standard interno ottenuto mediante l’uso del reattivo, il DTT, 
completamente deuterato. L’analisi quantitativa dei peptidi è stata condotta 
misurando le intensità relative delle coppie di peptidi, ottenuti per analisi MALDI/MS e 
LC-ESI/MS, aventi la stessa sequenza, ma marcati con le forme leggere e pesanti 
del reattivo, e quindi dotati di un peso molecolare differente di 6 Da in base al 
numero di atomi di deuterio presenti nel reattivo utilizzato. Per verificare la 
potenzialità di questa strategia nel determinare la quantità relativa di proteine 
fosforilate presenti in due differenti stati cellulari sono stati preparati campioni 
contenenti concentrazioni delle due proteine derivatizzate con DTT (D0) e DTT (D6), 
in rapporti molari pari a 1:1, 2:1, 4:1. I dati ottenuti dall’analisi di massa hanno 
confermato l’applicabilità di questa strategia per questo tipo di analisi (8). 
Nella seconda parte del lavoro di tesi sono state ottimizzate le condizioni sperimentali 
per il protocollo di arricchimento di fosfopeptidi in miscele complesse mediante ion 
metal affinity cromatography (IMAC). Inoltre sono stati messi a punto i parametri di 
acquisizione per analisi selettiva di fosfopeptidi mediante tecniche di spettrometria di 
massa (precursor ion scan, neutral loss and multiple reaction monitorino MRM). Per 
mettere a punto la strategia e verificarne l’ efficienza è stata utilizzata una proteina 
modello, l’α-caseina. Lo ione Fe(III) è stato scelto per effettuare la cromatografia 
IMAC. Il risultato di questo tipo di cromatografia è influenzato da vari fattori quali lo 
ione metallico, il gruppo chelante, le condizioni di legame e di lavaggio nonché quelle 
di eluizione. Per questo motivo, il primo passo è stato la scelta del gruppo chelante lo 
ione metallico più appropriato. L’ α-caseina idrolizzata con tripsina è stata sottoposta 
alla cromatografia di affinità utilizzando sia la resina NTA che IDA aventi 
rispettivamente come gruppo chelante l’acido nitrilo-triacetico e l’acido immino-
diacetico. Questa analisi è stata ripetuta più volte e i ritenuti provenienti dalle due 
cromatografie sono stati sottoposti all’analisi mediante spettrometria di massa 
MALDI. La resina IDA è stata scelta sulla base della maggiore presenza di specie 
fosforilate rispetto a quelle non fosforilate negli spettri MALDI. A questo punto 
prendendo come punto di partenza le condizioni riportate in letteratura sono state 
apportate delle modifiche che hanno permesso di isolare tutti i peptidi fosforilati 
dell’α-caseina. Inoltre è stato possibile riscontrare negli spettri la presenza di alcuni 
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peptidi non fosforilati ricchi di residui amminoacidici acidi. Infatti, questo tipo di 
strategia possiede la capacità di interagire preferenzialmente con la carica negativa 
del gruppo fosfato, ma presenta lo svantaggio di avere specificità variabile per i 
gruppi acidi, carichi negativamente Per ovviare a questo inconveniente è stata 
effettuata una reazione di esterificazione dei gruppi carbossilici delle miscele 
peptidiche, come proposto da Ficarro et. al (9), prima di sottoporle al passaggio di 
arricchimento. L’analisi MALDI-MS delle miscele peptidiche esterificate e arricchite 
ha sottolineato la presenza di tutti i peptidi fosforilati dell’alfa caseina, incluso il 
peptide penta fosforilato ed un decremento di peptidi aspecifici. È stato riscontrato, 
inoltre, che la reazione di esterificazione è solo parziale, generando eterogeneità 
molecolare. Questo fattore diminuisce la sensibilità nella rivelazione dei peptidi 
fosforilati. Per questo motivo, per minimizzare la presenza di peptidi contenenti 
residui acidi durante la cromatografia IMAC il pH della soluzione contenente 
campione è stato portato a 2.5. A questo valore di pH, i gruppi carbossilici presenti 
nella proteina sono protonati mentre il gruppo fosfato, è deprotonato in base ai 
differenti valori del pka dei gruppi carbossilici rispetto a quello dell’acido fosforico 
(pka1 1,8). Per verificare la validità di questa strategia per l’isolamento di specie 
fosforilate in miscele complesse, l’α-caseina è stata introdotta in un campione di 
siero. Quest’ultimo rappresenta un campione molto complesso le cui proteine più 
abbondanti sono l’albumina, le immunoglobuline di classe G, la trasferrina etc. 
L’analisi MALDI ha permesso di confermare la presenza delle specie fosforilate già 
precedentemente attribuite e una contemporanea diminuzione di peptidi aspecifici. 
Le miscele peptidiche arricchite di peptidi fosforilati sono state utilizzate per 
ottimizzare i parametri di acquisizione delle scansioni di precursor ion di neutral loss 
e di MRM. Infatti, utilizzando uno spettrometro di massa ibrido a trappola ionica 
lineare è stato possibile effettuare questo tipo di scansioni. Ad esempio, nel caso 
della precursor ion scan è stato possibile rivelare selettivamente i peptidi fosforilati, 
sfruttando la loro peculiare caratteristica di generare un particolare frammento a -79 
m/z, dovuto alla perdita del gruppo fosfato. La strategia messa a punto è stata 
utilizzata per identificare i peptidi liberi presenti in fluidi biologici come il siero, la 
saliva e le urine. Lo studio di questi peptidi e la caratterizzazione del loro stato di 
modifica post tradizionale sta diventando sempre più interessante a causa 
dell’informazione che possono fornire in merito ad alcune patologie. Essi possono 
rappresentare dei potenziali biomarker per diagnosticare numerose malattie (10). 
Questo studio ha permesso di identificare 13 diversi peptidi fosforilati liberi e 7 
differenti siti di fosforilazione. 
L’ultima parte di questo lavoro è stata impegnata nello sviluppo di una 
procedura di marcatura chimica selettiva di residui di fosfoSer/Thr con cloruro di 
dansile (5-dimetilammino-1-naftalene sulfonico cloruro) usata in combinazione a 
tecniche avanzate di spettrometria di massa (MS3).  
L’agente derivatizzante, dansil cloruro, è comunemente usato nell’analisi di 
proteine possedendo elevata reattività nei confronti di gruppi amminici primari e 
secondari. La sua capacità di fluorescenza consente di aumentare il limite di 
rivelabilità degli analiti derivatizzati. Fin dal 1968, sono state notate caratteristiche 
frammentazioni dei dansil-derivati, capaci di produrre ioni frammento a 170 m/z e 
234 m/z (11). Queste frammentazioni possono essere sfruttate per l’analisi selettiva 
di modifiche post tradizionali. In particolare, possono essere utilizzati come ioni 
reporter in scansioni del tipo precursor ion scan. Nel laboratorio dove ho svolto il mio 
lavoro di dottorato sono state studiate le caratteristiche frammentazioni di dansil 
derivati in strumenti a trappola ionica lineare. In questi studi e stato notato che lo ione 
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frammento a 234 m/z, a seguito di un ulteriore evento di frammentazione (MS3), è in 
grado di generare lo ione frammento a 170 m/z. In questo modo i dansil-peptidi 
possono essere rivelati selettivamente utilizzando analisi di tipo precursor ion scan, 
grazie al caratteristico ione frammento a 170 m/z. Un’ulteriore selezione degli ioni 
può essere realizzata sfruttando un’analisi MS3 dello ione 234 m/z. Il protocollo è 
stato messo a punto su una miscela peptidica di α-caseina idrolizzata con tripsina. 
La strategia ha previsto la reazione di beta eliminazione dei gruppi fosfato dei residui 
di p-Ser e p-Thr e successiva derivatizzazione mediante addizione di Michael di N-
(2-mercaptoetil) dansilamide (DANSH). Quest’ultima non disponibile 
commercialmente è stata sintetizzata a partire dal cloruro di dansile e dalla 2,2’-
ditiobis(etilammina). La miscela di peptidi è stata analizzata mediante LC-MSMS. In 
questo caso l’utilizzo dell’analisi MS3 ha consentito di ridurre notevolmente la 
complessità della miscela peptidica. In particolare sono state rilevate due specie 
associate ai peptidi monofosforilati dell’α-caseina (12). 
In conclusione, nel corso del dottorato sono state elaborate tre differenti 
strategie di analisi integrate a tecniche avanzate di spettrometria di massa. Queste 
tecniche hanno permesso di studiare la fosforilazione e affrontare le diverse 
problematiche connesse a questo tipo di modifica post-traduzionale. È chiaro, che 
queste strategie possono trovare un’ampia applicazione in ambito proteomico, nella 
caratterizzazione dello stato di fosforilazione di vari sistemi biologici per la 
comprensione dei meccanismi molecolari alla base della vita cellulare; in ambito 
farmaceutico, nell’identificazione  di nuovi biomarker per la diagnosi e la prognosi di 
numerose malattie.  
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Summary 
 
The proteome is defined as the set of all expressed proteins in a cell, tissue or 
organism. Proteome analysis presents specialized analytical problems in two major 
areas: i) dynamic expression range, expression proteomics, which aims to measure 
up- and down-regulation of protein levels and (ii) diversity of protein expression 
(multiple protein forms), functional proteomics, aimed at the characterisation of 
cellular compartments, multi-protein complexes and signalling pathways. 
One of the descriptors of a protein, which is amenable to proteomics 
technology, is the delineation of post-translational modifications (PTMs). The most 
important and abundant PTM that is used to modulate protein activity and propagate 
signals within cellular pathways and networks is the phosphorylation. 
There are many classical techniques designed to determine whether a protein 
is phosphorylated.  
This PhD thesis focuses on the development of new proteomic approaches 
based on classical biochemical methods coupled to new mass spectrometry methods 
to study the phosphorylation. These phosphoproteome studies aim at comprehensive 
analysing protein phosphorylation by identification of the phosphoproteins, exact 
localization of the residues that are phosphorylated, and preferably quantification of 
the phosphorylation. 
Due to low stoichiometry, heterogeneity and low abundance, enrichment of 
phosphopeptides is an important step of this analysis.  
The first section is focused on the development of new enrichment methods 
coupled to mass spectrometry. Thus, improved approach, based on simple chemical 
manipulations and mass spectrometric procedures, for the selective analysis of 
phosphoserine and phosphothreonine in protein mixtures, following conversion of the 
peptide phosphate moiety into DTT derivatives, is described. However the major aim 
of this work is devoted to the use of isotopically labelled DTT thus allowing a simple 
and direct quantitative MS analysis. 
The second part aims to the optimization of the IMAC (Ion, Metal, Affinity, 
Chromatography) protocol coupled to iterative mass spectrometry based scanning 
techniques (neutral loss, precursor ion, multiple reactions monitoring) to improve 
detection of phosphorylated peptides. 
A final part of the work is focused on the development of a strategy to study 
phosphorylation without preliminary enrichment but using the high performance of a 
novel hybrid mass spectrometer Linear Ion Trap.  
To prove their wide enforceability these methodologies were set up applied 
first on a model phosphoprotein, bovine α-casein, and then applied to different 
biological systems. 
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I. Introduction 
 
I.1 Proteomics Revolution 
 
 Proteomics — the analysis of genomic complements of proteins — has burst 
onto the scientific scene with stunning rapidity over the past few years, perhaps 
befitting a discipline that can enjoy the virtually instantaneous conversion of a 
genome sequence to a set of predicted proteins. 
 In fact, for almost two decades, major efforts have been directed at the 
polynucleotide level and, particularly, at the gene sequencing of a variety of different 
organisms. 
 Complete genome sequencing has been achieved for a wide variety of 
organisms, and efforts to sequence the complete human genome have resulted in 
completion of a first draft. Complete genomes for a steadily increasing number of 
organisms are now available 
(http://www.ncbi.nlm.nih.gov/Entrez/Genome/main_genomes.html). 
 While it is often conceptualized that one gene produces one protein, it is 
known that the expressed products of a single gene in reality represent a protein 
population that can contain large amounts of microheterogeneity. More than 100 
modification types are recorded and additional ones are yet to be discovered (1). All 
modified forms from one protein can vary in abundance, activity or location inside a 
cell. Indeed, cellular proteins are not invariant products of genes, but are subject to a 
high degree of interdependent processing at the protein level that is a critical 
component of cellular function and regulation. Clearly, post-translational modification 
of proteins is an event with dramatic effects on the complexity of the proteome. In 
addition, ability of a proteome is its capacity to regulate dynamically protein 
expression in response to external and internal perturbations under developmental, 
physiological, pathological, pharmacological and aging conditions. In fact, in contrast 
to the static genome, where all information could in principle be obtained from the 
DNA of a single cell, the proteome is dynamic and highly dependent not only on the 
type of cell, but also on the state of the cell. This means that genome sequencing will 
not be able to define all of the actors (proteins) in the forms in which they actually 
exist in cells.  
 Proteome analysis presents specialized analytical problems in two major 
areas: i) dynamic expression range, expression proteomics, which aims to 
measure up- and down-regulation of protein levels (2) and (ii) diversity of protein 
expression (multiple protein forms), functional proteomics, aimed at the 
characterisation of cellular compartments, multi-protein complexes and signalling 
pathways (3). 
 The dynamic range problem can be overcome by either increased separation 
power or pre-fractionation to enrich for lower abundance proteins (4). 
Overcoming the diversity of protein expression is more involved and represents a 
significant challenge for proteome (5).  
 It is becoming increasingly clear that the field of functional proteomics is to 
monitor and analyze the spatial and temporal properties of the molecular networks 
and fluxes involved in living cells and to identify the molecular species that participate 
in such networks via functional stimulation, perturbation, or isolation of these 
networks. 
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I.2 Proteomics methods: qualitative and quantitative proteome 
analysis 
 
I.2.1 The first Generation Technology 
 
 The complexity of a proteome can far exceed the capacity of analytical 
systems. The whole proteome of any organism, in fact is too complicated to be 
analyzed in a simple one-step process and direct attempts for the entire proteome 
analysis normally lead to limited amount of information (6). 
 Classical proteomic approaches have relied upon separating whole cell 
lysates by 2D Gel Electrophoresis (2D-GE). Historically, 2D-GE has been the tool of 
choice to resolve complex protein mixtures and to detect differences in protein 
expression patterns between normal and diseased tissue. 
 High-resolution gel electrophoresis, of which 2D-GE is currently the most 
powerful protein separation method, was already used as an analytical tool in the late 
70s (7). The 2D-GE consists in the separation of proteins by isoelectric point in one 
dimension and molecular weight in the second dimension. Despite these outstanding 
properties and widespread application, the systematic use of 2D-GE became an 
integral part of the proteomics 20 years ago. The protein spots were elettroblotted on 
the membrane and analyzed by Edman degradation to release N-terminal sequence. 
In fact, the Edman-based approach was generally slow because every protein spot or 
peptide peak had to be sequenced individually. In addition this identification method 
had low sensibility and there was not complete database of genome. Furthermore, 
proteins are often blocked at their N-terminal (acetylation, formylation or pyroglutamic 
formation).  
 2D-GE remained the highest resolution protein separation method available, 
but the ability to identify the observed proteins was always an extremely difficult 
problem. Although improvements in 2D gel technology had been realized since its 
introduction, three enabling technological advances have provided the basis for the 
foundation of the field of proteomics. The first advance was the introduction of large-
scale nucleotide sequencing of both expressed sequence tags (ESTs) and, more 
recently, genomic DNA. The second was the development of mass spectrometers 
able to ionize and mass-analyze biological molecules and, more recently, the wide-
spread introduction of mass spectrometers capable of data-dependent selection for 
fragmentation (MS/MS) (i.e., without the need for user intervention). The third was 
the development of computer algorithms able to match uninterpreted (or partially 
interpreted) MS/MS spectra with translations of the nucleotide sequence databases, 
thereby tying the first two technological advances together. Thus MS played a key 
role in the passage of 2-DE/image analysis to proteomics. In fact nowadays, mass 
spectrometry is considered as base technology for protein identification from 2D gels 
(8). However, mass spectrometric identification, although quite sensitive, is limited by 
the ability to reproducibly observe distinct spots on the 2-D gel electrophoresis. 
 Well-known drawbacks of the technique are limitations in the pI and molecular 
weight of proteins. In fact, specific classes of proteins have long been known to be 
excluded or under-represented in 2D gel patterns. These include very acidic or basic 
proteins, excessively large or small proteins and membrane proteins. Furthermore, 
difficult automation and reproducibility problems and low abundant proteins are either 
not detected at all due to the limited sensitivity achievable with commonly used dyes, 
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or they are masked by higher abundant comigrating proteins. Incremental 
improvements in 2DE technology, including more sensitive staining methods (10-11), 
large-format higher resolving gels (12) and sample fractionation prior to 2DE have 
alleviated, but not eliminated, these and other shortcomings of the 2DE/MS 
approach. 
To address the problem of quantification, global protein expression analysis or 
quantitative proteomics has historically been carried out using 2D gels. The 
comparative 2D gel approach is typically employed to identify proteins that are up- or 
down-regulated in a disease state. In such studies, a reliable analysis of quantitative 
changes of protein spots is important (9). Furthermore, recently new programs for 
comparison of 2D-maps like algorithms based on characteristics of spot image on gel 
(PDQuest, Phoretix 2D and Melanie); or algorithms based on direct comparison of 
images by distribution of intensity (Z3 and MIR) are rising. 
 
I.2.2 Protein Identification by mass spectrometry 
 
 To measure the mass of molecules, the test material must be charged (hence 
ionized) and desolvated (dry). The two most successful mechanisms for ionization of 
peptides and proteins are matrix-assisted laser desorption ionization (MALDI) and 
electrospray ionization (ESI). In MALDI the analyte of interest is embedded in a 
matrix that is dried and then volatilized in a vacuum under ultraviolet laser irradiation 
(13-14). Typically, the mass analyzer coupled with MALDI is a time-of-flight (TOF) 
mass analyzer that simply measures the elapsed time from acceleration of the 
charged (ionized) molecules through a field-free drift region. The other common 
ionization source is ESI, in which the analyte is sprayed from a fine needle at high 
voltage toward the inlet of the mass spectrometer at a lower voltage. The spray is 
typically either from a reversed phase HPLC (RP-HPLC) column or a nanospray 
device that is similar to a microinjection needle. During this process, the droplets 
containing analyte are dried and gain charge (ionize). The ions formed during this 
process are directed into the mass analyzer, which could be either a triple-
quadrupole, an ion trap, a Fourier-transform ion cyclotron resonance (FT-ICR), or a 
hybrid quadrupole TOF (Qq-TOF) type (15-16-8) (Fig.1). 
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Figure 1. Mass spectrometers used in proteome research. The left and right upper panels 
depict the ionization and sample introduction process in electrospray ionization (ESI) and 
matrix-assisted laser desorption/ionization (MALDI). The different instrumental configurations 
(a–f) are shown with their typical ion source. a, In reflector time-of-flight (TOF) instruments, the 
ions are accelerated to high kinetic energy and are separated along a flight tube as a result of 
their different velocities. The ions are turned around in a reflector, which compensates for 
slight differences in kinetic energy, and then impinge on a detector that amplifies and counts 
arriving ions. b, The TOF-TOF instrument incorporates a collision cell between two TOF 
sections. Ions of one mass-to-charge ( m/ z) ratio are selected in the first TOF section, 
fragmented in the collision cell, and the masses of the fragments are separated in the second 
TOF section. c, Quadrupole mass spectrometers select by time-varying electric fields between 
four rods, which permit a stable trajectory only for ions of a particular desired m/ z. Again, ions 
of a particular m/z are selected in a first section (Q1), fragmented in a collision cell (q2), and the 
fragments separated in Q3. In the linear ion trap, ions are captured in a quadruple section, 
depicted by the red dot in Q3. They are then excited via resonant electric field and the 
fragments are scanned out, creating the tandem mass spectrum. d, The quadrupole TOF 
instrument combines the front part of a triple quadruple instrument with a reflector TOF 
section for measuring the mass of the ions. e, The (three-dimensional) ion trap captures the 
ions as in the case of the linear ion trap, fragments ions of a particular m/ z, and then scans out 
the fragments to generate the tandem mass spectrum. f, The FT-MS instrument also traps the 
ions, but does so with the help of strong magnetic fields. The figure shows the combination of 
FT-MS with the linear ion trap for efficient isolation, fragmentation and fragment detection in 
the FT-MS section. 
 
 Two mass spectrometric methods for rapid identification of proteins are now in 
widespread use. One of these methods uses the characteristic distribution of peptide 
masses obtained by chemical or enzymatic fragmentation of proteins (17). A number 
of computer programs are available for using the observed peptide masses to search 
gene sequence databases for proteins that fit the mass fingerprint (18-19-20-21). The 
other method makes use of sequence tags (22-23); i.e., partial amino acid sequence 
information. Searching of gene sequence databases is again used to identify the 
protein at the gene level.  
 Indeed, the typical proteomics experiment consists of six stages. In stage 1, 
the proteins to be analyzed are isolated from cell lysate or tissues by biochemical 
fractionation, 2D-GE separation or affinity selection. Therefore, proteins are 
degraded enzymatically to peptides in stage 2, usually by trypsin, leading to peptides 
with C-terminally protonated amino acids, providing an advantage in subsequent MS 
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analysis. In stage 3, proteins are identified by matching a list of experimental peptide 
masses (obtained generally by MALDI-MS) with the calculated list of all peptide 
masses of each entry in a database. Mass fingerprint method works well for isolated 
proteins, but the resulting protein identifications are not sufficiently specific for protein 
mixtures (e.g. for comigrating proteins). 
 The addition of sequencing capability to the MALDI method should make 
protein identifications more specific than those obtained by simple peptide-mass 
mapping. In stage 4, the peptide mixtures are separated by one or more steps of 
high-pressure liquid chromatography. In stage 5, a mass spectrum of the peptides 
eluting at this time point is taken (MS spectrum). The program generates a list of 
these peptides for fragmentation and a series of tandem mass spectrometric 
experiments (stage 6). MS-MS data consist in the isolation of a given peptide ion, 
fragmentation by energetic collision with gas, recording of the tandem or MS-MS 
spectrum and storing for matching against protein sequence databases. The 
outcome of the experiment is the identity of the peptides and therefore the proteins 
making up the purified protein population. Often MS-MS instruments are classified in 
one of two categories: tandem in space or tandem in time. Tandem in space 
instruments require a distinct analyser for each stage (isolation and fragmentation) of 
MS-MS. Today, almost all tandem in space MS-MS instruments are either triple 
quadrupole (QqQ) or hybrid instruments quadrupole/time-of-flight (Q/TOF). Trapping 
instruments are typically tandem in time. The various stages of MS-MS are 
performed in the same analyzer but separated in time.  
 
Peptide Sequencing 
 
 In MS-MS experiments the isolated ions (termed parent ions) are induced to 
undergo a reaction that increases the internal energy of the ions, leading to 
dissociation. The ions resulting from the various reactions (product ions) are 
analyzed in the second stage of MS-MS. The scheme of a tandem MS experiment 
can be summarized in reaction in which mp+ is the parent ion, md+ is the product or 
fragment ion and mn the neutral fragment or another product ion if the parent ion is 
multiply charged: 
 
mp+ → md+ + mn 
 
 A crucial aspect of the MS-MS experiment is the reaction that occurs between 
the two MS stages. By far the most frequent reaction is unimolecolar dissociation, 
which is generally enhanced by some form of ion activation. The ion activation is 
necessary to increase the internal energy of the parent ion so that it will dissociate 
before analysis by MS2. In practice, the activation cannot be separated from the 
dissociation, so the ion activation techniques are typically referred to as dissociation 
methods. The dissociation method almost universally used is collision-induced 
dissociation (CID) (24). In CID, the parent ion collides with a neutral target (collision) 
gas and some of the kinetic energy of the parent ion can be converted to internal 
energy. High energy CID spectra (keV) tend to be dominated by fragment ions 
formed by charge-remote mechanism (25), while low energy CID spectra (< 100 eV) 
often show intense fragment ions formed by abundant neutral losses. The CID 
spectra of peptides recorded at low collision energy tend to show abundant fragment 
ions formed by cleavage of the peptide bonds, while high-energy CID spectra often 
contain fragment ions formed by other backbone and also side-chain cleavages (26). 
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 In mass spectrometric sequencing, the information that describes the amino 
acid sequence of a peptide is contained in a product ion spectrum. This product ion 
spectrum is obtained in a tandem mass spectrometry experiment by using collision 
induced dissociation of a protonated or multiply protonated peptide ion. 
Understanding the structure of protonated peptides and their fragmentation pathways 
plays key roles in one’s ability to interpret ion spectra.  
 Peptide sequence identification by mass spectrometry involves fragmentation 
of a peptide to produce smaller m/z fragments; ideally, measured m/z values of these 
pieces can be assembled to produce the original sequence. Cleavage is commonly 
accepted to occur predominantly through charge-directed pathways. The mobile 
proton model (29) is a general description of the need to transfer a proton or protons 
intramolecularly to cleavage sites throughout the peptide. Considering, for example, 
a doubly protonated tryptic peptide, one proton will be localized on C-terminal Arg or 
Lys side chain and the second may be localized at one of the amide bonds or the N-
terminal. In a collision process this second proton can be mobilized, giving a 
heterogeneous population of ions in which the second proton may reside at any one 
of the peptide bonds (mobile proton model). These transfers are facilitated by the 
proton affinity of heteroatoms. This interaction of the charge and heteroatoms is more 
important in the gas phase because the solvent molecules that typically stabilize the 
molecules in the solution phase are absent in the gas phase so internal groups in the 
molecule serve the role of “solvent” (28). Protonation of an amide nitrogen will 
weaken the amide bond and lead to cleavage, generating fragment ions. As result of 
the heterogeneous population of the precursor ion, a series of peptides bonds are 
cleaved, giving complementary series. A nomenclature (26) exists that is used to 
describe the fragment ion types that are produced by cleavage of different bonds 
along the peptide backbone and/or side chain. Cleavage of the backbone typically 
occurs at the peptide bond to produce b ions, if the amino terminal fragment retains 
the charge, or y ions, if the carboxy-terminal fragment retains the charge (fig. 2). In 
the case of multiply charged ions, a charge separation can occur to produce 
complementary ion pairs. Both partners of the complementary pair are not always 
detected in equal abundance, because they are not equally stable against further 
fragmentation or because instrument discrimination may enhance or diminish one 
partner of the pair. Although b and y ions are considered to be the most useful 
sequence ion types, because they correspond to cleavage of the amide bond, other 
ion types are observed and used in spectral interpretation. These include a ions 
which correspond formally to loss of CO from b ion; a Δm= 28 Da between two peaks 
suggests an a-b ion pair and is useful in identifying the ion series to which the peaks 
belong. The y series is sometimes accompanied by satellite peaks formally 
corresponding to NH3 loss from the y ions, allowing designation of y ion series. Ions 
that correspond to immonium ions, or fragments of immonium ions, of individual 
amino acid residues in a peptide are often detected, even for residues from the 
internal portion of the sequence (29).  
 
  12 
 
 
Figure 2. Schematic representation of nomenclature for fragmentation of peptide ions. 
 
I.2.3 The 2nd Generation Technology 
 
 While 2D-GE still can be considered the most widely used separation 
technique prior to MS analysis, liquid chromatographic and, to a lesser extent, 
capillary electrophoresis separations are increasingly used in so-called "gel-free 
approaches". For this set-up, all proteins present in the sample are usually 
hydrolysed to obtain a very complex mixture that is then subjected to further 
separation steps. 
 It is worth considering that a single-dimension peptide chromatography does 
not provide sufficient peak capacity to separate peptide mixtures as complex as 
those generated by the proteolysis of protein mixtures of, for example, total cell 
lysates. To provide more peak capacity, various combinations of peptide separation 
schemes have been exploited. Most popular at present are two-dimensional (strong 
cation exchange/reversed phase) (30-31-32) or three-dimensional (strong cation 
exchange/affinity/reversed phase) (33) chromatographic separations of peptide 
mixtures generated by tryptic digestion of protein samples. 
 This strategy, takes advantage of the higher separation efficiency of 
chromatographic techniques at the peptide rather than the protein level. 
 In both MALDI- and ESI-MS, the relationship between the amount of analyte 
present and measured signal intensity is complex and partially understood. Mass 
spectrometers are therefore inherently poor quantitative devices.  
 Various and different approach for quantitative protein profiling have been 
proposed. The proven technique of stable-isotope dilution makes use of pairs of 
chemically identical analytes having different stable-isotope composition that can be 
differentiated in a mass spectrometer owing to their mass difference. The ratio of 
intensities of the peptide peaks in a given mass spectrum give a relative ratio of 
abundance of the two species. The labelling protocols can be broadly classified into 
two groups based on the method of incorporation of the quantitative tag: biological 
incorporation, where labelling of the peptide/protein is achieved by growing cells in 
media enriched in stable isotope-containing anabolites, and chemical incorporation, 
which relies on the use of a derivatization reagent for chemical modification of 
proteins in a site-specific manner after harvest of the proteins. The biological 
incorporation made use of 15N-labeling in bacteria and yeast. Furthermore, the use of 
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the serine protease catalyzed attack of 18O water in the digestion step originally used 
for the de novo sequencing of peptides (68-69) has also been applied to quantitative 
proteomics (70-71). More recently, Ong and coworkers (33) have developed a 
uniquely powerful method using stable isotope-containing amino acids in mammalian 
cell culture (SILAC). The use of 13C substituted amino acids like 13Carginine with 
SILAC affords some additional advantages for quantitative analyses with liquid 
chromatography mass spectrometry. 
 Chemical incorporation methods, called tagging (or labelling) strategies, 
targeted towards specific amino acid residues (cysteine, histidine and methionine) or 
N- or C-terminal peptides. This enables the enrichment of subfractions via affinity 
clean-up, resulting in the identification of an ever increasing number of proteins (35). 
A typical approach based on the isotope stable affinity tagging and MS is isotope 
coded affinity tag (ICAT). The reagent consist of a cysteine reactive group, a linker 
that contains either a heavy or light isotope and a biotin affinity tag (Fig.3).  
 
 
Figure 3. ICAT structure. 
 
 The affinity tag is attached, by chemical modification, to cysteine, allowing the 
sample to be purified by affinity chromatography (in this case, biotin-avidin 
chromatography). If a relatively rare amino acid, like, e.g. cysteine, is chosen as a 
target, only a relatively small fraction of peptides will be targeted, resulting in a 
significant reduction of sample complexity due to the affinity separation concept. The 
light and heavy reagents, chemically identical but mass differentiate stable isotope 
tags, are used to label the cysteine residues from proteins of two different sources. 
The labelled proteins are then combined and digested with trypsin. Cysteine-
containing peptides are isolated using avidin affinity chromatography and 
subsequently identified, and quantified by MS. Each from one sample represent a 
quantitative standard for a chemically identical analyte from the other sample. The 
ratio of protein between the two states can then be determined by the measured 
peak ratio between the derivatized sample by two different form of ICAT reagent.  
iTRAQ reagent technology is a newly developed method by Applied 
Biosystems for relative quantification of proteins that place isobaric mass labels at 
the N termini and lysine side chains of peptides in a digest mixture. The reagents are 
differentially isotopically labelled such that all derivatized peptides are isobaric and 
chromatographically indistinguishable, but yield signature or reporter ions following 
MS2 that can be used to identify and quantify individual members of the multiplex set. 
The complete molecule consists of a reporter group (based on N-methylpiperazine), 
a mass balance group (carbonyl), and a peptide-reactive group (NHS ester). The 
overall mass of reporter and balance components of the molecule are kept constant 
using differential isotopic enrichment with 13C, 15N, and 18O atoms (Fig.4). The 
reporter group ranges in mass from m/z 114.1 to 117.1, while the balance group 
ranges in mass from 28 to 31 Da, such that the combined mass remains constant 
(145.1 Da) for each of the four reagents. The labelled peptide are identical in mass 
and, therefore, also identical in single MS mode. In MS-MS mode low mass reporter 
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ion signals allow quantitation, while peptide fragment ion signals allow protein 
identification (36). 
 
 
Figure 4. iTRAQ structure. 
 
I.3 Functional proteomics: the crucial role of the phosphorylation 
 
 One of the descriptors of a protein, which is amenable to proteomics 
technology, is the delineation of post-translational modifications (PTMs). The 
delineation of a protein’s function solely from a change in its abundance provides a 
limited view since numerous vital activities of proteins are modulated by PMTs that 
may not be reflected by changes in a protein abundance. 
 Protein phosphorylation is one of the most important and abundant PTM used 
to modulate protein activity and propagate signals within cellular pathways and 
networks (39). A primary role of phosphorylation is to act as a switch, to turn “on” or 
“off” a protein activity or a cellular pathway in reversible manner. This modification 
adjusts folding and function of proteins, e.g., enzymatic activities or substrate 
specificities, and regulating protein localization, complex formation and degradation. 
Cellular processes ranging from cell cycle progression, differentiation, development, 
peptide hormone response, metabolic maintenance and adaptation are all regulated 
by protein phosphorylation. The variety of functions in which phosphoproteins are 
involved necessitates a huge diversity of phosphorylations. Several amino acids can 
be phosphorylated by the four known types of phosphorylation. Serine, threonine and 
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tyrosine residues but also unusual amino acids such as hydroxy-proline can be O-
phosphorylated. N-, S- and acyl- phosphorylation are far less spread and occur 
mostly on histidine and lysine (N-phosphates), cysteine (S-phosphates) and aspartic 
and glutamic acid residues (acyl-phosphates). The O-phosphorylations are stable 
under acidic conditions, whereas N-phosphorylations are stable under alkaline 
conditions. Acyl-phosphates are very reactive molecules and are labile in acid as well 
as in alkali. Phosphocysteine shows a moderate stability under acidic and alkali 
conditions (40). 
 Moreover, protein phosphorylation is generally present at substoichiometric 
level in the cell (41). In fact, whereas some residues are always quantitatively 
phosphorylated, others may only be transiently modified (42).  
 Protein phosphorylation is tightly regulated by a complex set of kinases and 
phosphatases the enzyme responsible for protein phosphorylation and 
dephosphorylayion (43-44). It has been estimated that as many as one–third of the 
proteins within a given eukaryotic proteome undergoes reversible phosphorylation 
and there are more than 100000 estimated phosphorylation sites in the human 
proteome (45). The cooperation of kinases and phosphatases is highly dynamic, 
intensely regulated and phosphorylation cycle may take place on a very shot 
timescale. In addition to the problems concerning regulation, the analysis is 
complicated by the complexity of phosphorylation patterns: in many cases, the 
effects of phosphorylation are combinatorial and multiple sites are phosphorylated . 
 Thus, the highlighting of phosphoproteome is a huge and challenging task with 
regard to the dynamics and different kinds of phosphorylation generating a variety of 
phosphoproteins that are not accessible to a single analytical method. 
 
I.4 Phosphoproteome Tools 
 
I.4.1. Initial efforts 
 
 Although two-dimensional polyacrylamide gel electrophoresis (2D-GE) has 
been used primarily for the separation and quantification of the relative abundance of 
proteins from different systems, methods are also being developed to characterize 
the phosphoproteome. One classic approach for characterizing protein 
phosphorylation relies on (32P)-labeling, followed by two-dimensional gel 
electrophoresis (46-47). Typically gel spots of interest containing phosphorylated 
proteins are excised, digested, and analyzed by Edman sequencing or mass 
spectrometry.  
 A major advantage of this technique relies in the detection of both N-,S- and 
O- phosphorylation. The signals can be absolutely quantified. Introduction of 
radioactive phosphate-group can be done in vivo or in vitro. The latter is carried out 
by incubating, for an appropriate time, the protein with a chosen kinase and (γ-32P)-
ATP. Major drawbacks of in vitro labelling techniques relies in side reactions leading 
to some unspecific phosphorylations due to very high reagent concentrations and 
reaction conditions. Introduction of radioactive phosphate group in vivo is achieved 
by application of (γ-32P)-ATP to the tissue, cell ect. However, artificial 
phosphorylations can occur because of the cellular stress induced by the 
incorporated radioactivity for instance causing DNA damage and thus activating DNA 
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repair system or promoting apoptosis. Furthermore, constitutively phosphorylated 
proteins with low phosphate turn over rate incorporate only very small amount of 
radioactivity and may thereby escape detection.  
 The quantitative problem is approached by comparing difference in relative 
abundance of phosphoproteins, 32P-labeled, visualized by autoradiography 
measuring relative intensities of the spot on the gel (48). Nevertheless, the 32P 
labelling is not the method of choice for high-throughput proteome-wide analysis 
because of issues with handling radioactive compounds and the associated 
contamination of analytical instrumentation. 
 As an alternative approach, commercially available phospho-stains are used. 
They are less sensitive than radioactive methods but the handling of these “inactive” 
reagents is more convenient so far. As an example, Pro-Q Diamond, (Molecular 
Probes) a fluorescent dye, allows to detect 1-20 ng of phosphoprotein in 
polyacrylamide gel, depending on the phosphorylation state of the protein. For 
individual phosphoproteins, the strength of the signal correlates with the number of 
phosphate groups. Depending on the staining principle, this method is mostly specific 
for Ser/Thr- phosphorylations.  
 Antibodies can be used to discriminate among serine, threonine and tyrosine 
phosphorylation. The specifity and sensitivity of immunostaining are strongly 
dependent on the respective antibodies. Various phosphotyrosine antibodies of good 
specifity are available and only little cross-reactivity is observed (50). To measure 
changes in protein phosphorylation state, two distinct proteome sample can be run 
and immunoblotted and the intensity of spot can be compared. 
 Over the years, several strategies have been developed that increase the 
sensitivity of phosphoproteome analysis and eliminate the need for radioactive and 
antibody labelling. MS-based methods have been developed that provide more 
effective tools to identify, and potentially quantify, specific sites of phosphorylation. 
 
I.4.2. Mass spectrometry and phosphorylation on the rise 
 
 Recently, mass spectrometry based methods have emerged as powerful and 
preferred tools for the analysis of post-translational modifications including 
phosphorylation due to higher sensitivity, selectively, and speed than most 
biochemical technique (53-54). 
 Once a protein has been isolated, several technique can be used to identify 
and localize the modified amino acids. In some case, the precise measurement by 
mass spectrometry of the molecular weight of the intact protein, can address the 
average number of the modified residues just by looking at the increment of the 
protein mass compared with the unmodified one. However, the exact location and 
nature of the modifying group cannot be achieved just by mass spectrometric 
measurement of the intact protein. As an example a shift of 80-Da can be interpreted 
as arising by the addition of a phosphate group or may be due to Gly→His exchange 
generated by a point mutation. 
 To better characterize the phosphorylated residues of the protein it is 
necessary to analyze the peptide generated by enzymatic (usually trypsin) or 
chemical degradation of the protein. 
 Phosphopeptides may be identified simply by examination of the list of 
observed peptide masses for mass increases of 80 Da compared with the list of 
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expected peptide masses. Any ambiguities can be resolved by sequencing the 
peptide using tandem mass spectrometry (MS/MS) (52-53).  
 Although this method is relatively straightforward, it also misses many 
phosphorylated peptides because (51) peptide maps are frequently incomplete, even 
for non-phosphorylated proteins (some tryptic peptides are poorly ionized or poorly 
recovered (53)), the increased acidity of the phosphate group generally results in 
decreased ionization efficient of peptide (54), and competition for ionization peptides 
in a mixture results in suppression of signal for some peptide (54). To confirm, the 
identity of a phosphopeptide, a simple phosphatase reaction will cause a downward 
shift in mass of multiples 80 Da for each phosphopeptide. Furthermore, removing 
phosphate group could enhance the relative intensity of these peptides (67).  
 A mass spectrometry based approach to phosphopeptide analysis (55-56) is 
especially powerful when used in conjunction with electrospray ionization (ES) (63). 
Combined with on-line liquid chromatography, ESI-MS has formed the basis for 
several novel techniques for identifying phosphopeptides. In this last case, the ion 
suppression phenomena is reduced by separation of the peptides prior to ionization. 
This method has added benefit of concentrating dilute samples and removing salt 
that interferes with the ionization process. 
 Phosphopeptide detection by peptide mapping preceding and following 
enzymatic dephosphorylation circumvents the poor ionization efficiency of 
phosphopeptides. Larsen et al. have reported enzymatic dephosphorylation of 
complex peptide mixtures directly on a matrix assisted laser desorption ionization 
(MALDI) target (58).  
 Moreover, phosphopeptides have characteristic fragmentation patterns. In 
fact, PSD is a process where specific ions, called metastable, decompose in the flight 
tube because they are not sufficiently stable. In the case of serine and threonine 
phosphorylated peptides, the most common fragmentations are due to the loss of 
H3PO4, more abundant, and HPO3. These fragments don’t appear in the spectrum at 
the exact masses because they are not properly focused by mirror. 
 However, despite the advances in mass spectrometry for the phosphorylation 
analysis, some difficulties still remain. First, the generally low phosphorylation 
stoichiometry of most of the proteins such that phosphopeptides are essentially 
present in low amount in the generated complex peptide mixtures. Second, the 
increased hydrophilicity and hence reduced retention of phosphopeptides on 
reversed-phase materials. Finally, the selective suppression of their 
ionization/detection efficiencies in the presence of large amounts of 
unphosphorylated peptides during mass spectrometry analysis in positive mode. 
 
I.4.3. Enrichment of phosphoproteins and phosphopeptides  
 
 Separation technologies such as affinity, liquid reverse phase, ion exchange 
chromatographies and capillary electrophoresis prior to MS analysis have been 
gradual used in proteomics to enrich phosphoproteins that may otherwise be lost in 
detection. The enrichment step combined with the high sensitivity of MS technologies 
provides great potential for phosphoproteome characterization.  
 Enrichment at level of phosphoproteins and/or phosphopeptide becomes 
increasingly important when dealing with complex mixture. 
 Specific antibodies can be used to enrich phosphoproteins by 
immunoprecipitation (66) from complex lysates. In this case, the extraction of the 
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phosphoproteins led to the substantial simplification of the protein pattern and the 
enrichment of the low abundant phosphoproteins. 
 Recently, the use of miniaturized immobilized metal affinity chromatography 
(IMAC), in which phosphopeptides are bound noncovalently to resins that chelate Fe 
(III) or other trivalent metals, followed by base elution, has proved to be a potentially 
valuable method in phosphopeptide enrichment. 21–31. With further refinement, this 
technique may offer the best performance for large-scale phosphorylation analysis. 
(59).  
 Further several methods for selective enrichment of phosphoproteins and 
phosphopeptides use chemical modification of the phosphate group (64). This 
approach does not distinguish between O-glycosylated and phosphorylated analytes, 
therefore, requiring additional experiments to confirm phosphorylation. Zhou et al. 
(65) established a multi-step derivatization method that is capable of enriching not 
only Ser/Thr-phosphorylated but all types of phosphorylated peptides. Phospho-
peptides are bound to a sulfidryl-containing compound via phosphoamidate-bonds 
and can thereby be covalently linked to a solid support with immobilized iodocetyl-
groups. The phosphate-groups are not cleaved off the respective residues, so native 
phosphopeptides are obtained after elution with TFA. A drawback of this method is 
the expensive work that has to be done to block all amino- and carboxy-groups within 
the peptides quantitatively to prevent intramolecular and intermolecular 
condensation. 
 
I.5 Aim of the PhD thesis 
 
 This PhD thesis focuses on the development of new proteomic approaches 
based on classical biochemical methods coupled to new mass spectrometry methods 
to study the protein phosphorylation. Phosphoproteome studies aimed at 
comprehensive analysis of protein phosphorylation are based on a multi-task 
protocol addressing the identification of the phosphoproteins, exact localization of the 
phosphorylation sites, and preferably quantification of the extent of the 
phosphorylation. 
 Due to low stoichiometry, heterogeneity, and low abundance, enrichment of 
phosphopeptides is an important step of this analysis. Thus, a part of this thesis is 
focused on the development of new enrichment methods coupled to mass 
spectrometry.  
 A final part of the work aimed at the development of a strategy to study 
phosphorylation without preliminary enrichment by exploiting the high performances 
of a novel hybrid mass spectrometer, equipped with a Linear Ion Trap. To prove their 
wide enforceability these methodologies were first optimized by using a model 
phosphoprotein, bovine α-casein, and then applied to different biological systems. 
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II. Mapping phosphorylation sites: a new strategy based on 
the use of isotopically labelled DTT and mass 
spectrometry. 
 
II.1 Introduction 
 
The main methods that have been used in order to identify phosphorylation 
sites by MS involve the chemical modification of phosphopeptides. Usually the 
modification requires a β-elimination reaction in an alkaline environment to remove 
the phosphate group from phosphoserine and phosphothreonine, followed by a 
Michael addition reaction with different nucleophiles. The method was first introduced 
by Meyer to sequence phosphopeptides by Edman degradation (1) and since then 
many different nucleophilic agents have been used such as ethanethiol (2-3), 
ethanedithiol (4-5). A different derivatization method suitable for the analysis of 
tyrosine, serine and threonine phosphopeptides requiring several steps has been 
described by Zhou (6).  
New methods that involve modifying phosphoproteins with affinity tags in 
combination with stable isotope incorporation (7-8) have been developed for the 
specific enrichment and quantitation of phosphopeptides (see chapter 1). 
Gygi and co-workers have recently reported (9) an approach for quantitative 
differential analysis that employs isotope coded affinity tags (ICAT).  
Here, an improved approach, based on simple chemical manipulations and 
mass spectrometric procedures (see Scheme 1), for the selective analysis of 
phosphoserine and phosphothreonine in protein mixtures following conversion of the 
peptide phosphate moiety into DTT derivatives is described. The new residues in the 
sequence were shown to be stable and easily identifiable under general conditions 
for tandem mass spectrometric sequencing applicable to the fine localization of the 
exact site of phosphorylation. The suitability of the method with the principle of stable 
isotope coding is also demonstrated. However the major aim of the present work is 
devoted to the use of isotopically labelled DTT thus allowing a simple and direct 
quantitative MS analysis. 
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Scheme1. Strategy to map phosphorylation sites by labelling DTT  
 
II.2 Materials and Methods 
 
TPCK-treated Trypsin, dithiothreitol, barium hydroxide and alfa-cyano-4-
hydroxycinnamic acid were from Sigma-Aldrich (St. Louis, MO, USA). Deuterated 
dithiothreitol was purchased from CEA (Saclay, France). Sepharose thiopyridil resin 
was from Pierce Biotechnology (Rockford, IL, USA). All other reagents and solvents 
were of the highest purity available from Carlo Erba (Milan, Italy). 
 
In situ digestion 
 
Proteins were fractionated by SDS-electrophoresis on 12.5% polyacrylamide 
gels under reducing conditions  
The analysis was performed on the Comassie blue-stained proteins excised 
from gels. The excised spots were washed first with ACN and then with 0.1M 
ammonium bicarbonate. Protein samples were reduced by incubation in 10mM 
dithiothreitol (DTT) for 45 min at 56°C. The cysteines were alkylated by incubation in 
5mM iodoacetamide for 15 min at room temperature in the dark. The gel particles 
were then washed with ammonium bicarbonate and ACN. 
Enzymatic digestion was carried out with trypsin (12.5ng/µl) in 50mM 
ammonium bicarbonate pH 8.5 at 4°C for 4 hours. The buffer solution was then 
removed and a new aliquot of the enzyme/buffer solution was added for 18 hours at 
37°C. A minimum reaction volume, enough for the complete rehydratation of the gel 
was used. Peptides were then extracted washing the gel particles with 20mM 
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ammonium bicarbonate and 0.1% TFA in 50% ACN at room temperature and then 
lyophilised. 
 
Phosphate group modification 
 
β-elimination reactions were carried out by incubating the peptide mixture in 
0.1 M Ba(OH)2, at 37°C, for 90 min under nitrogen. Carbonic dioxide was then added. 
The precipitated barium carbonate was then removed by centrifugation at 13000 
g/min for 5 min. Then DTT, in the light and heavy form, 30% w/v in Hepes buffer 
10mM pH 7.5 was added for 3 hr, at 50°C under nitrogen. 
 
Isolation and enrichment of tagged peptides 
 
After addition reaction the peptide mixtures were treated with activated thiol 
sepharose resin directly in batch. The resin was washed in water twice and then with 
binding buffer, 0.1M Tris-HCl, pH7.5. The peptide mixture was added to the resin and 
washed with the binding buffer. The modified peptides were then extracted by using 
the elution buffer, 20mM DTT in 10mM Tris-HCl, and pH 7.5. 
 
MS analyses 
 
MALDI mass spectra were recorded using an Applied Biosystem Voyager DE-
PRO Instrument operating in reflector mode. A mixture of analyte solution and α-
cyano-hydroxycinnamic acid (10mg/ml in 70% acetonitrile, 0.1% trifluoroacetic acid) 
was applied to the metallic sample plate and dried at room temperature. Mass 
calibration was performed using external peptide standards by Applied Biosistems. 
Raw data were analysed using the computer software provided by the manufacturer 
and reported as monoisotopic masses. MSMS spectra were recorded using an 
Applied Biosystem 4700 Proteomics Analyzer mass spectrometer operating in 
reflector mode.  
Peptide mixture were analysed by LCMS on a single quadrupole ZQ 
electrospray (Waters Micromass) coupled to an HPLC (2690 Alliance purchased by 
Waters) on a Phenomenex 30 mm x 0.46 mm i.d. reverse-phase. Peptide mixture 
were eluted at a flow rate of 0.2 ml/min. with a 5-65% acetonitrile-water gradient in 60 
min. Data were acquired and processed by centroiding an isotopic distribution using 
the Mass-Lynx program (Micromass). 
 
II.3 Results and Discussion 
 
This study reports a novel approach to phosphoprotein mapping based on 
site-specific modification of phosphoseryl/phosphotheonyl residues. The validity of its 
applicability for the identification of the phosphorylation sites in peptides was tested 
by MALDI TOF/TOF mass spectrometer. Here, it is shown that an alternative 
conversion of the P-Ser and P-Thr residues into compounds, which are stable during 
collision induced dissociation, provided easily interpretable product ion spectra. 
To test this procedure under realistic but controlled conditions, it is carried out 
the reactions by using phosphorylated bovine α-casein, a normal protein utilised in 
these studies (10-11-9). The protein samples after separation from SDS 
polyalcrylamide gel were reduced, alkylated and digested in situ with trypsin (see 
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Material and Methods section). The peptide mixtures were then directly analysed by 
MALDI-MS (Table1). The phosphopeptides were identified by their 80 Da mass 
difference compared to the peptides expected from the sequence for the presence of 
the phosphate moiety. As an example, the signal at m/z 1660.6 was assigned to the 
peptide 106-119 within α-casein sequence carrying a phosphate group as reported in 
figure 1. The peptide mixture was submitted to the strategy described above (see 
scheme 1) and each step was monitored via MALDI-MS. Reaction conditions were 
optimised for both the beta elimination and DTT addition reactions. 
 
 
Figure 1. MALDI-MS analysis of the trypsin peptide mixture from α-casein. The insets report the 
amplification of the region of the spectrum showing the phosphorylated peptides. 
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Table 1. MALDI-MS analysis of the peptide mixture of bovine α-casein digested with trypsin. 
 
Experimental MH+ Theoretical MW Peptide Note 
3026.3 3025.4 166-193  
2316.31 2315.13 133-151  
1952.3 1950.94 104-119 1P 
1759.7 1758.93 8-22  
1660.5 1659.8 106-119 1P 
1384.5 1383.73 23-34  
1337.7 1336.6 80-90  
1267.5 1266.69 91-100  
946.3 945.5 35-42  
910.5 909.46 125-132  
875.6 874.55 1-7  
831.3 830.37 84-90  
748.5 747.3 194-199  
615.38 614.32 120-124  
 
II.3.1 β-elimination reaction 
 
Under strong alkaline conditions the phosphate moiety on Ser-P and Thr-P 
undergoes to β-elimination to form dehydroalanine (ΔSer) or dehydroalanine-2-
butyric acid (ΔThr) respectively. In the case of O-glycosylated peptides, the 
corresponding glycopeptides have to be separated by a simple lectin affinity 
chromathography step. The α,β-unsatured residues are potent Michael acceptor, 
which can readily react with a nucleophile (12-13). 
In the present study, the phosphate moieties were removed via barium 
hydroxide ion-mediated β-elimination from pSer and pThr. The barium hydroxide was 
used in place of the previously reported NaOH (14-15) taking in account the higher 
purity of this reagent and the higher reactivity towards the pThr residues. To get read 
of the removal reagent excess we simply made use of solid carbon dioxide. The use 
of this reagent permitted to remove the barium carbonate as a pellet on the bottom of 
a vial after centrifugation. It is north noting that when the pellet of barium carbonate 
was dissolved and analysed by MALDI-MS, no peptide was detected in the mass 
spectrum thus indicating the absence of a sort of aspecific precipitation. On the 
contrary, the mass spectral analysis carried out on the supernatant showed the 
occurrence of a series of signals corresponding to the β-eliminated peptides. As an 
example, the signal at m/z 1854.3 was assigned to the peptide 104-119 within α-
casein occurring 98 Da lower than that expected on the basis of the amino acid 
sequence, thus indicating that the pSer115 was converted in dehydroalanyl after β-
elimination reaction (Fig. 2). 
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Figure 2. MALDI-MS analysis of trypsin peptide mixture from α-casein following β-elimination 
reaction. The boxes report amplifications of the region of the spectrum showing the β-
eliminated peptides. The arrows indicate the disappearance of the phosphorylated peptides 
and the occurrence of the new β-eliminated signals occurring at minus 98Da. 
II.3.2. DTT as a bifunctional reagent 
 
 The β-eliminated peptide mixture was submitted to a Michael-type addition by 
using dithiothreitol (DTT) by following the procedure described (12). The rational 
behind the choice of this reagent is due to its higher solubility and reactivity with 
respect to the already proposed EDT (13-15). In fact EDT has limited solubility in 
aqueous medium, thereby requiring sample cleanup prior LCMS analysis since the 
conversion is carried out in the presence of substantial amount of organic solvent 
(16). The addition reaction results in the creation of a free thiol group in place of what 
was formerly a phosphate moiety. The extent of reaction was monitored via 
MALDIMS thus indicating that yield of the addition reaction thus revealing that the 
amount of DTT-modified peptide was about 70 % (Fig 3), as expected for a typical 
Michael reaction addition (12). A comparison made using EDT showed that even in 
the presence of a very large reagent excess yields were not higher than 30% (data 
not shown). However, the direct mass spectral analysis of a complete peptide 
mixture suffered of suppression phenomena leading to the unappearance of signals 
due to most of the phosphorylated peptides. 
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Figure 3. MALDI-MS analysis of trypsin peptide mixture of the protein after DTT labelling 
reaction. Insets: enlarged region of the spectrum showing the β-eliminated and DTT labelled 
peptides. 
 
II.3.3. Affinity capture of thiolated peptides 
 
 Specific enrichment of thiolated peptides has easily achieved by using a 
sepharose thiopyridil resin. MALDI-MS analysis performed on the peptides eluted 
from the affinity purification step reveals now major mass signals at m/z 1716.9, 
2008.3, 2039.1 and 3001.2. These values were assigned to the β-eliminated 
fragments 106-119, 104-119, 43-58 and 59-79 modified by 1, 1, 2 and 5 DTT adducts 
respectively as indicated in Figure 4.  
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Figure 4. MALDI-MS analysis of DTT labelled peptides following purification step. Each signal 
is attributed to the corresponding modified peptide according to Table 2. 
 
 It is worth nothing that the described procedure resulted in the identification of 
all the phosphorylated tryptic peptides, including the pentaphosphorylated one that 
has escaped in different attempts used (9-10-11). The data are summarised in Table 
2. 
 
Table 2. MALDI-MS analysis of the purified DTT labelled peptides of the triptic digest of the α-
casein. 
 
Experimental MH+ Theoretical MW Peptide Note 
3001.2 2999.9 59-79 5 DTT 
2039.1 2038.68 43-58 2 DTT 
2008.3 2006.94 104-119 1 DTT 
1716.9 1715.8 106-119 1 DTT 
II.3.4. MS/MS analysis 
 
 Sequence information can be obtained either by MALDI-TOF in the PSD mode 
or by MALDI TOF/TOF. The fine localization of the phosphorylation sites in the 
peptides was achieved by MS/MS sequencing. The conversion of P-Ser and P-Thr in 
DTT tagged residues originate compounds that are stable under high-energy 
collisions in the MALDI TOF/TOF instrument. In fact, the tandem mass spectral 
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analyses by MALDITOF/TOF performed on the precursor ion at m/z 2008.5 (Figure 
5) from the tryptic mixture of α-casein after labelling with DTT revealed the presence 
of diagnostic fragment ions.  
 
 
Figure 5. Tandem mass spectrometry identification of α-casein phosphopeptide. The Ser 
residue containing the DTT label is identified by the loss of m/z 223.4 between the y4 and y5 
ions of the modified peptide. 
 
 The derivatized product ions were identified from either the corresponding b or 
y product ion series. The MS-MS spectrum revealed the occurrence of the complete 
series of N-terminal fragment ions b1-b15 plus the C-terminal y1-y16 for the modified 
phosphopeptide with DTT labelled phosphoserine residue. The fragment ions y4 and 
y5, in fact, show a mass difference of 223 Da corresponding to a β-eliminated serine 
residue, labelled with DTT, thus confirming the phosphorylation site at Ser115. 
 
II.3.5 Differential isotope coded analysis 
 
 To address the problem of quantification (9-17-18), having created a thiol 
group at the phosphoserine/phosphothreonine site, it is possible to follow basically 
the strategy outlined by Gygi et al. (9). Because of the fact that we had the availability 
of fully deuterated DTT, we exploited a much simpler isotope tagging strategy. The 
peptides were quantified by measuring, in the mixture, the relative signal intensities 
for pairs of peptide ions of identical sequence differentially labelled with light or heavy 
DTT. The mass difference within the heavy DTT reagent (6 Da) reliably allows a 
good separation between the molecular ions. As an example the mass signals, 
recorded in the MALDI spectrum, at m/z 2008.5 and 2014.5 were attributed to the 
DTT labelled peptide 104-119 modified with the DTT light and heavy form 
respectively. Pairs of peptides tagged with the light and heavy DTT reagents are 
chemically identical and therefore serve as ideal mutual internal standards for 
quantitation. The ratio between the intensities of the lower and upper mass 
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components of these peaks provide an accurate measurement of the relative 
abundance of each peptide and hence of the related proteins in the original cell pool 
because the MS relative intensity of a given peptide is independent of the isotopic 
composition of the defined isotopically tagged reagent.  
 To further illustrate the ability of this labelling strategy in quantifying the 
relative phosphorylation of a peptide from two different samples, DTT and DTT-D6 
were used to label samples containing stoichiometric concentrations of α-casein in 
ratios of 1:1, 2:1 and 4:1. The peptide mixture were analysed by MALDIMS operating 
in reflector mode. The spectra were obtained by acquiring about 2000 shot/spectrum 
in order to produce a “stable” peak. In our experience this is the average number of 
shots to have an even distribution of shots on the entire well surface, thus allowing a 
confident averaging independently of the peptide content of the single crystals. As 
shown for the DTT peptide 104-109 (Figure 6), the ratios automatically integrated for 
each mass spectrum resulting in excellent agreement with the concentration used in 
the labelling experiment (Table 3). 
 
 
Figure 6. Stoichiometric conversion of the phosphorylated states using DTT-D0/D6 labelling via 
MALDI-MS. Partial MALDI-MS spectra of the modified peptide 104-119. Samples of α-casein 
containing ratios of 1:1, 2:1 and 4:1 were labelled with DTT-D0 :DTT-D6, combined, isolated via 
DTT strategy reported in the Scheme 1 and directly analysed via MALDI-MS. 
Table 3. Quantitative analysis by MALDI-MS. 
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Expected 
ratio  
DTT (D0) labelled 
peak area  
DTT (D6) labelled 
peak area  
Observed  
Ratio  
1:  1 29168.1 24306.7 1.2: 1 
2: 1 34318.05 18779.51 1.8: 1 
4: 1 142907.11 36411.46 3.9: 1 
 
 
 
 An aliquot of the same peptide mixture was submitted to a more rigorous 
quantitative analysis via LCMS (Figure 7) as reported in Table 4, demonstrating the 
correctness of the previous MALDI-MS data. 
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Figure 7. Stoichiometric conversion of the phosphorylated states using DTT-D0/D6 labelling via 
ESI-MS. LC-ESMS spectrum of the doubly charged ion of the modified peptide 104-119. 
Samples of α-casein containing ratios of 1:1, 2:1 and 4:1 were labelled with DTT-D0 :DTT-D6, 
combined, isolated via DTT strategy reported in the Scheme 1 and analysed via LC-ESIMS. 
 
 
Table.4 Quantitative analysis by LC-ESI-MS. 
 
Expected 
ratio  
DTT (D0) labelled 
peak area  
DTT (D6) labelled 
peak area  
Observed 
ratio  
1:  1 382829 396550 0.96: 1 
2: 1 1312411 578038 2.27: 1 
4: 1 2134041 505166 4.22: 1 
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II.4 Conclusions 
 
 This study is an integrated simple methodology, which involves chemical 
replacement of the phosphate moieties by affinity tags. This method to locate and 
quantitate phosphorylated residues may result of interest in signalling pathways and 
control mechanisms studies involving phosphorylation or dephosphorylation of 
serine/threonine residues. It is worth considering that such a quantitative approach 
can be extended to the labelling of the O-glycosylation sites. In fact, the O-
glycopeptides retained on a lectin affinity column can be eluted and submitted to the 
procedure described by Wells and coworkers (19). The quantitative analysis can be 
performed by using light and heavy forms of DTT to selective label the modified sites 
thus leading to a quantitative description of O-glycosylation related to different cell 
growth conditions. 
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III. Phosphoproteomics Applications by Improved 
Immobilized Metal Affinity Chromatography and Selective 
tandem mass spectrometry 
 
III.1 History and principle of IMAC 
 
In the last few years, a number of strategies devoted to the separation of 
phosphorylated proteins and peptides from the non-phosphorylated counterparts 
have been exploited. These include phosphoresidue enrichment strategies such as 
affinity purification by metal affinity chromatography (IMAC). 
Firstly introduced by Porath and coworkers in 1975, IMAC was originally 
termed metal chelate affinity chromatography, for use as a group separation method 
(1). IMAC represents an affinity separation method based on the coordination 
between peptides/proteins and metal ions on a solid support (matrix).  
Beginning in the 1990s, IMAC was increasingly employed as a pre-
fractionation tool in the field of proteomic research (2). 
To date, the most popular metal ions used in IMAC are Cu2+, Ni2+, Zn2+, Co3+, 
Fe3+ and Ga3+ (3). Transition ions bound resine-immobilize chelating ligands 
available from several suppliers. Commonly used chelating groups are bidentate (e. 
g. iminodiacetic acid, IDA, and aminohydroxamic acid), tridentate ( e.g. 
dipicolyamine), tetradentate (carboxymethylated aspartic acid and nitrilotriacetic 
acid) or pentadentate (N,N,N’-tris(carboxymethyl)ethylendiamine) chelating ligands 
according to the number of occupied coordination bonds (4). Appropriate 
combination of chelating ligands and metal ions is crucial for selectivity and 
adsorption efficiency of IMAC in separating target fractions, because chelating 
ligands adversely affect protein retention in chromatography (3). 
Chelating compounds are linked by means of spacers with solid supports, 
which hold physicochemical characteristics favourable for IMAC application: specific 
adsorption, good stability, high porosity, high flow rates and no degradation upon 
regeneration. Furthermore, these supports are easy to derive. 
Traditional stationary phases were based on gel matrices, such as agarose or 
crosslinked dextran. Some amino acid residues that have electron-donating side 
chains, especially those containing surface-exposed atoms of N, S, O, have high 
affinities for a series of metal ions. Specifically, exposed histidines are the common 
anchors for the binding of proteins to the column (4). Other residues, such as 
glutamic acid, aspartic acid, and tyrosine, can contribute to the metal binding.  
In addition to the types of chelators and properties of metal ions and proteins, other 
factors in mobile phase, such as pH, ionic strength and buffer composition, affect 
protein-metal binding too.  
The binding of proteins to IMAC can be processed at a given pH in which the 
electron donor groups on the protein surface are unprotonated. The pH value used 
in the binding buffer of IMAC cover a wide range depending on the used metal.  
The target proteins or peptides are eluted from IMAC by changing pH or using 
high concentrations of imidazole (competitive binding), based on the nature of the 
interaction. 
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III.2 Quadrupole scan modes and phosphoproteomics 
 
Owing to its reliability, speed and sensitivity, tandem mass spectrometry has 
become a valuable tool for peptide sequence analysis and PTM characterization. A 
limitation of this approach for phosphopeptide analysis is the large dynamic range 
between the non phosphorylated and phosphorylated peptides. After IMAC 
enrichment, phosphopeptides are separated by nanoflow reversed-phase high-
pressure liquid chromatography (RP-nHPLC) with online nano-electrospray 
ionization for subsequent tandem mass spectrometry (RP-nHPLC/ESI/MS-MS). 
Phosphopeptides undergo characteristic fragmentation pathways when 
subjected to collision-induced dissociation (CID) allowing them to be distinguished 
from non-phosphorylated peptides. In negative ion mode, for example, 
phosphopeptides fragment producing marker ions at m/z 79 (PO3-) and 63 (PO2-). 
These phosphate specific fragment ions serve as characteristic “reporter ions” for 
phosphorylated peptides in several instrumental methods. These diagnostic ions can 
be selectively detected in “precursor-ion scanning” experiments by MS-MS. Triple 
quadrupole mass spectrometers are generally used for this purpose. In this scan 
type Q1 is scanned across mass range and ions are fragmented in collision cell (q2). 
Q3 is set to transmit only the mass of the diagnostic fragment . Therefore only ions 
that are passed through Q1 and produce the diagnostic charged fragment will be 
detected (fig.1).  
 
 
Figure 1. Precursor ion scan experiment. 
 
The phosphopeptide analysis by precursor ion scans present the peculiarity 
that only those peptides that fragment producing the chosen marker ion, m/z 79, 
give rise to peaks in the spectrum, screening out all other species. 
The following sequencing of the corresponding phosphopeptide precursors 
requires a change in polarity and in buffer of the sample in order to obtain good MS-
MS spectra. This interferes with automation of the system. Despite this, the method 
is a powerful tool due to its high sensitivity and selectivity and its applicability for 
analysis of serine, threonine and tyrosine phosphorylated residues.  
A precursor ion scanning method that can be performed in positive mode has 
recently been developed for specific detection of phosphotyrosine-containing 
peptides (5-6). This method is based on the ability to selectively detect the 
immonium ions of phosphotyrosine residues that have an m/z value of 216.04. 
Immonium ions are generated by double fragmentation of the peptide backbone (7). 
CID of phosphoserine and phosphothreonine containing peptides in the 
positive ion mode often yields a neutral loss of H3PO4 via gas phase β-elimination 
reaction (8). Peaks corresponding to this loss (98 Da from singly charged precursor, 
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49 Da from doubly charged precursor, 32.66 from triply charged precursor, etc) are 
often the most abundant ions in the fragmentation spectrum. 
In neutral loss experiment, Q1 is scanned across a specific mass range. Ions pass in 
collision cell where are fragmented. Q3 is scanned over a similar mass range, offset 
by the neutral mass of the diagnostic fragment. Therefore, any molecule passing 
through Q1 and losing a neutral molecule of the defined mass, will then be 
transmitted through Q3 and detected (fig.2). 
 
 
Figure 2. Neutral loss experiment. 
 
Although mass spectrometry-based methods, such as precursor ion and 
neutral loss scans, are extremely useful for identifying unknown phosphopeptides 
from a complex mixture, they do not take advantage of any prior knowledge about 
the protein under investigation. 
Quite often a significant amount of information is available. This may include 
the primary sequence, the type of phosphorylation (serine/threonine vs. tyrosine), or 
predicted phosphorylation sites.  
This information can be used to predict precursor and fragment ion m/z 
values for a multiple reaction monitoring (MRM) experiment. MRM experiments, 
using a triple quadrupole instrument, are designed for obtaining the maximum 
sensitivity for detection of target compounds (8).  
MRM is a highly sensitive function of triple quadrupole mass spectrometers where 
the first quadrupole transmits only an ion of specific m/z (Q1 mass). This ion is then 
fragmented in the second quadrupole. The third quadrupole is set to transmit a 
specific product ion (Q3 mass). Detection of this product is therefore diagnostic with 
multiple “Q1 to Q3 transitions” assayed in a single experiment. Only ions with this 
exact transition will be detected (fig.3).  
Many MRM scans can be looped together in a single experiment to detect the 
presence of many specific ions in a complex mixture. 
 
 
Figure 3. Multiple Reaction Monitoring experiment. 
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III.3 Peptidomics of human body fluids as sources for clinical 
marker  
 
Searching for biomarker (specific proteins or peptides indicating the presents 
of abnormal states) in clinical diagnosis and therapy is one of the efforts in 
proteomics. 
Human body fluids have been rediscovered in the post-genomic era as great source 
of biological markers and perhaps particularly as source of the potential biomarker of 
disease. 
In particular, analysis of peptides in biological fluids holds promise of 
providing diagnostic and prognostic information for cancer and other diseases. 
“Peptidomics” is the field that deals with the comprehensive qualitative and 
quantitative analysis of peptides in biological samples (9). These peptides are either 
intact small molecules, such as hormomes, cytokines, growth factors or peptides 
that are released from larger protein precursors during protein processing. They may 
represent degradation products of proteolytic activity (fig 4).  
Thus, in biological fluids, peptides represent protein synthesis, processing, 
and degradation. Since the amount and repertoire of peptides in the circulation 
change dynamically according to the physiological or pathological state of an 
individual, it is possible that comprehensive peptide analysis (i.e., exploitation of the 
“peptidome”) may lead to the discovery of novel biomarkers or to new diagnostic 
approaches (10). 
With the development of new proteomic based tools to analyze tissue and 
blood samples from cancer patients, recently, many groups have reported the 
identification of biomarkers or biomarker patterns which allow the identification and 
detection of cancer patients (12) Among others, the surface-enhanced laser 
desorption ionization/time-of-flight mass spectrometry (SELDI/TOF-MS) has been 
used to identify differential peptide and protein expression in various biological fluids, 
such as serum, plasma, urine and pancreatic juice (13). 
 
 
Figure 4. Mechanisms of generation of multiple peptides from a protein, used as an example. 
Initially, this fragment is proteolyzed by endoproteases. Subsequently, the original fragment 
and other fragments are further processed by aminopeptidases and carboxypeptidases, as 
shown. At the end, a large family of peptides is generated from the original fragment. 
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III.4 Aim of the project 
 
Here, IMAC strategy has been optimized and coupled to iterative mass 
spectrometry based scanning techniques (neutral loss, precursor ion, multiple 
reactions monitoring) to improve detection of phosphorylated peptides. 
This strategy was implemented and validated by using phosphorylated bovine 
α-casein and then applied to the study of the phosphopeptidomics in biologic fluids 
(serum, saliva, urine etc). In fact, biologic fluid phosphopeptides have recently 
gained increasing interest as potential source of the diagnostic marker for diseases. 
Furthermore, enriched tryptic α-casein phosphopeptides were used to set up the 
best conditions for the MRM scan mode and then used for the selective identification 
of phosphorylation sites of nm23H1, a protein involved in mammalian cancer. 
 
III.5 Materials and Methods 
 
Proteomic grade trypsin, α-casein, dithiothreitol, FeCl3 and alfa-cyano-4-
hydroxycinnamic acid were purchased from Sigma (St. Louis, MO, USA). Chelating 
Sepharose (IDA) (Amersham bioscience). Acetonitrile HPLC ultra gradient was from 
Romil. All used solvents were of the highest purity available from Baker 
(Phillipsburg, NJ). All other reagents and proteins were of the highest purity available 
from Sigma. 
 
Reduction and alkylation of cysteine residues 
 
Protein was reduced in 300mM Tris-HCl, 1.25 mM EDTA, pH 8.5 containing 6 
M guanidinium chloride by incubation with a 10:1 molar excess of dithiothreitol over 
the total -SH groups at 37°C for two hours under nitrogen atmosphere. The free 
cysteine residues were alkylated by using a 5:1 molar excess over the total -SH 
groups of iodoacetamide, at room temperature for 30 min in the dark under nitrogen 
atmosphere. Protein samples were freed from the excess of reagents by gel filtration 
chromatography on PD10 Sephadex G25 column.  
 
Enzymatic hydrolysis 
 
Enzymatic digestion was carried out with trypsin in 50mM ammonium 
bicarbonate pH 8.5 at 37°C for 18 hours using an E/S ratio of 1/50 (w/w). 
 
IMAC Cromatography 
 
A ratio of 10:1 of peptide mixture to resin was used to ensure specific binding 
of phosphospecies. The resin IDA was charged with FeCl3 and stored using the 
recommended procedure. The charged resin was equilibrated with binding solution 
(15 % acetic acid and 60 % Acetonitrile , pH 2.5). The dried peptide mixture was 
suspended with binding solution and incubated with charged resin for three hours at 
room temperature. The washes were performed using washing solution (60 
acetonitrile, 5 % acetic acid) and a final wash by milly Q water. The eluition was 
performed using 2% NH3 in water (pH 12). 
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Acetonitrile precipitation 
 
Pathological serum samples were obtained from “ Servizio Analisi del 
Secondo policlinico di Napoli”. Salivary and urine samples were taken from 2 healthy 
voluntaries with informed consent. 
2 volumes of HPLC ultra gradient Romil were added to 1 volume of fresh biologic 
fluids followed by gentle mixing for 30 min at room temperature. The sample were 
spun for 15 min at 12,000 rpm and the high abundant precipitated proteins were 
removed and the supernatant was concentrated in speed Vac system and 
lyophilized. Supernatat protein concentration was determined using a Bio-Rad 
protein assay according to manufacturer’s instructions.  
 
MALDI mass spectrometry 
 
MALDI-TOF mass spectra were recorded using a Voyager DE-PRO mass 
spectrometer (Applied Biosystem, Framingham, USA) operating in reflector mode. A 
mixture of the peptide solution and α-cyano-hydroxycinnamic acid (10 mg/mL in 70% 
ACN and 10 mM citric acid in water) was applied to the metallic sample plate and 
dried at room temperature. The phosphopeptides mixture were mixed with 2,5-
dihydroxybenzoic acid (25 mg/mL in 50% CAN and 2% phosphoric acid in water) 
and applied on the sample plate. Mass calibration was performed using a mixture of 
peptides from Applied Biosystem, containing des-Arg1-Bradykinin, Angiotensin I, 
Glu1-Fibrinopeptide B, ACTH (1-17), ACTH (18-39) and Insulin (bovine) as external 
standards. Raw data were analysed using Data Explorer software provided by 
Applied Biosystem and reported as monoisotopic masses. 
 
nanoLC Mass Spectrometry 
 
A mixture of peptide solution was analysed by LCMS analysis using a 4000Q-
Trap (Applied Biosystems) coupled to an 1100 nano HPLC system (Agilent 
Technologies). The mixture was loaded on an Agilent reverse-phase pre-column 
cartridge (Zorbax 300 SB-C18, 5x0.3 mm, 5 μm) at 10 μl/min (A solvent 0.1% formic 
acid, loading time 5 min). Peptides were separated on a Agilent reverse-phase 
column (Zorbax 300 SB-C18, 150 mm X 75μm, 3.5 μm), at a flow rate of 0.3 μl/min 
with a 0% to 65% linear gradient in 60 min (A solvent 0.1% formic acid, 2% ACN in 
MQ water; B solvent 0.1% formic acid, 2% MQ water in ACN). Nanospray source 
was used at 2.5 kV with liquid coupling, with a declustering potential of 20 V, using 
an uncoated silica tip from NewObjectives (O.D. 150 µm, I.D. 20 µm, T.D. 10 µm). 
Data were acquired in information-dependent acquisition (IDA) mode, in which a full 
scan mass spectrum was followed by MS/MS of the 5 most abundant ions (2 s 
each). In particular, spectra acquisition of MS-MS analysis was based on a survey 
Enhanced MS Scan.(EMS) from 400 m/z to 1400 m/z at 4000 amu/sec. This scan 
mode was followed by an Enhanced Resolution experiment (ER) for the five most 
intense ions and then MS2 spectra (EPI) were acquired using the best collision 
energy calculated on the bases of m/z values and charge state (rolling collision 
energy) from 100 m/z to 1400 m/z at 4000 amu/sec. Data were acquired and 
processed using Analyst software (Applied Biosystems).  
 
 
Precursor ion scan 
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Spectra acquisition was based on a survey Precursor Ion Scanning. It was 
performed over a mass range of m/z 400-1400 at 333 amu/s ( with Q1 set to low 
resolution and Q3 set to unit resolution) with a nanopray voltage of -2350 V applied 
to a Picotip New Objective (O.D. 150 µm, I.D. 50 µm, T.D. 15 µm) (Woburn,MA). 
Precursors were collided in Q2 with a collision energy ramp of -25 to -65 V across 
the mass range. If a precursor of -79 was detected above a pre-set threshold value 
(2500 cps), the polarity was automatically switched to +2500V (after a 700 ms dwell 
at 0V) with the same gas settings and a positive ion Enhanced Resolution Scan was 
performed at 250amu/s to determine the charge state of the ion. The Information 
dependent acquisition (IDA) software automatically adjusts the mass for the polarity 
switch from negative ion to positive ion, and assigns a more accurate monoisotopic 
mass.  
Enhanced Product Ion (EPI) scans (MS/MS) were performed at 4000 amu/s 
and collision voltages were calculated automatically by rolling collision energy and it 
performed a maximum of one repeat before adding ion to the exclusion list for 60 s. 
Once this duty cycle was completed, the polarity was switched back to negative 
(after a 700 ms dwell at 0V) and the cycle repeated. The entire cycle duration, 
including fill times and processing times was less than 5.3 s. 
 
Neutral loss 
 
Spectra acquisition was based on a survey Neutral loss scanning. It was 
performed over a mass range of m/z 400-1400 at 333 amu/s ( with Q1 set to low 
resolution and Q3 set to unit resolution) with a nanopray voltage of 2500 V applied to 
a Picotip New Objective (O.D. 150 µm, I.D. 50 µm, T.D. 15 µm) (Woburn,MA). Ions 
are passed in Q2 where are fragmented with a collision energy ramp of 20 to 50 V 
across the mass range. Q3 is scanned over a similar mass range, off set by the 49 
Da. Therefore, the two most intense peaks that loss 49 Da are automatically 
selected for an ER and EPI scans with the above conditions.  
 
Multiple reaction monitoring 
 
4000 QTRAP in MRM mode for selective detection of phosphopeptides of α-
casein and nm23H1 was operated (Multiple Reaction Monitoring).  
The MRM transitions of potential α-casein and nm23H1 phosphopeptides were 
calculated by a software script developed by Applied Biosystems. 
The time taken to analyze each MRM transition is termed the “dwell time.” 
These MRM transitions (50 msec dwell time) were used to trigger dependent linear 
ion trap scans: enhanced resolution and enhanced product ion (EPI) scans. The 
total cycle time for this method was 3–5 sec. This data-dependent method is referred 
to as targeted MRM-IDA, for multiple reaction-monitoring information-dependent 
acquisition. 
In general, transitions were included for all tryptic peptides (maximum one 
missed cleavage) containing Ser, Thr, or Tyr residues with either one or two 
modifications and for doubly and triply charged species for the Q1 mass range 400–
1600 m/z. The number of MRM transition is dependent on various factors, including 
protein size, number of peptides following digestion, and the number of potential 
phosphorylation sites. It is, however, important to optimize the cycle time to around 
or below 5 s. Such a cycle time ensures that if the peak width is around 0.5 min it is 
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highly probable that a peptide is scanned for and analyzed at least twice as it is 
eluted and that one of these analyses will occur at, or close to, the apex of its elution 
profile. The software requires an amino acid sequence of the protein of interest, a 
starter method containing the LC conditions and an empty MRM-IDA experiment. 
The software will perform an in-silico digest of the protein and create a set of 
peptides each containing at least one possible site of modification. For each peptide, 
it will generate an MRM transition for the calculated m/z of the precursor ion and an 
appropriate fragment ion. The new method, specific for the protein of interest, is 
saved and submitted as a batch for data acquisition. The Agilent Nanoflow LC 
system and 4000 QTRAP were both controlled using Analyst 1.4.1. 
 
MASCOT analysis 
 
Spectral data were analyzed using Analyst software (version 1.4.1) and MS-
MS centroid peak lists were generated using the MASCOT.dll script (version 1.6b9). 
MS-MS centroid peaks were threshold at 0.1% of the base peak. MS/MS spectra 
were searched against Swiss Prot database using the licensed version of Mascot 
(Matrix Science), after converting the acquired MS-MS spectra in mascot generic file 
format. The Mascot search parameters were: taxonomy human for biological fluids 
and mammalian for α-casein; trypsin as enzyme for α-casein and nm23H1 and none 
for others cases allowing up to 3 missed cleavages, none fixed modifications, 
oxidation of M, pyroGlu N-term Q and phosphorylation of Y, S, T, as variable 
modifications, 0.4 Da MS/MS tolerance and 0.6 Da peptide tolerance. Spectral data 
were manually validated and contained sufficient information to assign not only the 
sequence, but also the site of phosphorylation. This conservative criterion resulted in 
omission of many peptides identified as being phosphorylated but for which spectral 
quality was insufficient to allow further characterization. 
 
III.6 Results and discussion 
 
This work described both the improvements to traditional IMAC and the use of 
a combination of fractionation procedures and complementary mass spectrometry 
based scanning approach to investigate the free phosphopeptides in biological 
fluids. 
The validation of peptide IMAC enrichment of phosphorylated bovine α-casein tryptic 
peptides was achieved by MALDI-MS. Thus, an aliquot of α-casein was used to 
spike human serum prior to start the enrichment/analysis procedure. 
The enriched phosphopeptide mixture was used to find the best conditions for 
the mass spectrometry based scanning techniques (neutral loss, precursor ion, 
multiple reactions monitoring).  
 
III.6.1 Peptide IMAC sample preparation 
 
Peptide IMAC was carried out with some modifications. Initial optimization of 
procedure was performed using tryptic peptides originating from α-casein. 
Commercial α-casein consists of α-casein S1 and α-casein S2 in traces and the 
preparations are usually contaminated with traces of beta-casein. Figure 5 shows 
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the sequence of α-casein. A list of the theoretical tryptic phosphorylated peptides 
derived from α-caseins S1-S2 and their molecular masses, is shown in table1 
 
RPKHPIKHQGLPQEVLNENLLRFFVAPFPEVFGKEKVNELSKDIGSESTEDQAMEDIKQ
MEAESISSSEEIVPNSVEQKHIQKEDVPSERYLGYLEQLLRLKKYKVPQLEIVPNSAEER
LHSMKEGIHAQQKEPMIGVNQELAYFYPELFRQFYQLDAYPSGAWYYVPLGTQYTDAP
SFSDIPNPIGSENSEKTTMPLW 
 
 
KNTMEHVSSSEESIISQETYKQEKNMAINPSKENLCSTFCKEVVRNANEEEYSIGSSSE
ESAEVATEEVKITVDDKHYQKALNEINQFYQKFPQYLQYLYQGPIVLNPWDQVKRNAV
PITPTLNREQLSTSEENSKKTVDMESTEVFTKKTKLTEEEKNRLNFLKKISQRYQKFALP
QYLKTVYQHQKAMKPWIQPKTKVIPYVRYL 
Figure 5. α-casein S1 and S2 sequence.  
 
Table 1. Phosphopeptides of bovine α-casein digested with trypsin. 
 
Protein Sequence Monoisotopic 
mass 
Modifications  Peptide 
 
α-casein s1 DIGSESTEDQAMEDIK 1926.68 2P 43-58 
α-casein s1 QMEAESISSSEEIVPNSVEQK 2719.90 5P 59-79 
α-casein s1 KYKVVPQLEIVPNSAEER 2079.90 1P 103-119 
α-casein s1 YKVPQLEIVPNSAEER 1950.94 1P 104-119 
α-casein s1 VPQLEIVPNSAEER 1659.78 1P 106-119 
α-casein s2 KNTMEHVSSSEESIISQETYK 2617.89 4P 1-21 
α-casein s2 NANEEEYSIGSSSEESAEVATEEVK 3007.72 4P 46-70 
α-casein s2 EQLSTSEENSK 1410.49 2P 126-136 
α-casein s2 TVDMESTEVFTK 1465.60 1P 138-149 
 
Evaluation of the phosphorylated peptide binding selectivity of the IMAC resin 
and the optimization of the binding/washing and eluting conditions was performed by 
comparing the relative intensities of the phosphorylated/non-phosphorylated tryptic 
peptides. 
A number of conditions in this protocol can affect the yield and population of 
the obtained phosphopeptides. The nature of the chelator, the stationary phase and 
the buffer systems are factors potentially important in improving selectivity. Two 
polysaccharide-based matrix were tested: sepharose with imminodiacetic acid (IDA) 
(Amersham bioscience) a tridentate ligand and agarose with nitrilotriacetic acid 
(NTA) (Qiagen) a quadradentate ligand (fig. 6). 
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Figure 6. Structure of IDA and NTA ligands. 
 
These chelating groups were charged with FeCl3 using the recommended 
procedure. 
The effectiveness of the isolation procedure was tested by using an equal 
amount of α-casein peptide mixture under standard conditions. The eluted 
phosphopeptides were analyzed by MALDI-MS to verify the enrichment protocol. 
Then, enriched peptide mixture was mixed in a ratio 1:1 (v/v) with a matrix solution 
of 2,5-DHB with phosphoric acid (see materials and methods section) in order, to 
improve the phosphopeptides ion response in MALDI-MS (17). 
The phosphopeptides were identified by their 80 Da mass difference 
compared to the peptides expected from the sequence for the presence of the 
phosphate moiety. As an example, the signal at m/z 1660.6 was assigned to the 
peptide 104-119 within α-casein sequence carrying a phosphate group as reported 
in figure 7. 
As clearly indicated in figure 7, enrichment procedure performed by using Fe3+-IDA-
agarose (panel A) showed greater selectivity and recovery in binding 
phosphopeptides versus non phosphorylated peptides, compared to Fe3+-NTA-
agarose (panel B) and therefore it was used in all subsequent IMAC experiments. 
 
Figure 7 A MALDI-MS analysis of enriched α-casein by Fe3+-IDA-agarose; B MALDI-MS of 
enriched α-casein by Fe3+-NTA-agarose. In blue are indicated unspecific no phosphorylated 
peptides. 
 
It should be considered that in these conditions the pentaphosphorylated 
peptide occurring within α-casein sequence was not detected. 
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Acidic peptides affect the specificity of peptide IMAC purification. To minimize 
the effect of non specific binding, methyl-esterification of peptide side chains was 
performed on the peptide mixture as suggested by Ficarro et al (37).  
In this method, the C-termini and aspartic and glutamic acid residues of the 
tryptic digest peptides were methylated prior to IMAC in order to preclude the 
previously observed non-specific binding. As shown in figure 8, MALDI-MS analysis 
revealed the presence of S1 α-casein phosphopeptides. It is worth considering that 
in the high mass region of spectrum a signal at m/z 2749.12 was detected. This 
signal was attributed to the peptide 59-79 carrying up to five phosphate moieties. 
Moreover unphosphorylated peptides persisted, possibly due to unspecific binding to 
the resin. 
 
 
 
 
Figure 8. MALDI-MS analysis of enriched methylated α-casein. 
 
However, peptide chemical modification reaction was not quantitative, as 
indicated by the occurrence of the satellite peaks at 14 Da higher than the 
theoretical ones. This effect diluted the sample into populations of modified and 
unmodified peptides. This effectively reduced the amount of any given peptide and 
increased the overall sample complexity. For this reason, methylation was omitted in 
the present study.  
To minimize non specific binding in IMAC step, the pH of sample was 
carefully adjusted to 2.5 value, which resulted in the protonation of the majority of 
glutamic and aspartic acid residues. The pKa1 value of the phosphoric acid is 1.8 
and therefore the phosphate group will still have had a negative charge at pH 2.5. In 
addition, a high-organic (60 % acetonitrile, 15% acetic acid pH 2.5) buffer was used 
to minimize the hydrophobic unspecific interactions with matrix and solubilize 
peptides before loading onto the IMAC resin. The elution was performed by pH 
changing. As eluting buffer a solution of volatile ammonia (pH 12) was chosen thus 
avoiding the presence of salts and other contaminants. 
The feasibility of the developed strategy to detect phosphopeptides in a highly 
complex mixture was probed by adding an aliquot of α-casein to human serum. 
 
 
  48 
 
 
Figure 9. Protein composition of human serum. 
 
Human serum is a complex body fluid that likely contains tens of thousands of 
proteins and peptides as shown in figure 9. Serum contains 60-80 mg/ml of proteins 
in addition to various small molecules including salts, amino acid and sugars. The 
major protein constituents of serum include albumin, immunoglobulins, trasferrin, 
and others. 
After enzymatic digestion, the complexity of mixture was increased of two 
orders magnitude (about 108 peptide). 
As shown in figure 10 and table 2, mass spectral analysis led to a complete 
coverage of S1 α-casein phosphopeptides and partial coverage of S2 
phosphopeptides. Only few signals attributed to non phosphorylated peptides were 
detected thus demonstrating the success of the enrichment strategy. 
 
 
Figure10. MALDI-MS analysis of enriched α-casein mixture in serum sample.  
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Table 2. List of identified α-casein phosphopeptides by MALDI-MS analysis. 
 
Protein Sequence Observed 
 m/z 
Modifications  Peptide 
 
α-casein s1 DIGSESTEDQAMEDIK 1927.79 2P 43-58 
α-casein s1 QMEAESISSSEEIVPNSVEQK 2721.14 5P 59-79 
α-casein s1 KYKVVPQLEIVPNSAEER 2080.18 1P 103-119 
α-casein s1 YKVPQLEIVPNSAEER 1952.06 1P 104-119 
α-casein s1 VPQLEIVPNSAEER 1660.86 1P 106-119 
α-casein s2 NTMEHVSSSEESIISQETYK 2619.09 4P 2-21 
α-casein s2 KNTMEHVSSSEESIISQETYK 2747.20 4P 1-21 
α-casein s2 TVDMESTEVFTKk 1594.76 1P 138-150 
α-casein s2 TVDMESTEVFTK 1466.66 1P 138-149 
 
III.6.2 Unique scanning capabilities using a Q-q-Q linear ion trap (Q 
TRAP) mass spectrometer 
 
Mapping phosphorylation sites within phosphoproteins by MALDI-MS is 
currently the method of choice for identifying phosphorylation sites because of its 
high sensitivity and accuracy. However, MALDI-MS analysis of phosphopeptides is 
challenging due to low ionization efficiency and suppression effects in the MS 
positive mode. Furthermore, the MALDI mapping analysis of the phosphopeptides 
and the identification of the phosphorylation sites is hard task without an a priori 
knowledge of protein sequence thus avoiding an application of phosphoproteomic 
analysis on a large scale. In addition, the presence of several possible 
phosphorylation sites complicates the correct assignment of phosphorylated 
residues. 
Reducing the complexity of peptide mixtures by enriching and separating 
phosphopeptides by liquid chromatography is the common method used in 
phosphoproteomics. Coupling liquid chromatography to hybrid mass spectrometers 
(LC-MS-MS) can overcome above problems leading to both the identification of 
phosphoproteins and the exact location of phosphorylation sites. 
In this work the detection of phosphorylated peptides was improved by 
selectively monitoring phosphopeptides in the mass spectrometer taking advantage 
of scanning capabilities of a new generation of instruments based on linear ion traps. 
The recently developed “linear ion traps” (LIT) offer faster scanning 
procedures and higher ion capacities due to larger trapping volumes together with 
the possibility of being used as third quadrupole in a triple quadrupole instrument. 
Thereby, the benefits of triple quadrupole instruments and ion traps are combined.  
The work described here was carried out on a 4000 Q-Trap (Applied 
Biosystems). Specific mass spectrometry scanning modes, such as neutral loss, 
precursor ion scanning and multiple reaction monitoring (MRM), have been 
implemented to improve the detection of the phosphorylation sites in highly complex 
peptide mixture. Furthermore, the nanospray ESI source combined with capillary 
chromatography system showed performances characterized by higher sensitivity 
and resolution, leading to the detection of samples even present at substoichiometric 
amount as phosphopeptides. 
In order to evaluate the performances of the LIT system and to determine the 
best acquisition conditions for neutral loss, precursor ion scanning and MRM, 
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standard samples of enriched α-casein phosphopeptides were used in preliminary 
experiments. 
 
Precursor ion scan of α-casein 
 
Precursor ion scan can be used to selectively identify phosphorylated 
peptides by detecting the m/z -79 (PO3-) product ions released during MS-MS.  
Briefly, in the precursor survey scan Q1 was set to low resolution and Q3 was 
operated at unit resolution to increase selectivity while keeping sensitivity. This step 
was performed in the negative ion mode. Once the ion of interest was detected in 
the survey scan, the instrument was toggled to positive mode and an Enhanced 
Resolution (ER) scan is performed. This scan was automatically performed at the 
highest resolution available, in order to improve mass accuracy on the 12C isotope 
and consequentially confirm the charge state. The cycle was completed with an EPI 
scan in the positive ion mode to provide fragmentation information for sequence 
tagging and database searching. 
The precursor ion analysis of tryptic α-casein peptides before the affinity 
chromatography identified only monophosphorylated phosphopeptides within S1 α-
casein sequence. 
The enriched α-casein mixture was submitted to the same selective mass 
spectrometry analysis. 
In this case, a large number of phosphorylated peptide ions were detected 
within S1 α-casein and S2 α-casein sequence. Table 3 summarized mass spectra 
results. The known phosphorylation sites confirmed by mass spectral data were 
indicated in yellow; a new phosphorylation site was indicated in red. These data 
emphasised the importance of the enrichment step. 
 
Table 3. Identified α-casein phosphopeptides by precursor ion scan analysis.  
 
Protein Observed 
m/z 
Monoisotopic 
mass 
Sequence Phosphorylatio
n site 
α-casein s1 554.30 1659.79 VPQLEIVPNSAEER S115 
α-casein s1 651.27-976.61 1950.95 YKVPQLEIVPNSAEER S115 
α-casein s1 643.2-963.36 1926.68 DIGSESTEDQAMEDIK S46-S48 
α-casein s2 670.21 2676.83 VNELSKDIGSESTEDQAMEDIK S41-S46-S48 
α-casein s2 733.81 1465.6 TVDMESTEVFTK S143 
 
As an example, figure 11 reports the identification steps of phosphopeptides 
performed on enriched α-casein trypsin digest.  
Panel A shows the survey scan of a signal at 641.2 m/z and at the retention 
time of 30.7 min. The analysis of phosphopeptides was restricted only to those 
species whose fragmentation produces the marker ion at m/z -79 due to the 
presence to the phosphate moiety. The specificity of the precursor scan was clearly 
indicated by the simplicity of the survey MS spectrum. 
Having proved by the precursor ion scan that the peptide at m/z 641.2 was 
phosphorylated, in order to fragment it the following step was to determine the exact 
charge state. The resulting ER scan performed in the positive mode for the same 
peptide was reported in panel B, thus indicating that the corresponding precursor ion 
at m/z 641.2 was a triply charged ion.  
The fine localization of the phosphorylation sites in the peptide was achieved 
by MS-MS sequencing. The corresponding MS2 scan was shown in Figure 11 C. 
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The MS-MS spectrum revealed the occurrence of the complete series of C-terminal 
fragment ions y1-y14 for the modified phosphopeptide carrying out two phosphate 
groups on serine residues. 
No pentaphosphorylated peptide was detected. This was due to the worst 
ionization of this peptide in electrospray positive mode. 
The selectivity of precursor ion scanning for phosphopeptides has been 
reported previously (18-19-20).  
However, there are a few cases where a precursor of 79 signal will be 
generated from non-phosphorylated peptides, most commonly from peptides 
containing cysteic acid and methionine sulphone. Therefore oxidation of both 
cysteine and methionine by performic acid should be avoided, if this PTM discovery 
workflow is to be undertaken.  
 
Figure 11. Precursor ion scan analysis of the diphosphorylated triply charged peptide at m/z 
641.2. 
 
Neutral loss scan of α-casein 
 
The potential of a neutral loss scan was investigated. Though a high degree 
of specificity is achieved by precursor ion scan, the duty cycle of the experiment is 
reduced, mainly due to the switching of polarity. In order to reduce the cycle time, a 
neutral loss in the positive mode of 98, 49 or 32.7 (corresponding to the neutral loss 
of phosphoric acid from 1+, 2+, and 3+ charge states, respectively) was used as an 
alternative for the survey scan. This approach eliminates the overheads associated 
with the switching of instrument polarity and provides a gain of 1.4 seconds in the 
cycle time.  
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A mixture of enriched IMAC α-casein peptides, was submitted to neutral loss 
analysis. The analysis was performed using the neutral loss of 49 as survey scan 
and the enhanced MS (EMS) as comparison.  
The spectra of phosphopeptide 104-119 within α-casein sequence related to 
the survey experiment steps are shown in figure 12. The selectivity of the neutral 
loss experiment is clearly evident. In fact, the corresponding trace shows the 
detection of only one relevant peptide at m/z 976.5, whereas the EMS trace, though 
more sensitive by 1–2 orders of magnitude, is more complex as illustrated in figure 
12A and 12B respectively.  
Traditional ion trap single EMS “survey scans” can be very sensitive, but they 
lack the selectivity required to identify peculiar peptide species in complex matrix.  
Furthermore, the complexity of the EMS spectrum and the relative intensity between 
phosphorylated/non phosphorylated species illustrated the challenge of the 
phosphoproteome analysis by mass spectrometry. However, at the same retention 
time, the neutral loss scan showed only one peak of interest, thus greatly simplifying 
the analysis. 
The loss of isotope information, and therefore charge state assignment, from 
the neutral loss experiment was gained by performing an ER scan for that mass. 
 
 
Figure 12. Comparison between the survey scan of Neutral Loss (A) and Enhanced MS EMS 
survey scan (B) at the retention time of 32.5. The EMS spectrum indicates that the ion of 
interest (m/z 976), though present, was suppressed by other species from the digest mixture 
that are co-eluting. 
 
The specificity of neutral loss scan is due the collision energy to produce the 
phosphoric acid loss from peptide. In a spectrum generated by scanning for neutral 
loss of phosphoric acid the signal-to-noise ratio of phosphopeptides signals depends 
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on the abundance of the fragmentation reaction and on the abundance of interfering 
ion signals.  
The amount of phosphoric acid loss was optimized by a standard 
phosphopeptide (monophosphorylated peptide of α-casein) and by selection of the 
optimal collision offset. With regard to interfering fragment signals, the ideal situation 
for application of neutral loss scanning would be the one in which the loss of 
phosphoric acid is the only or at least the most prominent fragmentation reaction. 
However, since peptides show an increasing tendency to backbone fragmentation 
with increasing charge state, there is a risk that multiply charged non phosphorylated 
peptides may show fragments located at -98/z Da relative to the molecular ion (z, 
number of charges) and thus giving rise to a signal in the neutral loss scan. The 
main reason for this effect is that the low collision offsets required for optimal 
detection of doubly and triply charged phosphopeptides are also optimal for peptide 
backbone fragmentation of multiply charged peptides.  
In this protocol the best value of collision offset for the neutral loss scan was 
ramped from start to 20 Collision Energy Volt and end to 50 Collision Energy Volt to 
minimize side fragmentations. 
This strategy was successful thanks to the detection of very few 
unphosphorylated peptides, it confirmed the identification performed by MALDI-MS 
and added new phosphopeptides of S1 α-casein phosphopeptides, S2 α-casein 
phosphopeptides and the beta casein one, as shown in table 4. 
 
Table 4. Identified α-casein phosphopeptides by neutral loss analysis.  
 
Protein Observed m/z Monoisotopic 
mass 
Sequence Phosphorylation 
site 
α casein S1 830.97 1659.79 VPQLEIVPNSAEER S 115 
α casein S1 976.51 1950.95 YKVPQLEIVPNSAEER S115 
α casein S1 964.36 1926.68 DIGSESTEDQAMEDIK S46-s48 
α casein S1 972.36 1942.68 DIGSESTEDQAM(ox)EDIK S46-s48 
α casein S2 733.86 1465.71 TVDMESTEVFTK S 143 
α casein S2 741.82 1481.63 TVDM(ox)ESTEVFTK S 143 
α casein S2 797.84 1593.67 KTVDMESTEVFTK S 143 
α casein S2 805.87 1609.69 KTVDM(ox)ESTEVFTK S 143 
Beta casein 1031.44 2060.86 FQSEEQQQTEDELQDK S35 
 
MRM Analysis.  
 
This method made use of MRM as a selective trigger for enhanced product 
ion (MS/MS) scans on phosphopeptides.  
MRM requires two ions to generate a positive result, making it very specific with very 
low background, enhancing sensitivity of detection. 
The Q1 mass is calculated for one peptide in doubly/triply charged form with 
up to two phosphate additions. The Q3 mass is calculated as either loss of 98 Da for 
each putative Ser(P) or Thr(P) or generation of y2 or b2 ions.  
This differed significantly from the above mass spectrometric technique 
(neutral loss scan) for identifying phosphopeptides (21). In a neutral loss scan, Q1 
scanned a specified mass range while Q3 scanned the same range, even if it lagged 
behind by a specified m/z (for example 49 m/z is useful for identifying doubly 
charged phosphopeptides). A neutral loss scan attempted to find any compound that 
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will lose a functional group during CID; while an MRM scan looked for a target 
peptide to generate a specific fragment. A common problem in using a neutral loss 
scan to discover phosphopeptides was that many phosphopeptides could generate a 
similar neutral loss, causing the mass spectrometer to waste time identifying a non-
modified peptide. Or worse, a phosphopeptide will not generate the specified neutral 
loss, and therefore will not be detected. A neutral loss scan is limited to the 
investigation of only one predicted fragmentation pathway (e.g., loss of 49 m/z), 
while a targeted MRM approach can investigate several predicted fragmentation 
pathways for the same peptide (loss of 49 m/z from 2+, loss of 32.7 m/z from 3+, 
formation of a b2 ion, etc.) . 
The sensitivity and selectivity of this method were assessed using the model 
phosphoprotein, α-casein. Two ions were monitored: loss of 98 Da and b2 ions. 
These analysis confirmed the previous attributions and also a new phosphorylation 
site within α-casein sequence. These results emphasized the high sensitivity of this 
experiment. 
The results are summarised in tables 5 and 6. 
 
Table. 5 MRM analysis of enriched α-casein peptides by monitoring b2 ions. 
 
Observed Transition Sequence Phosphorylation site 
Q1 830.8/Q3 197.1 VPQLEIVPNSAEER S 115 
Q1 554.3/Q3 197.1 VPQLEIVPNSAEER S 115 
Q1 976.4/Q3 292.1 YKVPQLEIVPNSAEER S 115 
Q1 651.2/Q3 292.1 YKVPQLEIVPNSAEER S 115 
Q1 964.8/Q3 229.1 DIGSESTEDQAMEDIK S46-S48 
Q1 643.8/Q3 229.1 DIGSESTEDQAMEDIK S46-S48 
Q1 648.5/Q3 229.1 DIGSESTEDQAM(ox)EDIK S46-S48 
Q1 972.3/Q3 229.1 DIGSESTEDQAM(ox)EDIK S46-S48 
Q1 866.6/Q3 214.1 VNELSKDIGSESTEDQAMEDIK S46-S48 
Q1 893.3/Q3 214.1 VNELSKDIGSESTEDQAMEDIK S41-S46-S48 
  
Table. 6 MRM analysis of enriched α-casein peptides by monitoring loss of 49 Da ions. 
 
Observed Transition Sequence Phosphorylation site 
Q1 830.8/Q3 781.8 VPQLEIVPNSAEER S 115 
Q1 554.3/Q3 521.5 VPQLEIVPNSAEER S 115 
Q1 976.4/Q3 927.4 YKVPQLEIVPNSAEER S 115 
Q1 651.3/Q3 618.6 YKVPQLEIVPNSAEER S 115 
Q1 964.8/Q3 915.3 DIGSESTEDQAMEDIK S46-S48 
Q1 923.3/Q3 875.3 DIGSESTEDQAMEDIK S48 
Q1 932.3/Q3 883.3 DIGSESTEDQAM(ox)EDIK S48 
Q1 972.3/Q3 923.3 DIGSESTEDQAM(ox)EDIK S46-S48 
Q1 866.6/Q3 834.0 VNELSKDIGSESTEDQAMEDIK S46-S48 
Q1 893.3/Q3 860.6 VNELSKDIGSESTEDQAMEDIK S41-S46-S48 
 
This strategy was applied to the characterization of the phosphorylation state 
of the nm23H1 (fig.13), a protein involved in tumor cell motility (38). The knowledge 
of the primary sequence, the type of phosphorylation on serine and the predicted 
phosphorilation sites allowed to predict precursor and fragment ion m/z values for a 
multiple reaction monitoring (MRM) experiment. 
 
ANCERTFIAIKPDGVQRGLVGEIIKRFEQKGFRLVGLKFMQASEDLLKEHYVDLKDRPF
FAGLVKYMHSGPVVAMVWEGLNVVKTGRVMLGETNPADSKPGTIRGDFCIQVGRNIIH
GSDSVESAEKEIGLWFHPEELVDYTSCAQNWIYE 
Figure 13. nm23-H1 sequence. 
 
  55 
 
The nm23H1 protein samples were reduced, alkylated and digested with 
trypsin (see Material and Methods section). The peptide mixture was then directly 
analysed by MALDI-MS. No phosphopeptide was detected by this analysis. The 
phosphopeptides and the phosphorylation sites were determined by tandem mass 
spectrometry analysis and database searching. The enriched peptide mixture was 
then submitted to LC-MS analysis by using 4000 Q-Trap in MRM mode coupled to a 
nano-HPLC system.  
A MRM experiment was performed. The Analyst software created a method 
with 45 transitions, corresponding to potential peptides phosphorylated on serine 
from nm23H1. Therefore, it became possible to probe for several predicted 
phosphopeptides from a known protein sequence.  
For example, a method using a specific MRM transition was employed to 
detect a phosphopeptide within nm23H1 sequence. In fact, the theoretical 
phosphoserine-containing peptide 115-128 giving rise to a doubly charged ion at m/z 
783.3, will lose a phosphate group (49 m/z) during CID to form a doubly charged 
fragment at m/z 734.3. These two values, Q1 = 783.3 and Q3 = 734.3, will be used 
to specifically detect this phosphopeptide. 
The MS-MS spectrum performed on the precursor ion at m/z 783.3 assigned 
at peptide 115-128 NIIHGSDSVESAEK within nm23H1 sequence, indicated the 
phosphorylation site at Ser122. The same peptide 115-128 at m/z 823.27 doubly 
charged was identified carrying a phosphate group on Ser 122 and Ser 125. This 
information was important to understand the regulator mechanism of nm23H1 during 
tumour development.  
 
Mascot analysis of the phosphopeptides 
 
All fragmentation spectra were interpreted both using Mascot software and de 
visu inspection. The Mascot expectation values used to confirm individual 
phosphopeptides spectra did not directly address the probability that a given serine, 
threonine, or tyrosine residue within the peptide was the phosphorylation site. If a 
phosphopeptide has more than one potential modification site and its spectrum is 
analyzed using MASCOT, one can at best compare the MASCOT peptide scores 
associated with phosphorylation to each potential sites to discriminate the modified 
one. Furthermore, Mascot relies on neutral loss of phosphoric acid (which appears 
as a loss of 98 Da from the modified amino acid) in MS-MS spectra to designate the 
exact phosphorylation site. However, this strategy suffers of some limits. In fact, not 
phosphorylated peptide fragments can undergo loss of H2O, yielding fragment ions 
with the same mass as a loss of H3PO4 from a peptide fragment ion containing a 
phosphorylated serine or threonine. Then, during fragmentation, the phosphate 
group on a modified serine or threonine residues does not always undergo complete 
neutral loss of H3PO4. Fragment ions in which the phosphate group is retained can 
provide valuable information regarding which amino acid is the modification site. 
Finally, instead of the neutral loss of H3PO4, phosphorylated serine and 
threonine fragment ions can undergo the neutral loss of HPO3. This can lead to the 
misidentification of the site of phosphorylation if these -80 Da fragments are 
misinterpreted as initially not phosphorylated sequence ions. All phosphopeptides 
were manually inspected to verify and complete the MASCOT assignments of y-
H20/H3PO4 or b-H2O/H3PO4 ions. Furthermore many MS-MS spectra had not 
MASCOT interpretation and were assigned by de novo sequence analysis. 
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III.6.3 PhosphoPeptidomics of biological fluids 
 
One goal of this study was to apply this strategy to the identification of free 
phosphopeptides in serum, saliva and urine. 
These samples contain large amount of proteins (for example albumin, 
amylase and uromodulin respectively) that must be depleted before the analysis of 
less abundant proteins. Any complexity reduction strategy greatly increases the 
number of less abundant proteins that can be subsequently analyzed. 
Biological fluids have been shown to contain peptides resulting from degradation of 
proteins and other tissues and the change in composition of these peptides and their 
PTMs can be indicative of changes in the physiology of organism. Because such 
peptides could be bound to highly abundant proteins, their depletion from biological 
fluids under native conditions may possibly result in the loss of the potential 
biomarkers. 
A combination of a precipitation protocol of the higher-abundance proteins 
and IMAC strategy was chosen. 
 
Acetonitrile Precipitation 
  
Many proteins are known to act as carriers for smaller proteins or peptides. 
Techniques to remove these abundant molecules using affinity columns or filtration 
systems may result in the loss of these smaller proteins of interest. For this reason, 
acetonitrile, was chosen to precipitate the large proteins out of solution (see Material 
and Methods section). These conditions dissociated smaller proteins from their 
carrier molecules, allowing the detection of a larger number of peptides (22).  
 
MS Analysis of phosphopeptide in biological fluids 
 
The supernatants were dry and the free peptide mixture of biological fluids 
was submitted to MALDI-MS and LC-MS-MS analysis. MALDI-MS analysis shown in 
Figure 14 was carried out to know the complexity of the samples and the masses of 
their peptides. However, the MALDI mapping procedure was not sufficient to identify 
any peptide. Thus, the same mixture was submitted to LC-MS-MS analysis. Tandem 
mass spectrometry allowed to know the sequence of peptides and thus the identity 
of proteins in the mixture as reported in table 7. All fragmentation spectra were 
identified by MASCOT searching inserting also phosho-Ser and Thr among variable 
modifications. Either in the serum or saliva or urine no free phosphopeptides were 
detected.  
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Figure. 14 a, b, c MALDI-MS analysis of precipitated peptides from serum, saliva and urine 
respectively. 
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Table 7. Identified proteins by MS-MS analysis of precipitated peptides from biological fluids. 
 
Origin  Identified protein Number of 
peptides 
Saliva (P02814) Submaxillary gland 
androgen-regulated protein 3 
homolog B precursor (Proline-rich 
protein 
19 
Saliva (P02812) Basic salivary proline-
rich protein 2 (Salivary proline-rich 
protein) (Con1 glycoprotein) 
30 
Saliva (P04281) Basic proline-rich 
peptide IB-1 
4 
Saliva (P02811) Basic proline-rich 
peptide P-E (IB-9) 
1 
Saliva (P02810) Salivary acidic proline-
rich phosphoprotein 1/2 precursor 
(PRP-1/PRP-2) (Parotid proline-r 
19 
Saliva (P10163) Basic salivary proline-
rich protein 4 allele S precursor 
(Salivary proline-rich protein Po 
16 
Saliva (P02808) Statherin precursor 2 
Saliva (Q14050) Collagen alpha-3(IX) 
chain precursor 
3 
Saliva (Q9UMD9) Collagen alpha-
1(XVII) chain (Bullous pemphigoid 
antigen 2) (180 kDa bullous 
pemphigoid an 
2 
Saliva (Q04118) Basic salivary proline-
rich protein 3 precursor (Parotid 
salivary glycoprotein G1) (Prolin 
4 
Urine  (P07911)Uromodulin precursor 7 
Serum  P02671 Fibrinogen alpha chain 
precursor 
15 
Serum  P01024 Complement C3 
precursor 
3 
Serum P22670 MHC class II Enhancer 
factor C   
1 
 
IMAC protocol and selective monitoring of free phosphopeptides by mass 
spectrometry  
 
Improved IMAC protocol was applied to enrich phosphopeptides mixture in 
order to identify the phosphorylated peptides inside biological fluids  
The conditions set up for model phosphopeptides analysis were employed for 
the enriched free phosphopeptides in biologic fluids. 
MALDI-MS analysis performed on serum and saliva after IMAC enrichment 
step was reported in figure 15 A and B respectively. MALDI-MS data, shown in panel 
A and B, clearly indicated the presence of a high number of signals with respect to 
the same analysis performed on the sample before IMAC enrichment (fig. 14 A-B). 
MALDI-MS analysis of enriched urine phosphopeptides did not give such good 
results. 
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Figure. 15 A-B MALDI-MS analysis of enriched peptide mixture from serum and saliva 
respectively. 
 
The selective analysis of phosphopeptides by MS-MS was then applied.  
MS-MS selective analysis were reiterated for two times for two different donators.  
High selectivity of precursor ion scan was emphasized for the analysis of free 
phosphopeptides of biological fluids.  
In these experiments a higher number of phosphopeptides with respect to 
those detected by using neutral loss analysis was identified despite inferior MS-MS 
quality spectra. This is probably due to the worse stability of the spray switching the 
polarity, the length of the total acquisition cycle and the different charged state of the 
ion parent between precursor ion and neutral loss analysis. In this case the neutral 
loss scan was performed at 49 Da corresponding to phosphoric acid neutral loss 
from doubly charged peptides whereas the precursor ion scan was performed on 
doubly and triply charged peptides. 
Figure 16 panel A shows the resulting survey precursor ion spectrum in 
negative ion mode related to 35 minutes of one of the serum free phosphopeptides, 
the resulting ER scan performed in the positive ion mode and the corresponding EPI 
scan performed on the precursor triply charged ion at m/z 515.86. Figure 16 panel B 
shows the resulting survey neutral loss of 49 Da at the same retention time of the 
same peptide but doubly charged; the resulting ER scan performed in the positive 
ion mode and the corresponding EPI scan performed on the precursor at m/z 
773.31.  
The specificity of the precursor ion and neutral loss scans is clearly indicated 
by the clarity of the survey MS spectrum.  
The comparison between the MS-MS spectra shows that the EPI spectra 
arising from doubly charged peptide is richer in signals and better quality with 
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respect to the same fragment spectrum than the triply charged peptide. Figure 16 
shows the partial sequence of this peptide. 
 
 
 
Figure. 15 A-B Comparison between Precursor ion scan and Neutral loss analysis of the same 
peptide with sequence DSpGEGDFLAEGGGVR respectively.  
 
As a whole, neutral loss analysis essentially confirmed previous results but 
allowed us to identify some phosphopeptides not detected before. However a minor 
number of analytes was detected by neutral loss scan compared to precursor ion 
scan analysis probably due to the presence of not phosphorylated peptides that 
unspecifically interacted with IMAC resin and gave rise to a loss of 49 Da during 
neutral loss analysis. All serum results are summarized in table 8. 
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Figure. 16 MS-MS spectrum of the signal double charged at m/z 773.33 with sequence 
DSpGEGDFLAEGGGVR. 
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Table 8 Identified free phosphopeptides from serum. Reported phosphorylation site in 
literature were underlined in yellow. 
 
 
Sequence peptide Protein Modification 
DSGEGDFLAEGGGV P02671 Fibrinogen α-chain pS 
ADSGEGDFLAEGGGV P02671 Fibrinogen α-chain pS 
ADSGEGDFLAEGGGVR P02671 Fibrinogen α-chain pS 
DSGEGDFLAEGGGVR P02671 Fibrinogen α-chain pS 
 
When the experiments were carried out by using an enriched saliva sample, 
many free phosphopeptides belonging to salivary proteins were observed in neutral 
loss and precursor ion scan analysis.  
As an example, the fragment identified at m/z 538.24 corresponding to 
statherin precursor was shown in Figure 17. In addition to a dominant H3PO4 loss ( 
m/z 98/2) ion at m/z 489.4 characteristic of a doubly charged monophosphorylated 
peptide, a continuous series ranging from y1 to y6 ions were observed. Moreover, a 
series of b ions, namely,  b3-H3PO4 , b4-H3PO4, and y7-H3PO4, which resulted 
from fragmentation of the β-eliminated 489.4 m/z ion were detected. In this case the 
loss of phosphoric acid was complete and assignment of correct phosphorylation 
site was hard. 
 
 
Figure 17. MS-MS spectrum of a free salivary monophosphorylated peptide at m/z 538.24 
 
Moreover, the MS analysis led to the detection of another free 
phosphopeptide identified as DpSpSEEKFLR within statherin sequence whose 
spectrum was shown in figure 18. As indicated, the spectrum exhibited two 
diagnostic ions for a doubly charged diphosphopeptide: a dominant H3PO4 loss (m/z 
98/2) ion at m/z 586.8 and a second H3PO4 loss (m/z 98/2) at m/z 537.8. A 
continuous series ranging from y7 to y10 ion consistent with a phosphoserine 
residue at both positions 2 and 3 were observed. It is clear that the interpretation of 
this spectrum is complicated by presence of different fragmentation series from 
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MH22+, MH22+- H3PO4 and MH22+- 2H3PO4 often unexplained by conventional b- and 
y- type ions. 
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Figure 18. MS-MS spectrum of a free salivary diphosphorylated peptide at m/z 635.74. 
 
Whereas, in other cases the loss of phosphoric acid was complete thus 
producing a spectrum easier to interpret but the challenging in assignment of the 
correct phosphorylation site still remained. As example, figure 19 shows the MS-MS 
spectrum of a double charged phosphopeptide at m/z 731.27, whose partial 
sequence was GGDpSQFIDEER identified by MASCOT analysis, with a complete 
loss of phosphoric acid and with an unique serine residue within sequence.  
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Figure19. MS-MS spectrum of ion at m/z 731.27. 
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A total of 9 free phosphopeptides and six phosphorylation sites within the four 
protein sequences were identified (tab.11). In particular, free phosphopeptides from 
salivary acidic praline-rich phosphoprotein ½ precursor (PRP), basic salivary praline-
rich protein 2, statherin precursor and histatin were detected. 
 
Table 11. Identified free phosphopeptides from saliva. Reported phosphorylation sites in 
literature were underlined in yellow. New phosphorylation sites were underlined in red. 
 
Sequence Protein Modification 
GGDSEQFIDEER P02810 Salivary acidic proline-rich phosphoprotein 1/2 
precursor (PRP-1/PRP-2) 
1P 
GGDSEQFIDEERQ P02810 Salivary acidic proline-rich phosphoprotein 1/2 
precursor (PRP-1/PRP-2) 
1P 
PGKPQGPPPQGGSKSRSARS P02812 Basic salivary proline-rich protein 2 2P 
PGKPQGPPPQGGSKSRSARS P02812 Basic salivary proline-rich protein 2 2P 
SSEEKFLR P02808 Statherin precursor 1P 
SSEEKFLR P02808 Statherin precursor 2P 
DSSEEKFLR P02808 Statherin precursor 1P 
DSSEEKFLR P02808 Statherin precursor 2P 
SHEKRHHGYR P15515 Histatin-1 precursor 1P 
 
It is worth that the analysis of free peptides is still challenging because of the 
missing knowledge of the C-terminal aminoacid. The fragmentation of tryptic 
peptides is optimised thanks to the presence of a basic aminoacid at C-terminal 
residue. Unfortunately many free peptides did not present a lysine or arginine at C-
terminal residue. In these analysis many peptides were found having different 
cleavage sites and this was reflected in the low quality of fragmentation spectra.  
No phosphopeptide was identified in urine. The analyzed urine samples 
belonged to healthy donors. The porous wall of the glomerular capillaries in the 
kidney normally allows only proteins with a molecular weight < 65 kDa into the 
tubular system, whereas larger proteins stay in the blood stream. The tubular cells 
subsequently reabsorb the smaller proteins, and only low concentrations of proteins 
are normally present in the normal urine (39). 
In conclusion, the combination of the IMAC improved protocol with selective 
“precursor ion” and constant “neutral loss” triple quadrupole scan modes confers the 
high sensitivity allowing rapid peptide identification and characterization at low 
concentrations.  
The unique capabilities of the Q-q-Q linear ion trap in selective ion scans are 
due to the decoupling and spatial separation of the ion isolation, fragmentation, and 
mass analysis steps of the instrument. 
 
III.7 Conclusions 
 
Tumor markers are critical in the diagnosis of diseases and monitoring of 
patients.  
Powerful analytical technologies and, especially, mass spectrometry, have 
allowed identification of new markers. Recently, it has been found that not only 
proteins but also peptides and their modifications can be indicators of early 
pathogenic processes. The extraordinary power of mass spectrometry in identifying 
and quantifying peptides in complex biological mixtures offers opportunities for 
developing novel technologies for diagnosis of cancer and other diseases (35). 
Since biological fluids contain high concentration of large abundant proteins such as 
albumin, uromodulin, histatin, it is generally accepted that these proteins must be 
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removed before analysis to allow comparison of other less abundant proteins. 
Moreover, enrichment methods are required to detect phosphospecies. 
In this study IMAC chromatography and selective mass spectrometry scans 
were improved to study phosphopeptidomics in biological fluids. One strategy to 
increase the sensitivity and selectivity was to use a linear ion trap to analyze the 
purified phosphopeptides.  
The application of this IMAC protocol coupled with MS-MS experiments 
significantly improved the analysis of phosphopeptides in biological fluids. Many 
peptides were detected in the enriched extract samples when submitted to the 
integrated strategy, whereas they resulted absent in the initial extract samples. 
In 2003, Marshall et al. claimed that peptides from the sera of normal 
individuals and patients who suffered myocardial infarction can produce MALDI-TOF 
patterns that provide an accurate diagnosis of myocardial infarction (23). In some 
patients who had occluded coronary arteries phosphorylated fibrinogen Aα levels 
increased as compared with patients who had patent coronary arteries. These 
results provide some support for the idea that an increased synthesis of fibrinogen in 
circulation may result in a procoagulant tendency. Thus, phosphorylated fibrinogen 
Aα content may serve as a risk index for thrombosis (24). 
Human saliva contains a large number of proteins which have important 
physiological functions. Nowadays, there is a growing interest for these proteins, due 
their potential usefulness for a proteomic analysis in the diagnosis of many different 
diseases. The knowledge of the phosphopeptides can give rise an important 
information about biochemical processes revealing potential target for therapy of 
diseases. 
Saliva is usually supersaturated with respect to the basic calcium phosphate 
salts that form dental enamel, a property which provides protection for the teeth. An 
undesirable side effect of this is that unwanted precipitation of solid calcium 
phosphate may occur in the salivary glands, the fluid of the mouth, or on dental 
enamel (25). However, this is avoided by the presence of proteins such as statherin 
(26), a phosphoprotein that prevents calcium phosphate precipitation and growth of 
hydroxyapatite crystals (25). The latter activity is shared by acidic proline-rich 
proteins (APRPs)1 (27). Statherin and APRPs loose these activities upon 
dephosphorylation (25). Moreover, the ability of APRPs to bind calcium and thereby 
aid in maintaining the concentration of ionic calcium in saliva also depends on 
phosphorylation of the proteins (28-29). In addition, dephosphorylation of APRPs 
decreases their binding to hydroxyapatite (30) thus preventing them from taking part 
in formation of dental pellicle, the thin layer of adsorbed proteins found on teeth 
which may provide protection against demineralization (31). Moreover, APRPs may 
be relevant modulators of bacterial colonization of the teeth (32- 33-34). 
In conclusion, the results obtained in this work demonstrated that the 
improved Immobilized Metal Affinity Chromatography and Selective tandem mass 
spectrometry of pre-fractionated biological fluids allowed the identification of 
potential biomarkers that may lead to the development of tests for screening of high-
risk individuals. This method should be widely applicable to the searching for 
biomarker in clinical diagnosis and therapy. 
 
 
  68 
 
III.8 References 
 
1. Porath J, Carlsson J, Olsson I, Belfrage G. Metal chelate affinity 
chromatography, a new approach to protein fractionation. Nature. 1975. 
18;258(5536):598-9. 
2. Shihua L. and Chhabil D. Iron(III)-Immobilized Metal Ion Affinity 
Chromatography and Mass Spectrometry for the Purification and Characterization of 
Synthetic Phosphopeptides. Anal. Biochem. 1999. 270: 9–14.  
3. Ueda EK, Gout PW, Morganti L. Current and prospective applications of metal 
ion-protein binding. J Chromatogr A 2003. 21;988(1):1-23. 
4. M.O. Collins, L.Yu., H.Husi, W.P. Blackstock, J.S. Choudhary, S.G.N. Grant. 
Robust Enrichment of Phosphorylated Species in Complex Mixtures by Sequential 
Protein and Peptide Metal-Affinity Chromatography and Analysis by Tandem Mass 
Spectrometry. Sci. STKE. 2005. 298: 16.  
5. Steen H, Kuster B, Mann M. Quadrupole time-of-flight versus triple-quadrupole 
mass spectrometry for the determination of phosphopeptides by precursor ion 
scanning. J Mass Spectrom. 2001. 36(7):782-90.  
6. Steen H, Kuster B, Fernandez M, Pandey A, Mann M. Detection of tyrosine 
phosphorylated peptides by precursor ion scanning quadrupole TOF mass 
spectrometry in positive ion mode. Anal Chem. 2001.  1;73(7):1440-8. 
7. Carr SA, Huddleston MJ, Annan RS. Selective detection and sequencing of 
phosphopeptides at the femtomole level by mass spectrometry. Anal Biochem. 
1996. 1;239(2):180-92.  
8. Bruins AP, Covey TR, Henion JD. Ion spray interface for combined liquid 
chromatography/atmospheric pressure ionization mass spectrometry. Anal Chem. 
1987. 59:2642–2646. 
9. Schulte, I.; Tammen, H.; Selle, H.; Schulz-Knappe, P. Peptides in body fluids 
and tissues as markers of disease. Expert Rev. Mol.Diagn. 2005. 5: 145-157. 
10. Schrader, M.; Schulz-Knappe, P. Peptidomics technologies for human body 
fluids. Trends Biotechnol. 2001. 19: S55-60. 
11. Jimenez-Reyes M, Sanchez-Aguirre FJ. Sodium and chlorine concentrations in 
mixed saliva of healthy and cystic fibrosis children. Appl Radiat Isot. 1996. 
47(3):273-7.  
12. Ebert, M. P.; Meuer, J.; Wiemer, J. C.; Schulz, H. U.; Reymond, M. A.; 
Traugott, U.; Malfertheiner, P.; Rocken, C. J. Proteome Res. 2004. 3: 1261-1266. 
13. Li, J.; Zhang, Z.; Rosenzweig, J.; Wang, Y. Y.; Chan, D. W. Clin. Chem. 2002. 
48: 1296-1304. 
14. Gruhler A, Olsen JV, Mohammed S, Mortensen P, Faergeman NJ, Mann M, 
Jensen ON. Mol Cell Proteomics. Quantitative phosphoproteomics applied to the 
yeast pheromone signaling pathway. 2005. 4(3):310-27.  
15. Giorgianni F, Beranova-Giorgianni S, Desiderio DM. Identification and 
characterization of phosphorylated proteins in the human pituitary. Proteomics. 
2004. 4(3):587-98. 
16. Ballif BA, Villen J, Beausoleil SA, Schwartz D, Gygi SP. Phosphoproteomic 
analysis of the developing mouse brain. Mol Cell Proteomics. 2004. 3(11):1093-101.  
17. Kjellstrom S, Jensen ON. Phosphoric acid as a matrix additive for MALDI MS 
analysis of phosphopeptides and phosphoproteins. Anal Chem. 2004 1;76(17):5109-
17.   
18. Zappacosta, F., Huddleston, M.J., Karcher, R.L., Gelfand, V.I., Carr, S.A. and 
Annan,R.S. Improved sensitivity for phosphopeptide mapping using capillary column 
  69 
 
HPLC and microionspray mass spectrometry: comparative phosphorylation site 
mapping from gel-derived proteins. Anal. Chem. 2002. 74: 3221-3231. 
19. Steen, H., Kuster, B., Fernandez, M., Pandey, A. and Mann, M. Detection of 
tyrosine phosphorylated peptides by precursor ion scanning quadrupole TOF mass 
spectrometry in positive ion mode Anal. Chem. 2001  73: 1440-1448.   
20. LeBlanc, J.C.Y., Hager, J.W., Ilisiu, A.M.P., Hunter, C., Zhong, F., Chu,I. 
Unique scanning capabilities of a new hybrid linear ion trap mass spectrometer (Q 
TRAP) used for high sensitivity proteomics applications Proteomics. 2003. 3: 859-
869. 
21. Shou W, Verma R, Annan RS. Mapping phosphorylation sites in proteins by 
mass spectrometry. Methods Enzymol. 2002. 351:279–296. 
22. Chertov O, Biragyn A, Kwak LW, Simpson JT, Boronina T, Hoang VM, Prieto 
DA, Conrads TP, Veenstra TD, Fisher RJ. Organic solvent extraction of proteins and 
peptides from serum as an effective sample preparation for detection and 
identification of biomarkers by mass spectrometry. Proteomics. 2004. 4(4):1195-203.   
23. Marshall, J.; Kupchak, P.; Zhu, W.; Yantha, J.; Vrees, T.; Furesz, S. Processing 
of serum proteins underlies the mass spectral fingerprinting of myocardial infarction. 
J. Proteome Res. 2003. 2: 361-372. 
24. Maurer MC, Peng JL, An SS, Trosset JY, Henschen-Edman A, Scheraga HA. 
Baker. Structural examination of the influence of phosphorylation on the binding of 
fibrinopeptide A to bovine thrombin. Biochemistry. 1998. 28:37(17): 5888-902.  
25. Hay, D. I., Moreno, E. C., and Schlesinger, D. H. Inorg. Perspec. Biol. Med. 
1979. 2: 271-285. 
26. Schlesinger DH, Hay DI. Complete covalent structure of statherin, a tyrosine-
rich acidic peptide which inhibits calcium phosphate precipitation from human parotid 
saliva. J Biol Chem. 1977. 10;252(5):1689-95.  
27.  Naurato N, Wong P, Lu Y, Wroblewski K, Bennick A. Interaction of tannin with 
human salivary histatins. J Agric Food Chem. 1999. 47(6):2229-34.  
28. Chan M, Bennick A. Proteolytic processing of a human salivary proline-rich 
protein precursor by proprotein convertases. Eur J Biochem. 2001. 268(12):3423-31. 
29. Hay DI, Carlson ER, Schluckebier SK, Moreno EC, Schlesinger DH. Inhibition 
of calcium phosphate precipitation by human salivary acidic proline-rich proteins: 
structure-activity relationships. Calcif Tissue Int. 1987. 40(3):126-32.  
30. Bennick A, Cannon M, Madapallimattam G. Factors affecting the adsorption of 
salivary acidic proline-rich proteins to hydroxyapatite. Caries Res. 1981;15(1):9-20. 
31. Moreno EC, Zahradnik RT. Demineralization and remineralization of dental 
enamel. J Dent Res. 1979. 58(Spec Issue B):896-903.  
32. Gibbons RJ, Hay DI, Cisar JO, Clark WB. Adsorbed salivary proline-rich protein 
1 and statherin: receptors for type 1 fimbriae of Actinomyces viscosus T14V-J1 on 
apatitic surfaces. Infect Immun. 1988. 56(11):2990-3. 
33. Gibbons RJ, Hay DI, Schlesinger DH. Delineation of a segment of adsorbed 
salivary acidic proline-rich proteins which promotes adhesion of Streptococcus 
gordonii to apatitic surfaces. Infect Immun. 1991. 59(9):2948-54.  
34. Bennick A, Cannon M, Madapallimattam G. The nature of the hydroxyapatite-
binding site in salivary acidic proline-rich proteins. Biochem J. 1979. 1;183(1):115-
26.  
35.  Hyoung-Joo Lee, Eun-Young Lee, Min-Seok Kwon and Young-Ki Paik 
Biomarker discovery from the plasma proteome using multidimensional fractionation 
proteomics. Current Opinion in Chemical Biology 2006, 10:42–49.  
  70 
 
36. Francesco Giorgianni; Sarka Beranova-Giorgianni; Dominic M. Desiderio. 
Identification and characterization of phosphorylated proteins in the human pituitary 
Proteomics 2004, 4, 587–598. 
37. Ficarro SB, McCleland ML, Stukenberg PT, Burke DJ, Ross MM, Shabanovwitz 
J, Hunt DF,White FM. Phosphoproteome analysis by mass spectrometry and its 
application to Saccharomyces Cerevisiae. Nat Biotechnol. 2002. 3:301-5. 
38. D’Angelo A, Garzia L, Andre A, Carotenuto P, Aglio V, Guardiola O, Arrigoni G, 
Cossu A, Palmieri G, Aravind L, Zollo M. Prune cAMP phosphodiesterase binds 
nm23-H1 and promotes cancer metastasis. Cancer Cell. 2004. 5:137-49. 
39. Ottiger C, Savoca R, Yurtsever H, Huber AR. Increased sensitivity in detecting 
renal impairments by quantitative measurement of marker protein excretion 
compared to detection of pathological particles in urine sediment analysis. Clin 
Chem Lab Med. 2006. 44(11):1347-1354.  
  71 
 
IV. Selective detection and identification of 
phosphopeptides by dansyl MS/MS/MS fragmentation 
 
IV.1 Dansyl Chemistry 
 
The challenge of large-scale functional genomics projects is to build a 
comprehensive map of the cell. In recent years, mass spectrometry (MS) has been 
recognized as the best tool for proteomic analysis. 
Several group have reported the analytical potential of chemical derivatization in 
conjunction with mass spectrometry for the analysis of synthetic and biological 
compounds. Some derivatizing agent improves the ionization and the sensitivity of 
analyses by MS.  
Dansyl chloride (DANS-Cl) is a fluorescent derivatizing agent commonly used 
in the analysis of proteins and other primary and secondary amines. The presence of 
a dimethylamino group in this compound makes it amenable to protonation under 
acidic conditions. Dansylation of compounds that are not readily ionized results in 
higher sensitivity in MS analysis. 
Since 1968 (1) the group, where I have sustained my phD work, discovered 
some interesting properties of 1-dimethylaminoaphthalene-5-sulphonyl- (DANS) 
amino acid derivatives. Since DANS derivatives give rise to a very intense fragment 
at m/z: 170, the “metastable refocusing” (a primordial precursor ion scanning) first 
was applied for the analysis of amine mixtures (2-3).  
Recently, revisiting these previous findings by using soft ionization procedures 
(ESI and MALDI), we have developed new strategies based on the use of dansyl 
chloride and linear ion trap aimed at identification of bacterial surface-exposed 
proteins and post- translational modification (PTMs) both in qualitative and 
quantitative terms. 
 
IV.2 Aim of the project 
 
Selective detection of phosphopeptides from proteolytic digests is a 
challenging and highly relevant task in many proteomics applications. Because of the 
impact of enzyme-catalyzed phosphorylation and dephosphorylation on the function 
of many proteins (4), there is a demand to improve the methods for a reliable 
analysis of phosphopeptides. Phosphoproteins often exist in low abundance in cells 
besides to corresponding non-phosphorylated parent forms, and they need selective 
isolation or enrichment before identification. Moreover, phosphopeptides are easily 
suppressed in mass spectrometry in both MALDI and ESI ionization modes. 
Furthermore, the low stoichiometry of phosphorylation in proteins makes important to 
increase the selectivity in the analysis (5). 
Treatment with an appropriate derivatizing agent has the potential to improve 
the ionization of a compound and therefore the detectability of analytes by MS. Here 
it was suggested that derivatization may include chemical moiety capable to give rise 
to characteristic fragment ions, thus allowing the exploitation of the enormous 
potential of MSn analysis (6-7). For the first time the novel acronym RIGhT (Reporter 
Ion Generating Tag) was introduced to indicate the general derivatization method 
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based on dansyl labelling of the targeted residues. In the case of phosphopeptide the 
procedure consists in the β-elimination of phospho-Ser/-Thr residues and the Michael 
addiction of the resulting α,β-unsatured residues with DAN-SH. The dansyl 
derivatization introduces: a) a basic secondary nitrogen into the molecule that 
enhances the efficiency of signal ionization; b) a dansyl moiety that fragments 
according to previous data (2-8). Using the great capabilities of a new hybrid mass 
spectrometer equipped with a linear ion trap analyzer, one can take advantage of the 
distinctive m/z 170 and m/z 234 fragments in MS2 and the diagnostic 234→170 
fragmentation in MS3 mode (scheme1). 
As a whole this approach, first applied on the identification of phosphorylation 
sites in model phosphopeptides, promise to enrich greatly our global view of the 
dynamic changes occurring even in complex matrices such as human serum. It is 
worth considering that O-glycosylated residues also can be targeted with the DAN 
reagent thus widening the range of effectiveness of the method. 
 
 
Scheme 1. Characteristic DANSIL-fragmentation.  
 
IV.3 Materials and Methods 
 
Proteomic grade trypsin, α-casein, myoglobin, bovine serum albumin, insulin, 
trasferrin, ribonuclease A, carbonic anhydrase, lysozime, glutathione S-transferase,  
enolase and tributylphosphine solution (stock solution 200mM in glass vial, sealed 
under Ar) were purchased from Sigma (St. Louis, MO, USA). Dansyl chloride and 
(NH2CH2CH2S)2 (cystamine) was of the highest purity available from SIGMA 
(BioChemika >98.0 %). Trifluoroacetic acid HPLC grade was from Carlo Erba 
(Milano, Italy). All used solvents were of the highest purity available from Baker 
(Phillipsburg, NJ). All other reagents and proteins were of the highest purity available 
from Sigma. 
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Phosphate group modification 
 
The β-eliminated peptide mixture (see Material and methods section of capitol 
2) was modified using DAN-SH via Michael-type addition. Briefly, DANSS was 
obtained by reaction of Dansil chloride (0.1 mg/mL dissolved in acetonitrile) with 
cystamine (molar ratio 3:1). Reaction was carried at 60° C for 2 hr. The product was 
purified by RP-HPLC using an Agilent Zorbax C8 column (4,6mm X 150mm) (Palo 
Alto, California) using a 5% to 65% linear gradient in 30 min from water to acetonitrile 
(ACN) and verified by ESI-MS-MS analysis. Dried DANS-S was dissolved in 10 mM 
Tris/HCl Buffer (~15 nmol/μL, pH 8.5) and reduced in presence of 20 mM 
tributylphosphine. Reaction was carried out for 30 min at room temperature under 
nitrogen. Product was purified by RP-HPLC in the same condition previously 
described and verified by ESI/MSMS analysis. 100 μL of DANSH solution (0.1 
mg/mL, dissolved in ACN/Water 3:1) was then added to an equal volume of the β-
eliminated peptide mixture solution (1 nmol/mL, in deionized water) in presence of 1 
mM tributylphosphine. Tris 2 M was added to the sample at a final concentration of 
100 mM (pH ~11). The reaction proceeded under nitrogen for 18 hours at 50 °C 
 
MALDI-TOF mass spectrometry 
 
MALDI-TOF mass spectra were recorded using a Voyager DE-PRO mass 
spectrometer (Applied Biosystem, Framingham, USA). Prior of analysis, peptide 
mixtures were purified using ZipTip pipette from Millipore (Billerica, MA, USA) using 
the recommended purification procedure. The peptides were eluted using 20 μL of 
50% ACN, 0.1% TFA in water. A mixture of the eluted peptide solution and α-cyano-
hydroxycinnamic acid (10 mg/mL in ACN: 0.1% TFA in water, 2:1, v/v) was applied to 
the metallic sample plate and dried at room temperature. Mass calibration was 
performed using a mixture of peptides from Applied Biosystem, containing des-Arg1-
Bradykinin, Angiotensin I, Glu1-Fibrinopeptide B, ACTH (1-17), ACTH (18-39) and 
Insulin (bovine) as external standards. Raw data were analysed using Data Explorer 
software provided by Applied Biosystem and reported as monoisotopic masses. 
 
nanoLC Mass Spectrometry  
 
Peptide mixture, obtained as previously described, was analysed by LCMS 
analysis using a 4000Q-Trap (Applied Biosystems) equipped with a linear ion trap 
(Scheme 1) coupled to an 1100 nano HPLC system (Agilent Technologies). The 
mixture was loaded on an Agilent reverse-phase pre-column cartridge (Zorbax 300 
SB-C18, 5x0.3 mm, 5 μm) at 10 μL/min (A solvent 0.1% formic acid, loading time 7 
min). Peptides were separated on a Agilent reverse-phase column (Zorbax 300 SB-
C18, 150 mm X 75μm, 3.5 μm), at a flow rate of 0.2 μL/min with a 5 to 65% linear 
gradient in 60 min (A solvent 0.1% formic acid, 2% ACN in water; B solvent 0.1% 
formic acid, 2% water in ACN). Micro ionspray source was used at 2.4 kV with liquid 
coupling, with a declustering potential of 50 V, using an uncoated silica tip from 
NewObjectives (Ringoes, NJ) (O.D. 150 µm, I.D. 20 µm, Tip. Diameter. 10 µm). 
Spectra acquisition was based on a survey Precursor Ion Scan. for the ion m/z.170. 
The Q1 quadrupole was scanned from m/z 500 to m/z 1000 in 2 sec, and ions were 
fragmented in q2 using a linear gradient of collision potential from 30 to 70 V. Finally, 
Q3 is settled to transmit only ions at m/z 170. This scan mode was followed by an 
enhanced resolution experiment (ER) for the ions of interest and then by MS3 and 
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MS2 acquisitions of the two most intense ions. MS2 spectra were acquired using the 
best collision energy calculated on the bases of m/z values and charge state (rolling 
collision energy). MS3 spectra were acquired using Q0 Trapping, with a trapping time 
of 150 ms and an activation time of 100 ms, scanning from m/z 160 to 240. The Q0 
Trapping tool is able to increase the sensitivity of the scan in the different ion trap 
scan types used. Data were acquired and processed using Analyst software (Applied 
Biosystems). 
 
IV.4 Results and discussion 
 
In an attempt to improve and simplify the plethora of methods so far suggested 
(10) a new approach was set up to label selectively phospho-Ser/-Thr residues by 
exploiting the features of novel linear ion trap mass spectrometer (11). Dansyl 
chloride is known to react with ε-amino group of lysine as well as the N-terminal 
amino group (9). Here, using chemical manipulations coupled with dansyl chloride 
labelling, a methodology capable of large-scale proteomic profiling of phosphorylation 
sites was shown. This method is based a) on the selective modification of pSer/Thr 
residues with a novel dansyl derivative of NH2(CH2)2SH, cysteamine, prepared 
according to material and methods sections and shown in Scheme 2 and b) on the 
selective detection and identification of labelled peptides by exploiting the 
characteristic fragmentation pathway of dansyl-derivatives. 
 
Scheme 2. Synthesis of DANS-SH. 
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Figure 1. a: Partial MALDIMS spectrum of the trypsin digest of α--casein. b: Partial MALDIMS 
spectrum of the β-eliminated peptide mixture. The mass signals related to the phosphorylated 
peptides are shifted of 98 Da due to the β-elimination reaction. c: Partial MALDIMS spectrum of 
the β-eliminated peptide mixture after N-(2-mercaptoethyl)dansylamide addition. The signals 
corresponding to the β-eliminated peptides show a mass increment of 310 Da. 
 
This approach was first applied to α-casein as model phosphoprotein. Thus, 
the phosphate moieties from a tryptic α-casein digest were removed from pSer and 
pThr via barium hydroxide ion-mediated β-elimination as already reported (11). The 
peptide mixture was then analysed by MALDIMS, using a Voyager DE-PRO mass 
spectrometer. Prior of analysis, peptide mixtures were purified using ZipTip pipette, 
using the recommended purification procedure.  
The MALDI-MS analysis showed the occurrence of signals corresponding to 
the β-eliminated peptides. As an example, the ion at m/z 1854.3 was assigned to the 
peptide 104-119 of α-casein occurring 98 Da lower than that expected, indicating that 
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the pSer115 was converted in dehydroalanyl after β-elimination reaction (Figure 1). 
The α,β-unsatured residues are Michael acceptor, which can readily react with a 
nucleophile. The β-eliminated peptide mixture was modified with DANSH via Michael-
type addition.  
The yield of addition reaction was monitored via MALDIMS, indicating that the 
extent of the reaction was good but not complete, as expected for a typical Michael 
reaction addition [(10) and references therein]. MALDIMS analysis performed on the 
peptide mixture revealed two ions at m/z 1873.5 and m/z 2163.9 assigned to the β-
eliminated fragments 106-119 and 104-119, modified by DANS (Δm=310 Da). 
In a proof of principle experiment, to investigate the feasibility of applying the 
method to proteomic analysis, triptic digest from 10 standard proteins (50 μg of a 
mixture in equimolar amount of myoglobin, bovine serum albumin, ovalbumin, 
carbonic anhydrase, RNase A, Lysozime, gluthatione S-trasferase, insulin, enolase, 
trasferrin) was spiked with 5 μg of α-casein triptic mixture modified with 
dansylcysteamine. 1 pmol of the peptide mixture was then submitted to LCMS 
analysis by using 4000Q-Trap coupled to a 1100 nano HPLC system. We settled an 
experiment combining a precursor ion scan with a MS3 linear ion trap scan modes. 
The previous one is a typical quadrupole scan mode which can be used when an ion 
loses a diagnostic fragment as a charged fragment. In a precursor ion scan, Q1 is 
scanned across a mass range and ions are fragmented in the collision cell. Q3 is set 
to transmit only the mass of diagnostic fragment. Therefore only ions that are passed 
through Q1 that fragment to produce the diagnostic charged fragment will be 
detected. Then the selected precursor ions are submitted to a sequence consisting of 
MS2 and MS3 experiments thus leading to the selective detection of the 
dansylpeptides. Figure 2A shows the reconstructed ion chromatogram for the 
selective dansyl transition 234→170 in MS3 mode. As indicated in the figure, only two 
ions were detected. Corresponding MS2 spectra led to the reconstruction of the entire 
sequences of the beta eliminated phosphopeptides 104-119 and 106-119 carrying a 
DANSH moiety. As an example, the MS/MS spectrum of the modified peptide 104-
119 is reported in Figure 2B. The modified ion is stable during collision induced 
dissociation, provided easily interpretable product ion spectra. In fact, the y and b 
product ions still retains the modifying group linked to the beta eliminated Ser residue 
thus allowing the exact localization of the phosphorylation site. It is worth considering 
that α-casein contains also a diphosphorylated and a pentaphosphorylated tryptic 
peptides which escaped to be detected using this approach propably due to the 
chemical physical characteristics of the modified fragments. In fact the introduction of 
a high number of dansyl moieties increase the hydrofobicity of the peptides, 
moreover the low efficiency of Michael addition results dramatically increased when 
more then one sites are present in the same peptide. However the ionization of 
multiphosphorylated peptides is a difficult challenge and among the proposed 
derivatization procedures only the modification strategy based on the use of 
dithiothreitol (10) led to the detection of intense ions of multiphosphorylated peptides 
in mass spectrometric analyses. 
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Figure 2. A Reconstructed ion chromatogram of the tryptic digest for the selective transition 
234→170 in MS3 mode. B MS/MS spectrum of the α-casein modified peptide 104-119. The 
fragment ions belonging to the b and y series are indicated 
 
IV.5 Conclusions 
In conclusion, it is well known that ion trap tandem mass spectrometry 
experiments offer high sensitivity because of the ability to accumulate precursor ions. 
Furthermore, the novel introduction of a linear ion trap with greatly increased capture 
efficiency and storage capacity resulted in new inputs in the proteomic field. As 
concerning the use of dansyl chloride as marker, a) DANS moiety introduces a strong 
basic group in peptides thus leading to an enhanced ionization; b) DANS peptide can 
be easily detected in precursor ion scan mode; c) DANS peptide can be selectively 
detected in MS3 mode (via transition 234→170) in even complex peptide mixture. 
Here the strategy proposed, taking in account the availability of linear trap to select 
specific labelled peptides giving rise to diagnostic MS3 product ions, resulted to be of 
useful in the phosphoprotein analysis. As a whole, this approach will be of interest in 
the phosphoproteome (and O-glycome) studies and has been successfully exploited 
to detect selectively phospho-Ser/Thr containing peptides.  
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in AntartProtein phosphorylation regulates many cellular processes and pathways, such as cell cycle pro-
gression, signal transduction cascades and gene expression. Selective detection of phosphopeptides
from proteolytic digests is a challenging and highly relevant task in many proteomics applications.
Often phosphopeptides are present in small amounts and need selective isolation or enrichment
before identification. Here we report a novel approach to label selectively phospho-Ser/-Thr residues
by exploiting the features of a novel linear ion trap mass spectrometer. Using dansyl labelling and
MS3 fragmentation, we developed a method useful for the large-scale proteomic profiling of
phosphorylation sites. The new residues in the sequence were stable and easily identifiable under
general conditions for tandemmass spectrometric sequencing. Copyright# 2006 JohnWiley & Sons,
Ltd.Reversible posttranslational modification is a general
mechanism for fine-tuning protein structure and function.
In particular, protein phosphorylation plays a key role in the
regulation of virtually all cellular events. Reversible protein
phosphorylation tightly regulates many critical biological
processes such as cell cycle, growth, differentiation and
metabolism.1 To gain further insight into the regulation of
these processes by reversible phosphorylation, it is often
necessary to characterize the phosphorylation state of
specific proteins under specific conditions.
Selective detection of phosphopeptides from proteolytic
digests is a challenging and highly relevant task in many
proteomics applications. Because of the impact of enzyme-
catalyzed phosphorylation and dephosphorylation on the
function of many proteins,2 there is a demand to improve the
methods for the reliable analysis of phosphopeptides.
Phosphoproteins often exist in low abundance in cells
alongside the corresponding non-phosphorylated parent
forms, and they need to be selectively isolated or enriched
before identification. Moreover, phosphopeptides are easily
suppressed in mass spectrometry (MS) in both matrix-
assisted laser desorption (MALDI) and electrospray (ESI)
ionization modes. Furthermore, the low incidence of
phosphorylation in proteins makes it important to increase
the selectivity of the analysis.3
Several groups have reported the analytical potential of
chemical derivatization in conjunction with ESI-MS for thendence to: A. Amoresano, Dipartimento di Chimica
e Biochimica, Complesso Universitario Monte Sant’
ia Cinthia 6, I-80126 Napoli, Italy.
ngamor@unina.it
grant sponsor: Ministero dell’Universita` e della
cientifica (Progetti di Rilevante Interesse Nazionale
2003; FIRB 2001); Programma Nazionale di Ricerche
ide 2004, Regione Campania L.R. 05/03.analysis of compounds of synthetic and biological origin.4,5
Treatment with an appropriate derivatizing agent can
improve the ionization of a compound and therefore its
detectability by ESI-MS. Here we suggest that derivatization
may include the addition of a chemical moiety that gives rise
to characteristic product ions, thus allowing the exploitation
of tandem multi-stage mass spectrometric (MSn) analysis.6,7
We introduce the novel acronym RIGhT (reporter ion
generating tag) to indicate a general derivatization method
based on the labelling of target residues with reagents
capable of generating reporter ions in MS2!MS3 exper-
iments. In the case of phosphopeptides the procedure
consists of the b-elimination of phospho-Ser/-Thr residues
and the Michael addition of the resulting a,b-unsaturated
residues with dansyl-cysteamine. The dansyl derivatization
introduces: (a) a basic secondary nitrogen into the molecule
that enhances the efficiency of ionization and (b) a dansyl
moiety whose fragmentation is known from previous data.8,9
Using a new hybrid mass spectrometer equipped with a
linear ion trap analyzer, one can take advantage of the
distinctive m/z 170 and 234 product ions in MS2 and the
diagnostic m/z 234! 170 fragmentation in the MS3 mode.
As a whole, this approach, first applied for the identifi-
cation of phosphorylation sites in model phosphopeptides,
promises to enrich our view of the dynamic changes
occurring even in complex matrices such as human serum.
It is worth considering that O-glycosylated residues can also
be targeted with the dansyl reagent thus widening the
effectiveness of the method.Copyright # 2006 John Wiley & Sons, Ltd.
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Materials and methods
Proteomic grade trypsin, a-casein, myoglobin, bovine serum
albumin, insulin, transferrin, ribonuclease A, carbonic
anhydrase, lysozyme, glutathione S-transferase, enolase
and tributylphosphine solution (stock solution 200mM in
glass vial, sealed under Ar) were purchased from Sigma (St.
Louis, MO, USA). Dansyl chloride and 2,20-dithiobis(ethy-
lamine) (cystamine) were of the highest purity available from
Sigma (BioChemika >98.0%). Trifluoroacetic acid (TFA,
HPLC grade) was from Carlo Erba (Milano, Italy). All used
solvents were of the highest purity available from Baker
(Phillipsburg, NJ, USA). All other reagents and proteins were
of the highest purity available from Sigma.
Peptides b-elimination
Enzymatic digestion of a-casein (4 nmol/mL) as well as of
other standard proteins was carried out using an enzyme/
substrate ratio 1:50 (w/w) in a 10mM ammonium bicarbon-
ate solution, at 378C for 18 h. The phosphate moieties from a
tryptic a-casein digest were removed from pSer and pThr by
barium hydroxide ion-mediated b-elimination.The
b-elimination reactions were carried out by incubating the
peptide mixture in 100mM Ba(OH)2, at 378C for 90min
under nitrogen. The reagent excess was removed by using
solid carbon dioxide. The precipitated barium carbonate was
removed by centrifugation at 13000 rpm for 5min. The
procedure was repeated once. The use of this reagent
permitted removal of the barium as a carbonate pellet at the
bottom of a vial.11 The peptide mixture was then analyzed by
MALDI-MS.
Dansyl-cysteamine addition
The b-eliminated peptide mixture was modified using
dansyl chloride via a Michael-type addition. The dansyl-
cysteamine was obtained by reaction of dansyl chlorideScheme 1. Dansyl-cys
Copyright # 2006 John Wiley & Sons, Ltd.(0.1mg/mL dissolved in acetonitrile) with cystamine (molar
ratio 3:1) at 48C for 2 h. The product was purified by
reversed-phase high-performance liquid chromatography
(RP-HPLC) using an Agilent Zorbax C8 column
(4.6mm 150mm; Palo Alto, CA, USA) using a 5% to 65%
linear gradient in 30min from water to acetonitrile (ACN)
and verified by ESI-MSMS. Dried dansyl-cysteamine was
dissolved in 10mM Tris/HCl buffer (15 nmol/mL, pH 8.5)
and reduced in the presence of 20mM tributylphosphine for
15min at room temperature under nitrogen (see Scheme 1).
The product was purified by RP-HPLC as previously
described and verified by ESI-MS/MS. Then, 100mL of
dansyl-cysteamine solution (0.1mg/mL, dissolved in ACN/
Water 3:1) were added to an equal volume of the b-
eliminated peptide mixture solution (1 nmol/mL, in deio-
nized water) in the presence of 1mM tributylphosphine. Tris
(2M) was added to the sample at a final concentration of
100mM (pH 11). The reaction proceeded under nitrogen
for 18 h at 508C.
MALDI-TOFMS
MALDI-TOF mass spectra were recorded using a Voyager
DE-PRO mass spectrometer (Applied Biosystems, Framing-
ham, MA, USA). The peptide mixtures were first purified
using ZipTip pipettes from Millipore (Billerica, MA, USA)
using the manufacturer’s recommended purification pro-
cedure. The peptides were eluted using 20mL of 50% ACN,
0.1% TFA in water. A mixture of the eluted peptide solution
and a-cyanohydroxycinnamic acid (10mg/mL in ACN/
0.1% TFA in water, 2:1, v/v) was applied to the metal sample
plate and dried at room temperature. Mass calibration was
performed using a mixture of peptides from Applied
Biosystems, containing des-Arg1-bradykinin, angiotensin I,
Glu1-fibrinopeptide B, ACTH (1–17), ACTH (18–39) and
insulin (bovine). Raw data were analyzed using Data
Explorer software provided by Applied Biosystems and
reported as monoisotopic masses.teamine synthesis.
Rapid Commun. Mass Spectrom. 2006; 20: 1400–1404
DOI: 10.1002/rcm
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The peptide mixture was analyzed by LC/MS using a
4000Q-Trap (Applied Biosystems) equippedwith a linear ion
trap coupled to an 1100 nano-HPLC system (Agilent
Technologies). The mixture was loaded on an Agilent
reversed-phase pre-column cartridge (Zorbax 300 SB-C18,
5 0.3mm, 5mm) at 10mL/min (solvent A: 0.1% formic acid,
loading time 7min). The peptides were separated on a
Agilent reversed-phase column (Zorbax 300 SB-C18,
150mm 75mm, 3.5mm), at a flow rate of 0.2mL/min with
a 5 to 65% linear gradient in 60min (solvent A: 0.1% formic
acid, 2%ACN inwater; solvent B: 0.1% formic acid, 2%water
in ACN). A micro-ionspray source was used at 2.4 kV with
liquid coupling, with a declustering potential of 50V, using
an uncoated silica tip (o.d. 150mm, i.d. 20mm, tip diameter
10mm) from New Objectives (Ringoes, NJ, USA). Spectra
acquisition was based on a survey precursor ion scan for
m/z 170. The Q1 quadrupole was scanned from m/z 500–
1000 in 2 s, and the precursor ions were fragmented in
q2 using a linear gradient of collision potential from 30 to
70V. Finally, Q3 was set to transmit only ions at m/z 170.
This scan mode was followed by an enhanced resolution
experiment (ER) for the ions of interest and then by MS3
and MS2 acquisitions of the two most abundant ions. MS2
spectra were acquired using the best collision energy
calculated on the bases of m/z values and charge state
(rolling collision energy). MS3 spectra were acquired
using Q0 trapping, with a trapping time of 150ms and
an activation time of 100ms, scanning fromm/z 160–240. The
Q0 trapping facility is able to increase the sensitivity of
the scan in the different ion trap scan types used. Data were
acquired and processed using Analyst software (Applied
Biosystems).RESULTS AND DISCUSSION
In an attempt to improve and simplify the plethora ofmethods
so far suggested11 we have set up a new approach to label
selectively phospho-Ser/-Thr residues by exploiting the
features of a novel linear ion trap mass spectrometer.12
Dansyl chloride is known to react with the e-amino group of
lysine as well as with the N-terminal amino group.10 Here,
using chemical manipulations coupled with dansyl chloride
labelling, we show a methodology capable of large-scale
proteomic profiling of phosphorylation sites. The method is
based on (a) the selective modification of pSer/Thr residues
with a novel dansyl derivative of cysteamine, prepared as
reported in the Experimental section and shown in Scheme 1,
and (b) the selective detection and identification of labelled
peptides by exploiting the characteristic fragmentation
pathway of dansyl derivatives.
We first applied this approach to a-casein as a model
phosphoprotein. The phosphate moieties from a tryptic a-
casein digest were removed from pSer and pThr by barium
hydroxide ion-mediated b-elimination as already reported.11
The peptide mixture was then analyzed by MALDI-MS,
using the Voyager DE-PRO mass spectrometer.
The MALDI mass spectra showed ions corresponding to
the b-eliminated peptides. As an example, the ion at m/z
1854.3 was assigned to the peptide 104–119 of a-caseinCopyright # 2006 John Wiley & Sons, Ltd.occurring 98 Th lower than expected, indicating that
the pSer115 was converted into dehydroalanyl after the
b-elimination reaction (Fig. 1). The a,b-unsaturated
residues are Michael acceptors, which can readily react
with a nucleophile. The b-eliminated peptide mixture was
modified with dansyl-cysteamine via Michael-type
addition.
The yield of the addition reaction was monitored by
MALDI-MS, and indicated that the extent of the reaction was
good but not complete, as expected for a typical Michael
reaction addition (see Ref. 11, and references cited therein).
MALDI-MS analysis performed on the peptide mixture
revealed two ions at m/z 1873.5 and 2163.9 assigned to the b-
eliminated fragments 106–119 and 104–119, modified by a
dansyl moiety (Dm¼ 310Da).
In a proof-of-principle experiment, to investigate the
feasibility of applying the method to proteomics analysis, a
tryptic digest from ten standard proteins (50mg of a
mixture in equimolar amounts of myoglobin, bovine
serum albumin, ovalbumin, carbonic anhydrase, RNase
A, lysozyme, glutathione S-transferase, insulin, enolase,
transferrin) was spiked with 5mg of an a-casein tryptic
mixture modified with dansyl-cysteamine. Then 1 pmol of
the peptide mixture was analyzed by LC/MS using the
4000Q-Trap coupled to the 1100 nano-HPLC system. We
set up an experiment combining a precursor ion scan with
an MS3 linear ion trap scan. In the precursor ion scan
mode, Q1 is scanned across the full mass range, and
ions are fragmented in the collision cell. Q3 is set to
transmit only the mass of the diagnostic product ion
(m/z 170). Therefore, only those precursor ions that pass
through Q1 that fragment to produce m/z 170 are detected.
The selected precursor ions are then submitted to a
combined MS2 and MS3 experiment to specifically detect
only those ions that produce the transition m/z 234! 170 in
the MS3 scan mode leading to the selective detection of
the dansylpeptides. Figure 2(A) shows a typical recon-
structed ion chromatogram for the transition m/z 234! 170
in MS3 mode. As indicated in the figure, only two ions
were detected. Corresponding MS2 spectra led to the
reconstruction of the entire sequences of the b-eliminated
phosphopeptides 104–119 and 106–119 carrying a
dansyl-cysteamine moiety. As an example, the MS/MS
spectrum of the modified peptide 104–119 is reported
in Fig. 2(B). The modified ion is stable during collision-
induced dissociation, providing easily interpretable
product ion spectra. In fact, the y and b product ions still
retain the modifying group linked to the b-eliminated Ser
residue, thus allowing the exact localization of the
phosphorylation site. However, this approach seems to
be amenable only for monophosphorylated peptides
since we were unable to detect the diphosphorylated
and pentaphosphorylated a-casein tryptic peptides. The
detection of multiphosphorylated peptides is a difficult
challenge and, among the proposed derivatization pro-
cedures, to the best of our knowledge, only the modifi-
cation strategy that we have proposed based on the use
of dithiothreitol11 has resulted in the confident
mass spectrometric analysis of multiphosphorylated
peptides.Rapid Commun. Mass Spectrom. 2006; 20: 1400–1404
DOI: 10.1002/rcm
Figure 1. (a) Partial MALDI mass spectrum of the trypsin digest of a-casein. (b) Partial MALDI mass
spectrum of the b-eliminated peptide mixture. The ions related to the phosphorylated peptides are shifted by
98Th due to the b-elimination reaction. (c) Partial MALDI mass spectrum of the b-eliminated peptide mixture
after dansyl-cysteamine addition. The ions corresponding to the b-eliminated peptides show a mass
increment of 310Da.
Phosphorylation sites by MS3 fragmentation 1403CONCLUSIONS
It is well known that ion trap tandem mass spectrometry
offers high sensitivity because of the ability to accumulate
precursor ions. Furthermore, the introduction of a linear ion
trap with greatly increased capture efficiency and storage
capacity has resulted in new inputs in the proteomics field.
Use of dansyl chloride as marker leads to (a) the dansylCopyright # 2006 John Wiley & Sons, Ltd.moiety introducing a strong basic group in peptides thus
giving enhanced ionization; (b) easy detection of dansyl
peptides in the precursor ion scan mode; and (c) selective
detection of dansyl peptides in the MS3 mode (via the
transitionm/z 234! 170) even in a complex peptide mixture.
The proposed strategy, using a linear ion trap to select
specific labelled peptides giving rise to diagnostic MS3
product ions, was useful in phosphoprotein analysis. ThisRapid Commun. Mass Spectrom. 2006; 20: 1400–1404
DOI: 10.1002/rcm
Figure 2. (A) Reconstructed ion chromatogram of the tryptic digest for the selective transitionm/z 234! 170 in
MS3 mode. (B) MS/MS spectrum of the a-casein modified peptide 104–119. The product ions belonging to the
b and y series are indicated.
1404 A. Amoresano et al.approach will be of interest in phosphoproteome (and O-
glycome) studies and it has been successfully exploited to
selectively detect phospho-Ser/-Thr-containing peptides.
The introduction of MS3 analysis actually replaces an off-
line chromatographic step (affinity chromatography) aimed
at isolating the labelled peptides (see Ref. 11, and references
cited therein) with the obvious advantages of avoiding time-
consuming analysis and increasing sensitivity.
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In a previous characterization of the ABCA subfamily
of the ATP-binding cassette (ABC) transporters, we
identified potential protein kinase 2 (CK2) phosphoryl-
ation sites, which are conserved in eukaryotic and pro-
karyotic members of the ABCA transporters (Peelman,
F., Labeur, C., Vanloo, B., Roosbeek, S., Devaud, C.,
Duverger, N., Denefle, P., Rosier, M., Vandekerckhove,
J., and Rosseneu, M. (2003) J. Mol. Biol. 325, 259–274).
These phosphorylation residues are located in the con-
served cytoplamic R1 and R2 domains, downstream of
the nucleotide binding domains NBD1 and NBD2. To
study the possible regulation of the ABCA1 transporter
by CK2, we expressed the recombinant cytoplasmic do-
mains of ABCA1, NBD1R1 and NBD2R2. We demon-
strated that in vitro ABCA1 NBD1R1, and not
NBD2R2, is phosphorylated by CK2, and we identified
Thr-1242, Thr-1243, and Ser-1255 as the phosphorylated
residues in the R1 domain by mass spectrometry. We
further investigated the functional significance of the
threonine and serine phosphorylation sites in NBD1 by
site-directed mutagenesis of the entire ABCA1 followed
by transfection into Hek-293 Tet-Off cells. The ABCA1
flippase activity, apolipoprotein AI and AII binding, and
cellular phospholipid and cholesterol efflux were en-
hanced by mutations preventing CK2 phosphorylation
of the threonine and serine residues. This was con-
firmed by the effect of specific protein kinase CK2 in-
hibitors upon the activity of wild type and mutant
ABCA1 in transfected Hek-293 Tet-Off cells. The activi-
ties of the mutants mimicking threonine phosphoryla-
tion were close to that of wild type ABCA1. Our data,
therefore, suggest that besides protein kinase A and C,
protein kinase CK2 might play an important role in vivo
in regulating the function and transport activity of
ABCA1 and possibly of other members of the ABCA
subfamily.
The role of the ABCA11 transporter, a member of the sub-
family A of the ATP binding cassette transporters, in the efflux
of cellular phospholipids and cholesterol has become well es-
tablished (2). Several studies link ABCA1 mutations to im-
paired cellular cholesterol and phospholipid efflux characteris-
tic of Tangier disease and high density lipoprotein-deficiency
patients (3–5). Expression of WT and mutant ABCA1 in cul-
tured cells demonstrated the correlation between the level of
expression and activity of the ABCA1 transporter, the extent of
binding to the apolipoprotein AI (apoAI) acceptor and the efflux
of cellular lipid (6).
Human ABC transporters consist of a cytoplasmic nucleotide
binding domain (NBD), which binds and hydrolyzes ATP, and
of a membrane-spanning domain through which the substrate
is translocated (7–8). Besides these elements, regulatory do-
mains with putative phosphorylation sites were described in
several human transporters (7). We carried out an extensive
analysis of the subfamily A of the ABC transporters and
showed that this subfamily consists of 13 human ABCA and of
many eukaryotic and prokaryotic ABCA homologues (1). Mul-
tiple alignments of the subfamily A transporters demonstrated
the high degree of sequence conservation and the particular
topology of this subfamily. In the ABCA subfamily, the intra-
cellular N-terminal residues are followed by a first transmem-
brane helix, by a long extracellular loop, and by a downstream
cluster of five transmembrane helices separated by short loops.
The transmembrane domain is followed by a cytoplasmic nu-
cleotide binding domain NBD1 and by a downstream sequence
of 80 conserved residues. In the full ABCA transporters, which
have a high internal symmetry, these elements are repeated in
the second half of the transporter (1). Among the human trans-
porters of the ABCA subfamily, mutations in ABCA1 have been
linked to Tangier disease, whereas mutations in ABCA2 impair
the transport of retinyldiene and cause retinal degeneration
(9). In both transporters, mutations in the nucleotide bind-
ing domains decrease the ATPase activity and thereby impair
the transport activity of the mutants. Point mutations in the
ABCA1 and ABCA2 extracellular loops probably affect
the three-dimensional structure of the transporters and de-
crease their association with acceptor proteins required for
substrate export (10).
The 80-residue segments downstream of the NBDs are con-
served in the eukaryotic ABCAs and in the prokaryotic sub-
family 7 precursors (1). In ABCA1 none of the natural muta-
tions causing either Tangier disease or familial hypo--
* The costs of publication of this article were defrayed in part by the
payment of page charges. This article must therefore be hereby marked
“advertisement” in accordance with 18 U.S.C. Section 1734 solely to
indicate this fact.
§ To whom correspondence should be addressed: University of Ghent,
Department Biochemistry, Hospitaalstraat 13, B-9000 Ghent, Belgium.
Tel.: 32-9-264-92-73; Fax: 32-9-264-94-96; E-mail: stein.roosbeek@
UGent.be.
1 The abbreviations used are: WT, wild type; ABCA1, ATP binding
cassette A1; MALDI, matrix-assisted laser desorption ionization time;
NBD, nucleotide binding domain; PKA and PKC, protein kinase A and
C, respectively; CK2, protein kinase 2; Hek, human embryonic kidney;
PS, phosphatidylserine; PE, phosphatidylethanolamine; GFP, green
fluorescent protein; DMEM, Dulbecco’s modified Eagle’s medium; FBS,
fetal bovine serum; PBS, phosphate-buffered saline.
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lipoproteinemia occur in these sequences, although one of the
Tangier mutations is located close to this domain (11). The
functional significance of the conserved sequences downstream
of the NBDs is still unknown; they might have a regulatory
function, as proposed for other transporters (12). Phosphoryl-
ation by protein kinase A or C has been demonstrated for
several ABC transporters, including cystic fibrosis transmem-
brane conductance regulator (13), P-glycoprotein (14), and re-
cently ABCA1 (15–17). According to See et al. (15) serines 1042
and 2054 in NBD are phosphorylated by PKA in vitro and may
potentially regulate ABCA1 function (15). Yamauchi et al. (16)
report that apoAI activates PKC, resulting in phosphorylation
and stabilization of ABCA1 (16). According to Martinez et al.
(17), the potential phosphorylation sites for protein kinase 2
(CK2) and PKA in the ABCA1-PEST sequence, threonine 1286
and 1305, respectively, are constitutively phosphorylated and
protect ABCA1 against calpain-mediated degradation. PKA
and CK2 inhibitors did not, however, alter phosphorylation of
these residues.
Among the kinases, protein kinase 2 or CK2 is a constitu-
tively active Ser/Thr protein kinase essential for cell viability
(18). CK2 can target at least 200 proteins (19) and is implicated
in a wide variety of cellular functions such as tRNA and rRNA
synthesis, apoptosis. and cell survival and transformation (20).
The CK2 phosphoacceptor sites consist of clusters of acidic
residues located mostly downstream from phosphorylatable
seryl or threonyl residues. Prediction of consensus sequence
motives in human ABCA1 using PROSITE identified 39 poten-
tial CK2 phosphorylation sites in ABCA1. Among these, the
1242TTLEE and 2211TTLDQ motives within the 80-residue R1
and R2 domains, downstream of, respectively, NBD1 and
NBD2, were conserved in most members of the human ABCA
subfamily (1). Another potential CK2 phosphorylation site,
1255SGVD, is conserved in ABCA4, ABCA6–10, and ABCA12
but is absent in all NBD2s. Thus, it is conceivable that modu-
lation of the ABCA1 transport activity might occur through
serine or threonine phosphorylation by protein kinase CK2.
In this report we demonstrate that in vitro the NBD1R1
and not the NBD2R2 domain of ABCA1 is phosphorylated by
CK2, and we used mass spectrometric methods to directly
identify Thr-1242, Thr-1243, and Ser-1255 as the phosphoryl-
ated residues. We further investigated the functional signifi-
cance of these CK2 phosphorylation sites in NBD1R1 by
site-directed mutagenesis of ABCA1. The ABCA1 flippase ac-
tivity, the transporter ability to bind apolipoproteins AI and
AII and to induce cellular phospholipid and cholesterol efflux,
were enhanced by mutations preventing phosphorylation at
that site. The specific CK2 inhibitors 4,5,6,7-tetrabromobenzo-
triazole and apigenin also enhanced the activity of ABCA1
transfected into Hek-293 Tet-Off cells, thus confirming the
effect of the mutations. Our data, therefore, suggest that be-
sides PKA and PKC, protein kinase CK2 might play an impor-
tant role in vivo in regulating the function and transport ac-
tivity of ABCA1 and possibly other members of the ABCA
subfamily.
EXPERIMENTAL PROCEDURES
Materials—Tosylphenylalanyl chloromethyl ketone-treated trypsin,
barium hydroxide, and -cyano-4-hydroxycinnamic acid were from
Sigma. Other mass spectrometry reagents and solvents were of highest
purity from Carlo Erba (Milan, Italy). NBD-labeled cholesterol, phos-
phatidylserine (PS), phosphatidylethanolamine (PE), and phosphati-
dylcholine were purchased from Aventi Polar Lipids (Alabaster). Rho-
damine hydrochloride and concanavalin A Alexa Fluor 633 were
obtained from Molecular Probes (Leiden, The Netherlands). Doxycy-
cline was purchased from Sigma. [methyl-3H]Choline and [7-3H]choles-
terol were purchased from Amersham Biosciences. Hek-293 Tet-Off
cells were purchased from Clontech (Erembodegem, Belgium). Recom-
binant apoAI was expressed in Escherichia coli (21), and plasma apoAII
was prepared by ultracentrifugal isolation of high density lipoprotein,
delipidation, and purification by DEAE chromatography as previously
described (22). The CK2 inhibitor 4,5,6,7-tetrabromobenzotriazole was
a gift of Dr. Shugar (Poland), Apigenin in Me2SO was purchased from
Sigma.
Construction of the Expression Vectors—For expression of the His-
NBD1R1 domain between residues 861 and 1306 and of His-
NBD2R2 between residues 1877 and 2232, vectors were constructed
using the pET28a plasmid (Novagen, Madison, WI). DNA fragments
encoding the protein sequences were PCR-amplified and cloned into the
pET28a vector, and mutant plasmids were made by overlapping PCR.
WT and mutant plasmids were checked by sequencing and by restric-
tion analysis.
A bidirectional pBI-ABCA1/GFP vector encoding a hemagglutinin-
tagged ABCA1/GFP fusion protein (23) was used to generate eight
constructs encoding the threonine and serine ABCA1 mutants. The
SplI/SplI fragment (nucleotides 3626–4535) was inserted into the SplI
site of a pMCS5 vector (Molecular Biologische Technologie). Mutagen-
esis was performed by standard PCR, and mutated SplI fragments were
transferred back into the SplI-digested pBI-ABCA1/GFP vector. All
constructs were verified by restriction analysis and sequencing.
Expression and Purification of Soluble Recombinant His-NBD1R1
and His-NBD2R2 in E. coli—The length of the NBD1R1 and
NBD2R2 constructs were selected to obtain soluble recombinant pro-
teins and to avoid expression in the E. coli inclusion bodies (24). Pro-
teins were expressed in transformed BL21(DE3)pLysS E. coli grown in
LB medium (Invitrogen) under isopropyl-1-thio--D-galactopyranoside
induction. Cells were centrifuged at 9000  g for 10 min, washed with
PBS, resuspended in 10 ml of lysis buffer (50 mM Tris-HCl, pH 7.6, 300
mM NaCl, 1 mM phenylmethylsulfonyl fluoride, 2 g/ml leupeptin, 2
g/ml aprotinin), and sonicated on ice 3  5 min at 60 watts.
Both His-NBD1R1 and His-NBD2R2 were purified by affinity
chromatography on a Ni-PROBOND™ column. The column was equil-
ibrated in a 50 mM Tris-HCl, pH 7.6, buffer containing 300 mM NaCl, 1
mM -mercaptoethanol, 5% glycerol (v:v), 10 mM imidazole and incu-
bated overnight at 4 °C with the cell lysate. Stepwise elution with 100
mM imidazole eliminated E. coli protein contaminants, whereas the
His-NBDR proteins eluted at 500 mM imidazole. The eluate was
desalted on a HiTrap-Sepharose column and stored either at 4 °C or
80 °C. Sample purity was checked by 12% SDS-PAGE.
In Vitro Phosphorylation Assays—Recombinant CK2 and its - and
-subunits were expressed in Sf9 cells and purified to homogeneity (25).
For electrophoretic experiments, 2 or 8 g of recombinant NBD1R1,
NBD2R2, or mutants were incubated at 22 °C with either [-32P]ATP
or 10 M ATP and 10 mM MgCl2 in the presence of 0.3 g of oligomeric
CK2 or 1.0 g of CK2. The phosphorylated proteins were analyzed by
SDS gel electrophoresis and autoradiography after 15 min. For mass
spectrometric analysis, recombinant NBDR proteins were incubated
with CK2 for 30 min at 30 °C in the presence of 0.2 mM ATP. The
reaction was terminated by 5 min of boiling and drying the samples.
Mass Spectrometric Analysis of the Phosphopeptides—Purified
NBDR proteins before and after treatment with CK2 were subjected
to reduction with an excess of dithiothreitol, alkylation using iodoacet-
amide, and digestion with trypsin. To obtain the corresponding alkene
moiety from the phosphate esters, the -elimination reaction was opti-
mized and simplified by incubating the peptide mixture in 5 M Ba(OH)2
at 37 °C for 90 min under nitrogen. Solid carbonic dioxide was then
added to eliminate the precipitated barium carbonate, which was re-
moved by centrifugation at 13,000  g for 5 min (26).
MALDI mass spectra were recorded using a Applied Biosystem Voy-
ager DE-PRO instrument operating in reflector mode. A mixture of the
analyte and of -cyanohydroxycinnamic acid (10 mg/ml) in acetonitrile,
ethyl alcohol, 0.1% trifluoroacetic acid (1:1:1, v/v/v) was applied to the
metal sample plate and dried under vacuum. Mass calibration was
performed with insulin at 5734.5 Da and a matrix peak at 379.3 Da as
internal standards. Raw data were analyzed by using computer soft-
ware provided by the manufacturer and reported as average masses.
Cell Cultures—Hek-293 Tet-off cells were cultured in DMEM media
plus 10% fetal bovine serum (FBS), L-glutamine, and Geneticin on
12-well plates coated with poly-D-lysine. Cells were transfected for 24 h
with the GFP-ABCA1 constructs using a mixture of polyethyleneimine
and DNA at a 2/1 polyethyleneimine/DNA charge ratio and subse-
quently grown for 24 h. Cells were washed twice with phosphate-
buffered saline (PBS) and incubated for 1 min with 500 l of trypsin
(Invitrogen). After the addition of 1 ml of PBS, 1% FBS and 0.5 mM EDTA,
cells were filtered and kept on ice for flow cytometry. The percentage of
transfected cells was determined by fluorescence-activated cell sorter
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analysis on a FACScalibur (BD Biosciences) with an excitation wave-
length of 488 nm and an emission wavelength of 530 nm.
Measurement of the ABCA1 Flippase Activity—Mock- and ABCA1-
transfected Hek-293 Tet-Off cells were incubated at 37 °C for 45 min
with 5 M NBD lipid, washed with PBS at 4 °C, and incubated with 64
M sodium dithionite in a Tris-HCl buffer, pH 10, for 5 min at 4 °C. The
fluorescence intensity of the NBD probe before (Imax) and after (Iq) dithio-
nite quenching was measured on a Bio-Tek FLX 800 microplate reader
with excitation and emission wavelengths of 485 and 528 nm, respec-
tively. Percent quenching was calculated as (Imax  Iq)/(Imax)  100.
Similar measurements were performed in the presence of 50 M
4,5,6,7-tetrabromobenzotriazole and apigenin CK2 inhibitors on Mock-
transfected and Hek-293 cells transfected with WT ABCA1 and with the
T1242A, T1243A, T1242A/T1243A, and T1242D/T1243D ABCA1
mutants.
Monitoring of ApoAI and -AII Binding to Hek-293 Tet-Off Cells—
After transfection with WT ABCA1, cells were washed twice with a 10
mM HEPES buffer, pH 7.4, containing 1.8 mM CaCl2, 1 mM MgCl2, 5 mM
KCl, 150 mM NaCl and incubated with carboxyrhodamine-labeled re-
combinant apoAI or -AII at concentrations between 0 and 50 g/ml for
1 h at 4 °C to monitor extent of binding. In subsequent experiments
cells transfected with WT and mutant ABCA1 were incubated with 20
g/ml apoAI or -AII for 1 h at 4 °C. Cells were detached by mild
trypsinization for 2 min at 37 °C using 0.05 g/liter trypsin in PBS and
kept on ice, and flow cytometric recordings were performed. Cells were
subdivided into three populations as a function of their level of ABCAI
expression, reflected by the GFP fluorescence intensity. Apoprotein
binding data were calculated for each cell population based upon the
mean carboxyrhodamine fluorescence intensity (27).
Phospholipid and Cholesterol Efflux to ApoAI and ApoAII Induced by
ABCA1—Phospholipid and cholesterol efflux were measured using both
radioactivity and fluorescence. For radioactive measurements, Hek-293
Tet-Off cells transfected with WT and mutant ABCA1 were washed
twice with DMEM and incubated either with 1 Ci/ml [methyl-3H]cho-
line or [3H]cholesterol in DMEM plus 2.5% FBS. After 24 h cells were
washed twice with DMEM and incubated with 1 ml of DMEM plus 0.2%
bovine serum albumin for 16 h at 37 °C. Cells were washed twice with
DMEM and incubated at 37 °C with 20 g/ml recombinant apoAI for 4 h
FIG. 1. Topology of the N-terminal half of an ABCA full-transporter. Six transmembrane helices are followed by the cytoplasmic NBD and
the conserved regulatory R domain. The C-terminal half has an identical topology. The alignment of the R1 and R2 domains showing conservation
of the potential CK2 phosphorylation sites at residues Thr-1242, Thr-1243 and Ser-1255 are shown for several species of ABCA1.
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for [methyl-3H]choline efflux or 6 h for [3H]cholesterol efflux. Superna-
tant was collected and centrifuged for 10 min at 810  g. 500 l of
supernatant was transferred into 5 ml of scintillation liquid (Optiphase
Hisafe 3). Cells were washed with PBS and lysed with 1 ml of NaOH
(0.1 N). 500 l of cell suspension was transferred into 5 ml of scintilla-
tion liquid (Optiphase Hisafe 3). 3H counts per minute (cpm) were
measured in a liquid scintillation counter (Wallac 1409), and % lipid
efflux was calculated as (cpm in supernatant/(cpm in supernatant 
cpm in cells))  100. For measurements using fluorescence, Hek-293
Tet-Off cells transfected with WT and mutant ABC-A1 were labeled
with either 5 M NBD phospholipid or 2.5 M NBD cholesterol for 45
min at 4 °C. Cells were washed 3 times with 1 ml of PBS and incubated
with 500 l of DMEM containing either 20 g/ml recombinant apoAI or
40 g/ml apoAII. Efflux was measured either after 4 h of incubation at
37 °C for NBD phospholipids or after 6 h for NBD cholesterol by meas-
uring NBD fluorescence intensity. Percentage efflux was calculated as
((Icontrol  IapoAI)/Icontrol)  100.
Confocal Microscopy—Cellular localization of the expressed ABCA1
WT and mutants was analyzed by confocal microscopy using GFP
fluorescence at excitation and emission wavelengths of, respectively,
488 and 509 nm. Hek-293 Tet-Off cells were plated on poly-D-lysine-
coated Lab-Tek® German borosilicate confocal microscope slides at a
density of 2.5  104 cells/chamber in 400 l in DMEM plus 10% FBS,
transfected, grown for 48 h in DMEM plus 10% FBS and washed twice
with PBS. Cells were incubated with 25 g/ml concanavalin A Alexa
fluor 633, an endoplasmic reticulum-specific fluorescence dye, for 30
min. Cells were washed with PBS, and the Alexa fluor 633 fluorescence
was measured using the excitation and emission wavelengths of, re-
spectively, 632 and 647 nm.
ABCA1 Half-life Measurement—To determine the half-life of WT and
mutant ABCA1, the transporter flippase activity was measured as a
function of time in transfected Hek-293 Tet-Off cells, which were
treated with 100 ng/ml doxycycline to stop transcription of the ABCA1
constructs (28, 29). The ABCA1 flippase activity for phosphatidyleth-
anolamine was measured as described above using NBD PE after 0, 30,
60, 90, and 120 min. The half-life was estimated from half the total
activity decay (28).
RESULTS
Identification of Protein Kinase CK2 Phosphorylation Sites
on ABCA1—Fig. 1 shows a schematic diagram of the N-termi-
nal half of ABCA1, consisting of a membrane-spanning domain
made of six helices followed by the cytoplasmic NBD and the
regulatory R domain. The C-terminal half of ABCA1 has an
identical topology (1). Among the 39 potential CK2 phosphoryl-
ation sites predicted by PROSITE in ABCA1, we focused upon
those located in NBD1, NBD2, and in the conserved down-
stream R1 and R2 domains (1). Eight potential CK2 sites are
predicted within the cytoplasmic NBD1R1 domain between
residues 861 and 1306. One site at 989TVEE is in NBD1,
whereas three sites at 1242TTLE, 1243TLEE, and 1255SGVD are
located in the R1 domain. By comparison, seven CK2 sites are
predicted between the C-terminal residues 1877–2232, four of
which are in NBD2 and two, 2211TTLD and 2225SDDD, are in
the R2 domain. We examined the conservation of the human
ABCA1 Thr-1242, Thr-1243, and Ser-1255 residues in ABCA
sequences of other species (Fig. 1). As previously reported for
other transporters of the ABCA family (1), the threonine
residues are better conserved in the N-terminal R1 compared
with the R2 domain, whereas Ser-1255 is conserved only in
mammalian ABCA.
To investigate the in vitro phosphorylation properties of the
ABCA1 cytoplasmic domains, we expressed the NBDR do-
mains in E. coli and used the purified recombinant proteins as
substrates for protein kinase CK2 assays in vitro using both
the CK2 holoenzyme or its isolated  catalytic subunit. Fig. 2
shows that only ABCA1 NBD1R1 and not NBD2R2 is phos-
phorylated in vitro by CK2. Interestingly, only the CK2 holoen-
zyme but not its -subunit was able to phosphorylate the
NBD1R1 substrate, indicating that the presence of the CK2
regulatory subunit is required for efficient phosphorylation.
As the 1242TTLE, 1243TLEE, and 1255SGVD are the best
conserved potential CK2 phosphorylation sites in NBD1, we
carried out site-directed mutagenesis at these positions both in
the recombinant NBD1R1 protein and in the entire ABCA1
construct. In both systems we engineered several mutants de-
signed at preventing phosphorylation by mutation either of the
target threonines and serine, T1242A, T1243A, T1242A/
T1243A, S1255A, or of the downstream cluster of acidic resi-
dues, E1245Q, E1246Q, E1245Q/E1246Q. Mutants were also
designed to mimic phosphorylated residues as T1242D,
T1243D, T1242D/T1243D.
All NBD1R1 mutants were expressed as soluble proteins in
E. coli and purified at yields comparable with WT NBD1R1
(24). Using recombinant CK2, phosphorylation of the Thr-Ala
mutants was not completely abolished, suggesting the presence
of multiple CK2 phosphorylation sites within this domain (data
not shown).
This was confirmed by MALDI mass spectrometric analysis
of the native and phosphorylated recombinant NBDR pro-
teins (Table I). The phosphopeptides were identified by their
mass differences due to the presence of phosphate moieties
compared with the peptide masses expected from the protein
sequence. In agreement with the phosphorylation assays, we
observed no phosphorylation of NBD2R2; in WT NBD1R1
we observed that the signal at m/z 4542.5 corresponds to the
ABCA1 peptide 1229–1269, carrying three phosphate groups
at Thr-1242, Thr-1243, and Ser-1255. The peptide mixture was
then submitted to the -elimination reaction followed by
MALDI mass spectrometric analysis. Under strong alkaline
conditions elimination of the phosphate moiety on Ser(P) and
Thr(P) to form dehydroalanine (Ser) or dehydroalanine-2-
butyric acid (Thr) yields new signals corresponding to the
-eliminated peptides. The signal at m/z 4249.5 was assigned
to the 1229–1269 ABCA1 peptide, occurring 299 Da lower, thus
confirming phosphorylation at the three positions. Analysis of
the T1242A, T1243A, and T1242A/T1243A NBD1 mutants sup-
ports the loss of either one or two threonine phosphorylation
sites in the mutated peptides, whereas the Ser-1255 site is
preserved. Analysis of the S1255A mutant demonstrates the
loss of one phosphorylation site in the Val-1251—Arg-1272
tryptic peptide (Table I). These data confirm that besides Thr-
1242 and Thr-1243, Ser-1255 is another CK2 phosphorylation
site in ABCA1. None of the predicted CK2 phosphorylation
sites in the NBD1 (residues 866–995) or between NBD1 and
the R1 domain was phosphorylated.
ABCA1 Activity Increases Linearly with Protein Expression—
Hek-293 Tet-Off cells were transfected with varying amounts
FIG. 2. In vitro phosphorylation of recombinant NBD1R1
(residues 861–1306) and NBD2R2 (residues 1877–2232) pro-
teins by the CK2 holoenzyme (22) and by its  catalytic sub-
unit. Either 1 or 4 g recombinant NBDR were incubated with 0.3 g
of CK222 or 1.0 g of CK2 and P
32-labeled ATP. Phosphorylated
proteins were detected by autoradiography.
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of ABCA1-GFP DNA, between 1 and 10 g. Extent of transfec-
tion was estimated as the product of the GFP fluorescence
intensity and the number of transfected cells, both measured
by fluorescence-activated cell sorter analysis (23). As a result of
an increased flippase activity, the percentage of NBD PE in the
plasma membrane outer leaflet increased linearly between 20
and 58% for a 5-fold increase of WT ABCA1 transfection (Fig.
3A). Parallel data were obtained for both apoAI binding to
transfected cells (Fig. 3B) and phospholipid efflux (Fig. 3C).
This linear relationship between ABCA1 expression and activ-
ity was used to normalize the activity of ABCA1 mutants com-
pared with WT ABCA1.
Mutation of the CK2 Phosphorylation Sites Increases ABCA1
Flippase Activity—To assess the effect of CK2 phosphorylation
on the ABCA1 flippase activity we measured phospholipid flip-
flop by WT ABCA1 and the mutants. Incubation of ABCA1-
transfected Hek-293 Tet-Off cells with NBD phospholipids at
37 °C and subsequent quenching of the fluorescence with so-
dium dithionite at 4 °C yielded the percentage of labeled phos-
pholipid in the outer leaflet of the plasma membrane. In mock-
transfected cells there was around 30 and 25% NBD PE and
NBD PS, respectively, in the plasma membrane outer leaflet.
After transfection with 3 g of ABCA1-GFP DNA, these per-
centages increased to 38 and 35%, indicative of phospholipid
flip-flop by ABCA1.
Compared with WT ABCA1, set as 100%, the PE and PS
content in the outer leaflet of the plasma membrane increased
up to 130  14 and 123  8% for the T1242A mutant, 154  15
and 148  11% for the T1243A mutant, 170  15 and 207 
16% for the T1242A/T1243A mutant, 141  11 and 136  10%
for the S1255A mutant, and 141  13 and 120  9% for the
E1245Q/E1246Q mutant, respectively (Fig. 4). All measure-
ments were performed in triplicate, and the differences were
significant at p  0.01 using a Student t test. In contrast, when
the threonine residues were mutated to aspartic acid to mimic
a phosphorylated residue, the phospholipid content in the
membrane outer leaflet decreased compared with that of the
Thr-Ala mutants and came closer to that of WT ABCA1 (Fig. 4).
The effect of the specific CK2 inhibitors 4,5,6,7-tetrabromo-
benzotriazole and apigenin on the flippase activity in Hek-293
Tet-Off cells transfected with WT ABCA1 and with the
T1242A, T1243A, T1242A/T1243A, S1255A, and T1242D/
T1243D mutants was consistent with the above data. Incuba-
tion with 50 M either 4,5,6,7-tetrabromobenzotriazole or api-
genin increased the flippase activity of WT ABCA1 by 30  2.6
and 25  3.4% (n  3, p  0.001), respectively, whereas the
flippase activity increased only by around 5  0.7% (n  3, p 
0.01) in cells transfected with ABCA1 mutants.
Mutations of the 1242TTLEE and 1255SGVD CK2 Phosphoryl-
ation Sites Modulate the Binding of ApoAI and ApoAII to
ABCA1—We compared the binding of carboxyrhodamine-la-
beled apoAI and apoAII to the Hek-293 Tet-Off cells trans-
fected with WT and ABCA1 phosphorylation mutants by flow
cytometric analysis (27). We analyzed apolipoprotein binding to
three cell populations, with low, middle, and high levels of
transfection, estimated from the GFP fluorescence, with cut-
offs at 7 and 20 for population 1 (ABCA1), 21 and 90
for population 2 (ABCA1), and 91 for population 3
(ABCA1) (27). Subtraction of the carboxyrhodamine fluo-
rescence intensity of Mock-transfected cells yielded saturation
curves, with a plateau above 10 g/ml for apoAI/Rho and
apoAII/Rho binding to WT ABCA1 (Fig. 5). Apparent binding
constants to the three cell populations were 7, 30, and 24 
108 M for apoAI binding compared with 4, 16, and 17  108
M for apoAII binding. These values are comparable with those
measured for apoAI/Cy5 binding to WT ABCA1 (27).
The carboxyrhodamine fluorescence intensity due to specific
binding of 20 g/ml apoAI or apoAII to cells transfected with
ABCA1 mutants was expressed relative to WT ABCA1 (Fig. 6).
ApoAI- and apoAII-specific binding to the cells transfected with
the single threonine and serine ABCA1 mutants increased
FIG. 3. Relationship between WT ABCA1 activity and the ex-
tent of WT ABCA1 transfection into Hek-293 Tet-Off cells. A,
percentage of NBD PE quenching by sodium dithionite as a measure of
the NBD PE flip-flop from the membrane inner to outer leaflet. B,
specific binding of apoAI to ABCA1-transfected cells. A.U., absorbance
units. C, NBD PE efflux to apoAI.
TABLE I
Mass spectrometric analysis of NBD1R1 phosphorylation
NBD1R1 Tryptic peptide Molecular mass Molecular mass after-elimination Phosphorylated residues
Da Da
WT Leu-1229–Arg-1269 4542.5 4249.5 Thr-1242, Thr-1243, Ser-1255
T1242A Leu-1229–Lys-1250 2483.6 2385.9 Thr-1243
T1242A Val-1251–Arg-1272 2411.6 2313.7 Ser-1255
T1243A Leu-1229–Lys-1250 2483.1 2385.2 Thr-1242
T1243A Val-1251–Arg-1272 2411.2 2313.2 Ser-1255
T1242A/T1243A Leu-1229–Lys-1250 2356.1 2356.1
T1242A/T1243A Val-1251–Arg-1272 2411.6 2313.7 Ser-1255
S1255A Val-1251–Arg-1272 2297.7 2297.7
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compared with WT ABCA1. This increase was more pro-
nounced for the T1243A mutation either alone or in combina-
tion with the T1242A mutation, whereas the effect of the
T1242A and S1255A mutants was similar. The E1245Q/
E1246Q mutation of the downstream acidic residues, which
also impairs CK2 activity, similarly increased cellular apoAI
and apoAII binding. The T1242D, T1243D, T1242D/T1243D
mutations, which mimic CK2 phosphorylation, had an opposite
effect to the Thr-Ala mutations, as apoprotein binding to cells
transfected with these mutants amounted to around 110% of
WT ABCA1.
Mutation of the CK2 Phosphorylation Sites in ABCA1 Mod-
ulates Phospholipid and Cholesterol Efflux to ApoAI and
ApoAII—Phospholipid and cholesterol efflux to apoAI and
apoAII together with phospholipid distribution across the
plasma membrane were measured for Hek-293 Tet-Off cells
transfected with WT ABCA1 and with the phosphorylation
mutants. Data were normalized to account for differences in
expression levels between WT ABCA1 and mutants. ABCA1
lipid efflux was measured using both radioactive-labeled and
fluorescent-labeled lipids, yielding comparable data. Only the
results for NBD-labeled lipids are given in Fig. 7, A and B.
Incubation of the transfected Hek-293 Tet-Off cells, labeled
with NBD phospholipids or NBD cholesterol with either unla-
beled apoAI or apoAII decreased the NBD lipid fluorescence
intensity due to the efflux of labeled lipids to the unlabeled
apoprotein acceptors. The saturation curves for the percentage
of phospholipid efflux were similar to the apoprotein binding
curves and reached a plateau around 20 g/ml apoAI or apoAII.
The percentages of NBD-labeled phosphatidylethanolamine
and cholesterol efflux to apoAI induced by WT ABCA1 were
around 7 and 4%, respectively. Using radioactive-labeled PE
and cholesterol, efflux percentages were, respectively, 8.5 and
4.7%, comparable with those measured using fluorescence. PE
and PS efflux to apoAI and apoAII (Fig. 7A) and cholesterol
efflux to apoAI (Fig. 7B) were expressed relative to WT ABCA1
for all mutants after normalization. The T1242A and T1243A
mutations either alone or in combination and the E1245Q/
E1246Q mutation, which all decrease CK2 activity, increased
phospholipid and cholesterol efflux (Fig. 7, A and B). The effect
FIG. 4. NBD phospholipid quench-
ing in the plasma membrane of Hek-
293 Tet-Off cells transfected with WT
and mutant ABCA1. Quenching by the
ABCA1 mutants is expressed relative to
WT ABCA1 after normalization. , NBD
PS; f, NBD PE.
FIG. 5. Fluorescence intensity of
carboxyrhodamine-labeled-apoAI ()
and -apoAII (f) bound to Hek-293 Tet-
Off cells transfected with WT ABCA1
as a function of the apoprotein con-
centration. Binding was calculated for
three cellular populations transfected at a
high (ABCA1; ABCA1-GFP fluores-
cence91), intermediary (ABCA1; 91
ABCA1-GFP fluorescence 21), and low
level (ABCA1; 21  ABCA1-GFP fluores-
cence 7) A.U., absorbance units.
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of the S1255A mutant on lipid efflux was comparable with the
single threonine mutants. The T1242D, T1243D, and T1242/
T1243D mutations had an opposite effect as the efflux induced
by that mutant was close to WT ABCA1. These effects parallel
those observed for apoprotein binding to the mutant-trans-
fected cells (Fig. 6).
Cellular Localization of the ABCA1 WT and Mutants—Using
confocal microscopy, we observed the same cellular localization
of WT and mutant ABCA1, which were mainly found at the
plasma membrane of transfected Hek-293 Tet-Off cells. Incu-
bation of the ABCA1-transfected cells with the endoplasmic
reticulum-specific fluorescence dye concanavalin A Alexa fluor
633 showed that only a small percentage of ABCA1 WT and
mutants is localized in the endoplasmic reticulum (Fig. 8).
These results indicate that mutations of the CK2 phosphoryl-
ation sites have little effect upon the cellular trafficking of the
ABCA1 transporter.
ABCA1 WT and Mutants Have Similar Half-lives—The de-
crease of ABCA1 flippase activity as a function of time was
used to estimate the transporter half-life. In agreement with
previous reports, we observed a short half-life of 	40 min for
WT ABCA1 (30). All mutants had similar half-lives compared
with wild type ABCA1, varying between 35 and 50 min (data
not shown), indicating that mutations of the CK2 phosphoryl-
ation sites do not significantly affect the ABCA1 turnover.
DISCUSSION
In this paper we showed that besides PKA (15) and PKC
(16–17), protein kinase CK2 is an important kinase to regulate
ABCA1 activity. We further demonstrated that phosphoryla-
tion occurs at conserved threonine and serine residues in the
R1 domain, downstream of NBD1. CK2-specific phosphoryla-
tion in the R1 domain affects the major functions of the ABCA1
transporter, including phospholipid flip-flop, ABCA1 binding to
apoAI and apoAII, and cellular phospholipid and cholesterol
efflux, in a coordinated manner. Mutations aimed at suppress-
ing the phosphorylation sites increase these activities, whereas
the activity of mutants mimicking phosphorylation of the thre-
onine residues is close to that of WT ABCA1. Cellular treat-
ment with specific CK2 inhibitors further supports these data.
Using recombinant WT and mutant NBD1R1 proteins, we
further showed that they are in vitro substrates for CK2. Com-
bined mutation of either the two threonines or the downstream
acidic residues in the recombinant NBD1R1 domain did not
completely suppress protein phosphorylation. This is in agree-
ment with the mass spectrometric identification of the CK2 phos-
phorylation sites in NBD1R1, identifying residue Ser-1255
besides Thr-1242 and Thr-1243 as a putative ABCA1 phospho-
rylation site. This was then confirmed by the engineering of the
S1255A mutant, whose activities are comparable with those of
the T1242A mutant. Threonines 1242 and 1243 had been iden-
tified as some of the best conserved residues belonging to poten-
tial CK2 phosphorylation sites in cytoplasmic ABCA1 domains.
These residues are conserved in most of the human and mam-
malian ABCA transporters and in several other species and even
in family 7 bacterial transporters (1). The serine 1255 residue is
not as highly conserved as the threonines among the different
ABCA1 species or within the ABCA family. However, because
serine is often the preferred substrate of CK2 (20), it might
constitute a primary phosphorylation site in ABCA1, in analogy
with the data obtained for PTEN phosphatidylinositol 3
-
phosphatase (31). The alignment of the R1 and R2 domains
shows the correspondence between the consensus CK2 phospho-
rylation sequence around residue Thr-1242 in R1 and residue
Thr-2211 in R2. Threonine 2212 in NBD2 does not belong to a
CK2 consensus sequence, whereas Ser-1255 in R1 has no coun-
terpart in R2. As shown both by autoradiography and mass
spectrometry, CK2 phosphorylation seems restricted to the N-
terminal R1 domain of ABCA1. Because mutations of the CK2
phosphorylation sites and treatment with specific CK2 inhibitor
both increase the ABCA1 flippase and cellular efflux activities as
well as apoprotein binding, CK2 phosphorylation of the ABCA1
R1 domain might contribute to the in vivo regulation of ABCA1
functionality.
Although there is a high degree of sequence homology be-
tween the N- and C-terminal cytoplasmic domains of ABCA1,
several reports suggest that NBD1 and NBD2 might have
specific functions. There are differences between the NBDs
ATPase activity, as we measured a 3-fold higher activity for
recombinant ABCA1 NBD1 compared with NBD2 (24). Folding
and association of the two NBD domains are not identical
(32–33), and several reports suggest that NBD1 and NBD2
share a common interface in ABC full transporters (32–33).
The activation cycle of the ABCA transporters consists of ATP
binding and hydrolysis, ADP dissociation accompanied by con-
FIG. 6. Carboxyrhodamine-labeled-
apoAI (f) and -apoAII () binding to
Hek-293 Tet-Off cells transfected
with WT and mutant ABCA1. The apo-
protein binding to mutant transfected
cells is expressed relative to WT ABCA1
after normalization.
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formational changes in the NBD domains, and finally, of sub-
strate transport across the membrane. This process is not
random but is probably initiated through ATP binding to the
nucleotide binding domain with highest affinity (34). It is quite
conceivable that phosphorylation of the R1 domain by CK2
could bring a conformational change to this domain and conse-
quently to NBD1 to start the activation cycle.
The recent x-ray structure of the vitamin B12 transporter
BtuCD (33) suggests that the two NBD domains interact with
each other in an anti-parallel way and that these interactions
are stabilized by interactions between the NBD downstream
domains. The NBD downstream domains in the maltose trans-
porter correspond to the conserved R1 and R2 domains identi-
fied in the ABCA subfamily. Interactions between R1 and R2 in
the ABCA subfamily might enhance the cooperativity between
the N- and C-terminal half of the ABCA transporters and, thus,
contribute to a fine regulation of the transporter activity. These
interactions are likely to be dependent upon the phosphoryla-
tion state of the protein domain. Serine and threonine phos-
phorylation by a cytoplasmic CK2 kinase might, thus, repre-
sent another mechanism for the intracellular regulation of the
transporter activity.
Protein kinase CK2 is a constitutively active kinase that is
implicated in a variety of cellular functions including cell pro-
liferation, differentiation, and survival (19). Our experiments
showed that the regulatory  subunit of CK2 is required to
achieve optimal phosphorylation of the ABCA1 substrate.
Thus, this transporter belongs to the class I of the CK2 sub-
strates whose phosphorylation is strictly dependent upon the
presence of the CK2 subunit (35). On the other hand, we
observed an increased functionality of the protein when its
phosphorylation is abrogated, suggesting that CK2 acts as a
down-regulator of ABCA1 function. A similar function of CK2
was previously described for Engrailed 2 secretion (36).
Regulation of ABCA1 might occur in different ways; phos-
phorylation might change the expression or cellular location of
FIG. 7. A, NBD phospholipid efflux to
apoAI and apoAII after incubation of
transfected Hek-293 Tet-Off cells with 20
g/ml apoAI or apoAII for 6 h at 37 °C.
Efflux by ABCA1 mutants is expressed
relative to WT ABCA1 after normali-
zation. Open squares, NBD PS efflux
to apoAI; gray squares, NBD PE efflux to
apoAI; filled squares NBD PE efflux to
apoAII. B, NBD cholesterol efflux
to apoAI (filled squares) after incubation
of the transfected cells with 20 g/ml
apoAI for 6 h at 37 °C. Efflux by ABCA1
mutants is expressed relative to WT
ABCA1 after normalization.
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ABCA1. This is, however, not likely as 1) our confocal micro-
scopic data showed similar locations at the plasma membrane,
and 2) the expression of the Thr-Ala and Ser-Ala mutants was
lower than of WT ABCA1. We also showed that ATP binding
and ATPase activity are not affected by the threonine to ala-
nine or by the glutamic acid to glutamine mutations (23). The
Trp exposure and the secondary structure of the various mu-
tants of the NBD1R1 domain were quite similar. The struc-
tural changes due to phosphorylation are, therefore, probably
minimal, and a likely effect of CK2 phosphorylation is, there-
fore, the modulation of the cooperativity between NBD1 and
NBD2 in native ABCA1.
The activities of several ABC transporters are regulated by
their phosphorylation, as demonstrated for the cystic fibrosis
transmembrane regulator, which is phosphorylated both by
PKA and PKC (13). Phosphorylation of the P-glycoprotein by
PKA and PKC seems to modulate swelling-activated Cl cur-
rents (14), not drug transport (37). PKA activation by cAMP
analogues increased ABCA1 phosphorylation and cellular cho-
lesterol efflux (15). Mutation of a PKA phosphorylation site in
ABCA1 impaired apoAI-mediated release of cellular lipid (15).
According to Yamauchi et al. (16) ABCA1 phosphorylation is,
furthermore, critical for the stability and integrity of the trans-
porter (16). PKC is activated by apoAI, and it subsequently
phosphorylates and stabilizes ABCA1. According to Martinez
et al. (17), a PEST sequence in ABCA1 is critical for apoAI
protection against ABCA1 degradation by calpain. This se-
quence includes the casein kinase CK2 and PKA potential
phosphorylation sites Thr-1286 and Thr-1305, respectively.
These authors found little effect of the casein kinase inhibi-
tors on ABCA1 phosphorylation, in contrast with our find-
ings, and concluded that CK2 probably does not phosphoryl-
ate the Thr-1286 residue in the PEST sequence. Although
this residue belongs to a potential CK2 phosphorylation site
in ABCA1, it is localized in a low conservation sequence in
the ABCA family and might not become phosphorylated, in
contrast to the conserved Thr-1242, Thr-1243, and Ser-1255
residues tested in our study. Furthermore, we measured the
effect of the CK2 inhibitors on the specific ABCA1 activity,
whereas Martinez et al. (17) investigated the extent of total
ABCA1 phosphorylation by autoradiography. Besides PKA
and PKC, which increase ABCA1 activity, CK2 might play an
opposite role and act as a down-regulator of ABCA1 in the
cell.
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Mapping Phosphorylation Sites Using  Isotopically-Labelled Dithiothreitol and MS
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Mapping phosphorylation sites: a new strategy based
on the use of isotopically-labelled dithiothreitol and
mass spectrometry
Angela Amoresano and Gennaro Marino*
Department of Organic Chemistry and Biochemistry, Federico II University of Naples, Naples, Italy and School of Biotechnological Sciences,
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Phosphoproteomics, nowadays, represents a front line in functional proteomics as testified by the number of papers recently appear-
ing in the literature. In an attempt to improve and simplify the methods so far suggested we have set up a simple isotope-coded
approach to label and quantitate phospho-Ser/-Thr residues in protein mixtures. First of all, after appropriate oxidation of
cysteine/cystine residues followed by tryptic hydrolysis, we have optimised and simplified the -elimination reaction to get the corre-
sponding alkene moiety from the phosphate esters. This was achieved by (a) separating the elimination reaction from the addition
reaction, (b) the use of Ba(OH)2 as alkali reagent and (c) its further elimination by the simple addition of solid CO2 to the peptide
mixture. The Michael reaction was then performed, after the removal of BaCO3 by centrifugation, by adding dithiothreitol (DTT) to
the peptide mixture. Finally, the direct purification of the modified phosphopeptides was performed on a thiol-sepharose column.
The availability of fully deuterated DTT, introducing a 6 Da difference with respect to the non-deuterated species, allows
quantitation of the differential extent of signalling modification when analysed by matrix-assisted laser desorption/ionisation mass
spectrometry (MALDI-MS) and liquid chromatography/mass spectrometry. The entire procedure has been set up by using bovine-
casein, and resulted in the identification of all the phosphorylated tryptic peptides, including the tetraphosphorylated peptides, which
escaped all previously reported procedures.
Keywords: -casein, phosphoproteome, ICAT, mass spectrometry
Introduction
In the living cell, many processes are governed not only
by the relative abundance of proteins but also by rapid and
transient regulation of the activity, association and localiza-
tion of proteins and protein complexes. Dynamic post-
translational modification is a general mechanism for main-
taining and regulating protein structure and function. One of
the most important protein modifications that highly influ-
ences protein activity and propagates signals within cellular
pathways is phosphorylation.1 Protein phosphorylation is
recognized as the most important action in the regulation of
cell functions. Although regulation can occur at the level of
protein synthesis along with concomitant changes in the
extent of phosphorylation, there are also examples of regula-
tion of protein function by phosphorylation without altering
protein abundance. Therefore, the precise characterization
of the subset of proteins in the proteome that becomes modi-
fied in vivo by phosphorylation (phosphoproteome) as well
A. Amoresano et al., Eur J. Mass Spectrom. 10, 401–412 (2004) 401
DOI: 10.1255/ejms.599 ISSN 1356-1049 © IM Publications 2004
*Corresponding author: Professor Gennaro Marino, Dipartimento di
Chimica Organica e Biochimica, Complesso Universitario Monte Sant’
Angelo, Via Cinthia 6, I-80126 Napoli, Italy. E-mail:
gmarino@unina.it.
as the localization and quantitation of the phosphorylation
sites are essential to fully understand how proteins are acti-
vated or inhibited within the signal-transduction pathway,
thus allowing speculations to be made about the set of kin-
ases and phosphatases involved.2–6
Unfortunately, information on the protein phosphory-
lation cannot be deduced from gene sequences. Techniques
to identify the phosphorylation site by 32P-labelling coupled
with Edman sequence analysis are generally thought to be
difficult and not always precise. Phosphoamino acid anti-
bodies have been exploited recently but their use has actu-
ally been restricted to tailor-made immunological applica-
tions.7–10 Another approach involves the use of immobilized
metal–ion affinity chromatography (IMAC) to selectively
retain and enrich phosphopeptides from mixtures.11-13 How-
ever, non-phosphorylated peptides also can be isolated
through non-specific interaction thus complicating subse-
quent analyses.
Mass spectrometry is widely employed nowadays as a
key tool in the analysis of protein phosphorylation14–21 since
the pioneering work of Pucci and co-workers.22 Recent
advances in proteomics procedures and technologies have
led to high-throughput protein identification in a complex
protein mixture. New methods that involve modifying phos-
phoproteins with affinity tags, in combination with stable
isotope incorporation,23–27 have been developed for the spe-
cific enrichment and quantitation of phosphopeptides. Gygi
and co-workers have recently reported28 an approach for
quantitative differential analysis that employs isotope-coded
affinity tags (ICAT). This method involves the affinity-iso-
lation of cysteine-containing peptides by modifying proteins
with a Cys-specific reagent that contains a linker arm con-
necting a thiol group to a biotin moiety. The ICAT reagent is
used in both “light” and “heavy” forms: eight hydrogen
atoms in the linker arm have been substituted by eight deute-
rium atoms in the heavy version of the reagent.
Derivatization of two distinct proteomes with the two ver-
sions of the ICAT reagent provides a basis for protein
quantitation.
In this paper, we describe an improved approach, based
on simple chemical manipulations and mass spectrometric
procedures (see Scheme 1), for the selective analysis of
phosphoserine and phosphothreonine in protein mixtures
following conversion of the peptide phosphate moiety into
dithiothreitol (DTT) derivatives. The new residues in the
sequence were shown to be stable and easily identifiable
under the general conditions for tandem mass spectrometry
sequencing, applicable to the precise localization of the
exact site of phosphorylation. The suitability of the method
with stable-isotope coding is also demonstrated.
While this work was in progress, a paper by Wells29
described an almost identical approach for selective labeling
of O-glycosylation sites. However, the major aim of the
present work is devoted to the use of isotopically-labelled
DTT, thus allowing a simple and direct quantitative analysis
by mass spectrometry.
Results and discussion
This paper reports a novel approach to phosphoprotein
mapping, based on site-specific modification of phospho-
seryl/phosphothreonyl residues. The validity of its applica-
bility for the identification of the phosphorylation sites in
peptides was tested using a matrix-assisted laser/desorption
ionization (MALDI) tandem time-of-flight mass spectrome-
ter (ToF/ToF-MS). Here, we have shown that an alternative
conversion of the P-Ser and P-Thr residues into compounds,
which are stable during collision-induced dissociation
(CID), provides easily interpretable product-ion spectra.
To test our procedure under realistic but controlled con-
ditions, we carried out the reactions by using phosphorylated
bovine -casein, a normal protein utilized in these stud-
ies.24,25,28 The protein samples after separation on sodium
dodecyl phosphate (SDS) polyacrylamide gel were reduced,
alkylated and digested in situ with trypsin (see Materials and
Methods section). The peptide mixtures were then directly
analysed by MALDI-MS (Table 1). The phosphopeptides
were identified by their 80 Da mass difference compared
with the peptides expected from the non-phosphorylated
sequence. As an example, the signal at m/z 1951.9 in Figure
1 was assigned to the peptide 104–119 within the -casein
sequence, but carrying a phosphate group. The peptide mix-
ture was submitted to the strategy described above (see
Scheme 1) and each step was monitored via MALDI-MS.
Reaction conditions were optimized for both the -elimina-
tion and DTT-addition reactions.
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Scheme 1.
-Elimination reaction
Under strongly alkaline conditions, the phosphate
moiety on P-Ser and P-Thr undergoes -elimination to form
dehydroalanine (Ser) or dehydro-2-aminobutyric acid
(Thr), respectively. In the case of O-glycosylated peptides,
the corresponding glycopeptides have to be separated by a
simple lectin-affinity chromatography step. The ,-
unsatured residues are potent Michael acceptors, which can
readily react with a nucleophile.30,31
In the present study, the phosphate moieties were
removed via barium hydroxide ion-mediated -elimination
from P-Ser and P-Thr. The barium hydroxide was used in
place of the previously reported NaOH32,33 taking in account
the higher purity of this reagent and its higher reactivity
towards the P-Thr residues. To facilitate removal of excess
reagent, we simply made use of solid carbon dioxide. The
use of this reagent permitted the removal of barium carbon-
ate as a pellet on the bottom of a vial after centrifugation. It is
worth noting that when the pellet of barium carbonate was
dissolved and analysed by MALDI-MS, no peptide was
detected in the mass spectrum, thus indicating the absence of
any sort of non-specific precipitation. On the contrary, the
mass spectral analysis carried out on the supernatant showed
the occurrence of a series of signals corresponding to the -
eliminated peptides. As an example, the signal at m/z 1854.3
was assigned to the peptide 104–119 of -casein since it
occurs 98 Da lower than the mass recorded for the
phosphorylated peptide, thus indicating that P-Ser115 was
converted to dehydroalanyl by the -elimination reaction
(Figure 2).
DTT as a bifunctional reagent
The -eliminated peptide mixture was submitted to a
Michael-type addition by using dithiothreitol (DTT) and
following the procedure described.30 The rationale behind
the choice of this reagent is due to its higher solubility and
reactivity compared with the already proposed 1,2-ethane-
dithiol (EDT).31–33 In fact, EDT has limited solubility in aque-
ous medium, thereby requiring sample clean-up prior to
liquid chromatography (LC)/MS analysis since the conver-
sion is carried out in the presence of a substantial amount of
organic solvent.34 The addition reaction results in the cre-
ation of a free thiol group in place of what was formerly a
phosphate moiety. The extent of reaction was monitored
using MALDI-MS and indicated that the yield from the
addition reaction of a DTT-modified peptide was about 70%
(Figure 3), as expected for a typical Michael reaction addi-
tion.30 A comparison made using EDT showed that, even in
the presence of a very large reagent excess, yields were not
higher than 30% (data not shown). However, the direct mass
spectral analysis of a complete peptide mixture suffered
from suppression phenomena leading to the non-appearence
of signals due to most of the phosphorylated peptides.
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Experimental MH+ Theoretical MW Peptide Note
3026.3 3025.4 166–193
2316.31 2315.13 133–151
1952.3 1950.94 104–119 1P
1759.7 1758.93 8–22
1660.5 1659.8 106–119 1P
1384.5 1383.73 23–34
1337.7 1336.6 80–90
1267.5 1266.69 91–100
946.3 945.5 35–42
910.5 909.46 125–132
875.6 874.55 1–7
831.3 830.37 84–90
748.5 747.3 194–199
615.38 614.32 120–124
Note reports the number of phosphate groups (P) added to the peptides
Table 1. MALDI-MS analysis of the peptide mixture of bovine alpha-casein digested with trypsin.
Affinity capture of thiolated peptides
Specific enrichment of thiolated peptides is easily
achieved using a Sepharose thiopyridyl resin. MALDI-MS
analysis performed on the peptides, eluted from the affinity
purification step, now reveals major ion signals at m/z
1716.9, 2008.3, 2039.1 and 3001.2. These values were
assigned to the -eliminated fragments 106–119, 104–119,
43–58 and 59–79 modified by 1, 1, 2 and 5 DTT adducts,
respectively, as indicated in Figure 4. It is worth noting that
the described procedure resulted in the identification of all
the phosphorylated tryptic peptides, including the
pentaphosphorylated peptide that has so far escaped detec-
tion in different attempts.24,25,28 The data are summarized in
Table 2.
Tandem mass spectrometry (MS/MS) analysis
Sequence information can be obtained either by
MALDI-ToF in the post-source decay (PSD) mode or by
MALDI-ToF/ToF. The precise localization of the phos-
phorylation sites in the peptides was achieved by MS/MS
sequencing. The conversion of P-Ser and P-Thr into DTT-
tagged residues provides compounds that are stable under
high-energy collision in the MALDI-ToF/ToF instrument.
In fact, the tandem mass spectral analyses by MALDI-
ToF/ToF performed on the precursor ion at m/z 2008.5 (Fig-
ure 5) from the tryptic mixture of -casein after labelling
with DTT revealed the presence of diagnostic fragment ions.
The derivatized product ions were identified from either the
corresponding b- or y-fragment ion series. The MS/MS
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Figure 1. MALDI-MS analysis of the trypsin peptide mixture from -casein. The insets report the amplification of the region of the
spectrum showing the phosphorylated peptides.
spectrum revealed the complete series of N-terminal frag-
ment ions (b1–b15) plus the C-terminal ions (y1–y16) for
the modified phosphopeptide with a DTT-labelled phospho-
serine residue. The fragment ions y4 and y5, in fact, show a
mass difference of 223 Da corresponding to a -eliminated
serine residue, labelled with DTT, thus confirming the
phosphorylation site as Ser115.
Differential isotope-coded analysis
To address the problem of quantification,28,35,36 having
created a thiol group at the phosphoserine/phosphothreonine
site, it is possible to follow, basically, the strategy outlined
by Gygi et al.28 However, because of the availability of fully-
deuterated DTT, we exploited a much simpler isotope-tag-
ging strategy. The peptides were quantified by measuring, in
the mixture, the relative signal intensities for pairs of peptide
ions of identical sequence differentially labelled with light
or heavy DTT. The mass difference between the light and
heavy DTT reagent molecules (6 Da) reliably provides a
good separation between the molecular ions. As an example,
the mass signals recorded in the MALDI spectrum, at m/z
2008.5 and 2014.5, were attributed to the DTT-labelled pep-
tide 104–119, modified with the light DTT and heavy DTT
forms, respectively. Pairs of peptides tagged with the light
DTT and heavy DTT reagents, respectively, are chemically
identical and, therefore, serve as ideal mutual internal stan-
dards for quantitation. The ratio between the intensities of
the lower and upper mass components of these peaks pro-
vides an accurate measurement of the relative abundance of
each peptide and, hence, of the related proteins in the origi-
nal cell pool because the relative intensity in the mass spec-
trum of a given peptide is independent of the isotopic
composition of the defined, isotopically-tagged reagent.
To further illustrate the ability of this labelling strategy
in quantifying the relative phosphorylation of a peptide from
two different samples, DTT and DTT-D6 were used to label
samples containing stoichiometric concentrations of -
casein in ratios of 1 : 1, 2 : 1 and 4 : 1. The peptide mixtures
were analysed by MALDI-MS operating in reflectron mode.
The spectra were obtained by acquiring about 2000 shots per
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Figure 2. MALDI-MS analysis of trypsin peptide mixture from -casein following the -elimination reaction. The boxes report ampli-
fications of the region of the spectrum showing the -eliminated peptides. The arrows indicate the disappearance of the
phosphorylated peptides and the occurrence of the new -eliminated signals occurring at minus 98 Da.
spectrum in order to produce a “stable” peak. In our experi-
ence, this is the typical number of shots giving an even distri-
bution of shots on the entire well surface, thus allowing a
confident averaging independently of the peptide content of
the single crystals. As shown for the DTT peptide 104–109
(Figure 6), the ratios were automatically integrated for each
mass spectrum, resulting in excellent agreement with the
concentration used in the labelling experiment (Table 3). An
aliquot of the same peptide mixture was submitted to a more
rigorous quantitative analysis via LC/MS (Figure 7), as
reported in Table 4, demnnstrating the correctness of the
previous MALDI-MS data.
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Figure 3. MALDI-MS analysis of the trypsin peptide mixture from the protein after DTT labelling reaction. Insets: enlarged region of
the spectrum showing the -eliminated and DTT-labelled peptides.
Experimental MH+ Theoretical MW Peptide Note
3001.2 2999.9 59–79 5 DTT
2039.1 2038.68 43–58 2 DTT
2008.3 2006.94 104–119 1 DTT
1716.9 1715.8 106–119 1 DTT
Note reports the number of dithiothreitol (DTT) groups added to the peptides
Table 2. MALDI-MS analysis of the purified DTT-labelled peptides of the tryptic digest of -casein.
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Figure 5. Tandem mass spectrometry identification of -casein phosphopeptide. The Ser residue containing the DTT label is identi-
fied by the loss of m/z 223.4 between the y4- and y5-ions of the modified peptide.
Figure 4. MALDI-MS analysis of DTT-labelled peptides following purification step. Each signal is attributed to the corresponding
modified peptide according to Table 2.
Conclusions
This paper reports a simple integrated methodology,
which involves chemical replacement of the phosphate
moitties by affinity tags. This method for locating and
quantitating phosphorylated residues should provide results
of interest in signalling pathways and control mechanism
studies involving phosphorylation or dephosphorylation of
serine/threonine residues. Work is presently in progress on
samples of different origin (bacterial, yeast, human) to
validate this simple methodology set up on real examples.
It is worth considering that such a quantitative approach
can be extended to the labelling of O-glycosylation sites. In
fact, the O-glycopeptides retained on a lectin-affinity
column can be eluted and submitted to the procedure
described by Wells and co-workers.29 The quantitative
analysis can be performed by using light and heavy forms of
DTT to selectively label the modified sites, thus leading to a
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Figure 6. Stoichiometric conversion of the phosphorylated states using DTT-D0/D6 labelling via MALDI-MS. Partial MALDI-MS spec-
tra of the modified peptide 104–119. Samples of -casein containing ratios of 1 : 1, 2 : 1 and 4 : 1 were labelled with DTT-D0/DTT-
D6, combined, and isolated using the DTT strategy reported in Scheme 1 and directly analysed via MALDI-MS.
quantitative description of O-glycosylation related to
different cell growth conditions.
Materials and methods
Materials and reagents
TPCK-treated trypsin, dithiothreitol, barium hydroxide
and -cyano-4-hydroxycinnamic acid were from Sigma–
Aldrich (St Louis, MO, USA). Deuterated dithiothreitol was
purchased from CEA (Saclay, France). Sepharose
thiopyridyl resin was from Pierce Biotechnology (Rockford,
IL, USA). All other reagents and solvents were of the high-
est purity available from Carlo Erba (Milan, Italy).
In-situ digestion
Proteins were fractionated by SDS-electrophoresis on
12.5% polyacrylamide gels under reducing conditions.
The analysis was performed on the Comassie blue-
stained proteins excised from gels. The excised spots were
A. Amoresano et al., Eur J. Mass Spectrom. 10, 401–412 (2004) 409
Expected ratio DTT (D0-labelled) peak area DTT (D6-labelled) peak area Observed ratio
1 : 1 29168.1 24306.7 1.2 : 1
2 : 1 34318.05 18779.51 1.8 : 1
4 : 1 142907.11 36411.46 3.9 : 1
Table 3. Quantitative analysis by MALDI-MS.
Expected ratio DTT (D0) labelled peak area DTT (D6) labelled peak area Observed ratio
1 : 1 382829 396550 0.96 : 1
2 : 1 1312411 578038 2.27 : 1
4 : 1 2134041 505166 4.22 : 1
Table 4. Quantitative analysis by LC/ESI-MS
washed first with acetonitrile (ACN) and then with 0.1 M
ammonium bicarbonate. Protein samples were reduced by
incubation in 10 mM dithiothreitol (DTT) for 45 min at
56°C. The cysteines were alkylated by incubation in 5 mM
iodoacetamide for 15 min at room temperature in the dark.
The gel particles were then washed with ammonium bicar-
bonate and ACN.
Enzymatic digestion was carried out with trypsin
(12.5 ng L–1) in 50 mM ammonium bicarbonate pH 8.5 at
4°C for 4 h. The buffer solution was then removed and a new
aliquot of the enzyme/buffer solution was added for 18 h at
37°C. A minimum reaction volume, enough for the complete
rehydratation of the gel was used. Peptides were extracted
by washing the gel particles with 20 mM ammonium bicar-
bonate and 0.1% trifluoroacetic acid (TFA) in 50% ACN at
room temperature and then lyophilized.
Phosphate group modification
-Elimination reactions were carried out by incubating
the peptide mixture in 55 M Ba(OH)2, at 37°C, for 90 min
under nitrogen. Solid carbon dioxide was then added. The
precipitated barium carbonate was then removed by
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Figure 7. Stoichiometric conversion of the phosphorylated states using DTT-D0/D6 labelling and electrospray (ES)MS. The LC/ESMS
spectrum shows the doubly-charged ion of the modified peptide 104–119. Samples of -casein containing ratios of 1 : 1, 2 : 1 and
4 : 1 were labelled with DTT-D0:DTT-D6, combined, and isolated using the DTT strategy reported Scheme 1 and analysed via
LC/ESMS.
centrifugation at 13,000 g for 5 min. Then DTT, in the light
and heavy (fully-deuterated) form, 30% w/v in 10 mM
Hepes buffer (pH 7.5), was added during 3 h, at 50°C under
nitrogen.
Isolation and enrichment of tagged peptides
After the addition reaction, the peptide mixtures were
treated with activated thiol sepharose resin directly in batch.
The resin was first washed in water (× 2) and then with
0.1 M Tris-HCl binding buffer, (pH 7.5). The peptide
mixture was added to the resin and washed with the binding
buffer. The modified peptides were then extracted using
20 mM DTT in 10 mM Tris-HCl elution buffer (pH 7.5).
Mass spectrometric analyses
MALDI mass spectra were recorded using an Applied
Biosystem Voyager DE-PRO instrument operated in the
reflectron mode. A mixture of analyte solution and -cyano-
hydroxycinnamic acid [10 mg mL–1 in acetonitrile + ethyl
alcohol + 0.1% trifluoroacetic acid (1 : 1 : 1, v / v/ v)] was
applied to the metallic sample plate and dried under vacuum.
Mass calibration was performed with insulin at m/z 5734.5
and a matrix peak at m/z 379.3 as internal standards. Raw
data were analysed by using computer software provided by
the manufacturers and reported as average masses. MS/MS
spectra were recorded using an Applied Biosystem 4700
Proteomics Analyzer mass spectrometer operating in reflec-
tron mode.
Peptide mixtures were analysed by LC-MS on a single-
quadrupole ZQ electrospray instrument (Waters
Micromass) coupled to an HPLC (2690 Alliance purchased
by Waters) on a Phenomenex 30 mm × 0.46 mm i.d.
reversed-phase column. Peptides from the mixture were
eluted at a flow rate of 1 mL min–1 with a 10–95%
acetonitrile-water gradient over 60 min. Data were acquired
and processed by centroiding an isotopic distribution using
the Mass-Lynx program (Micromass).
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